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Abstract 
Introduction: A pathologist doing a pediatric autopsy will commonly assess child’s 
development by comparing the postmortem data to standardized population parameters 
using body and organ measurement charts. Although a number of resources are available, 
many are outdated and have significant limitations. 
Objectives: To create Ontario population-specific organ and body measurement mean 
charts for infants and to explore relationships between body measurements/organ weights 
and cause of death, age, and gender of the deceased. 
Methods: A database of 900 cases of infant and neonatal deaths that were investigated by 
Ontario coroners from 2000 to 2010 was retrospectively analyzed. 
Results and Conclusions: No differences were found between the cause of death 
groups in relation to the body weight, heart, and pancreas weights. Lungs, brains, livers 
and spleens tended to be heavier in SIDS and SUDS cases compared to Control group 
while adrenal glands and kidneys had a tendency of being smaller. 
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Chapter 1  
1 Introduction   
1.1 Current Tendencies in Infant Mortality 
Infant mortality rate is defined as the rate at which the children of less than 1 year of age 
die.  It is a significant indicator of the well-being of a society because it strongly 
correlates with the socioeconomic development of a country.   
According to the World Health Organization, in 2015 there were 5.9 million pediatric 
deaths under the age of 5 years worldwide1. Of these, 75% occurred in the first year of 
life. A child's risk of dying is highest during the neonatal period, i.e. within the first 28 
days of a child’s life (45% of deaths under the age of 5)2. The highest incidence of these 
deaths occurs in low- and middle-income countries because of a lack of access to 
affordable health care. In low-income countries, the mortality under the age of 5 is about 
14 times higher than in developed regions2. 
The government of Canada monitors and documents the data on infant deaths. The infant 
and neonatal death rate for Canada in 2015 was 4.9 per 1000 live births and for Ontario – 
5.0 per 1000 live births. This translates to approximately 300 infant deaths per year in 
Canada,  200 of which are reported in Ontario3. Although Canada has significantly 
reduced its infant mortality rate over the last few decades, the rate continues to be 
relatively high for its level of socioeconomic development, ranking second-to-last among 
17 peer countries4. This could be attributed to the advances in management of high-risk 
deliveries, increased rate of successful deliveries of preterm/low birth weight infants, and 
improved fertility therapies, which increase the number of multiple births. All of these 
factors could be contributing to relatively high infant mortality in Canada. In addition, the 
registration of live births and stillbirths is not standard amongst the peer countries, 
allowing for the exclusion of low birth weight infants which are at higher risk of 
mortality, therefore leading to underreporting of infant deaths4. 
According to Statistics Canada, in 2009, ten leading causes of infant mortality included: 
congenital malformations and chromosomal abnormalities (22.4%); preterm gestation 
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and low birth weight (13.4%); sequelae of maternal complications of pregnancy (9.8 %); 
deaths related to placental complications (6.5%); Sudden Infant Death Syndrome (SIDS) 
(6.1%); intrauterine hypoxia and birth asphyxia (3.2%); neonatal hemorrhages (2.7%); 
bacterial sepsis of newborn (2.2%); complications of labour and delivery (1.8%); and 
accidental and unintentional injuries (1.6%)5.  
A great number of early childhood deaths are preventable through low-cost practical 
interventions addressing maternal health and effective antenatal and early childhood 
care2. Thorough investigation of pediatric deaths is a major component in the prevention 
of future fatalities. This has been documented by an increased awareness that Sudden 
Unexplained Death in Infancy (SUDI) associated with unsafe sleeping environments led 
to a 50% decrease in infant deaths since 20006,7. Data pertaining to the causes of pediatric 
mortality are important to prioritize future disease specific interventions and to assess 
trends in burden of various diseases8,9. 
 
Pediatric death investigation is a complex process with multiple parties involved.  
Although many components of the investigation are crucial, postmortem examination of 
the deceased child is frequently a key component in identifying why the child died.  In 
the course of a postmortem examination, a pathologist assesses the overall physical 
development of the child by comparing the body and organ measurements against 
published reference values. Currently used reference sources on pediatric body and organ 
parameters have been shown to be outdated and difficult to understand10–13. 
1.2 Sudden Death in Infancy 
Several studies have identified a number of risk factors associated with sudden infant 
death, including infant’s sleeping position, nature of bedding, maternal smoking during 
pregnancy, and environmental temperature7,14. Only roughly 15 percent of sudden infant 
death cases can be explained after a complete autopsy is performed15. Among common 
known causes are infections, cardiovascular anomalies, child abuse, and metabolic or 
genetic disorders16,17. Of the remaining 85%, the most common is Sudden Infant Death 
Syndrome (SIDS).  
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SIDS or “crib death” refers to death of a child younger than 1 year of age who dies 
suddenly and unexpectedly during sleep, and the death remains unexplained after a 
thorough death investigation and complete postmortem examination18. In essence, SIDS 
is a diagnosis of exclusion and should not be applied to situations of accidental asphyxia, 
inflicted injuries, or significant disease15. 
SIDS was first defined in 1969 by the National Institute of Child Health and Human 
Development15. The original definition described the syndrome as “sudden death of an 
infant or young child which is unexpected by history, and in which a thorough 
postmortem examination fails to demonstrate an adequate cause of death”19. However, 
with the evolving knowledge on SIDS, in 1989 the definition was amended to “sudden 
death of an infant under 1 year of age which remains unexplained after a thorough case 
investigation, including performance of a complete autopsy, examination of the death 
scene, and review of the clinical history”15,19. SIDS deaths are unlikely in the 1st month of 
life, when other causes of death are more prevalent (e.g. infections, congenital, genetic 
and metabolic disorders). SIDS has the highest prevalence in the 2nd and 3rd months of 
life partly attributed to the fact that infants use their nasal passages to breath20. There is a 
decrease in incidence after 6 months of age once an infant has greater functional mobility 
in being able to roll14,15. 
1.3 SIDS Terminology 
Scientific and medical literature is inconsistent in using definitions and terminology on 
sudden and unexpected death in infants. The term “Sudden Unexpected/Unexplained 
Death in Infancy” (SUDI) is based on the 2005 publication of the National Association of 
Medical Examiners referring to SUDI as an umbrella diagnosis for deaths that are 
initially unexplained. It should not be confused with SIDS diagnosis. The variable use of 
terminology in different death investigation systems hampers clear understanding and 
effective classification of sudden infant death. 
. 
There are ongoing efforts to standardize the certification and classification of infant 
deaths across Canada. The Ontario death investigation system uses the term SIDS as a 
classification of a unique category of natural infant deaths, for which a specific 
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underlying natural cause (i.e. cardiac, neurologic or metabolic) may be found in the 
future21.  The SIDS definition is strictly applied to exclude cases with sleep associated 
circumstances and social risk factors. 
 
To standardize cause and manner of death reporting in Ontario, all infant deaths are 
classified into four distinct categories22. The first category (category 1) includes any case 
with a definitive cause of death revealed at autopsy. The second category (category 2) is 
for cases fitting the SIDS definition, excluding cases where sleep-associated 
circumstances (adult bed, waterbed, sofa, child carrier, car seat, non-approved playpen or 
bassinet) and/or social risk factors (involvement with child welfare agencies, history of 
domestic violence, alcohol or other substance abuse in the caregivers) are present. The 
third category (category 3) includes cases with no anatomical or toxicological cause of 
death when there are sleep-associated circumstances, social risk factors or cases that do 
not meet the SIDS definition. The fourth category (category 4) represents deaths where 
anatomical/toxicological findings do not establish a cause of death (e.g. healed fractures) 
and non-accidental injury cannot be excluded.  
 
1.4 Sleep Environment 
One of the most important risk factors for sudden unexpected death in infants relates to 
prone (facedown) sleeping position of the infant7. Launching of the “Back to Sleep” 
campaign in 1994 as a way to increase public awareness of risks of sudden death in 
infants, initially aimed at reducing “crib deaths” by 10%6,7. The campaign exceeded 
expectations with an approximately 50% decline in sudden infant deaths observed over 
the next 5 years7,16, further emphasizing the important role of the sleep environment. In 
addition to the sleeping position of the child, other unfavorable factors include: 
unsuitable/soft sleeping surfaces, loose bedding, bed sharing, overheating during sleep, 
unaccustomed sleeping position (putting an infant in a position other than the one he/she 
usually sleeps), and exposure to smoking (either in the environment or in the womb)14. 
The Government of Canada Public Health Agency continues to raise awareness about 
safe sleep environment for infants providing evidence-based information to health care 
practitioners and caregivers7.  Among five main recommended principles of safe sleep 
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addressing modifiable risk factors are: placement of the infant in a supine sleep position, 
use of certified cribs/cradles/bassinets, avoidance of bed sharing and smoking, and 
promotion of breastfeeding. 
 
1.5 Ontario Pediatric Death Investigation 
The Ontario death investigation system is the largest in North America and is a 
partnership of the Office of the Chief Coroner for Ontario (OCCO) and the Ontario 
Forensic Pathology Service (OFPS) operating under the authority of the Ministry of 
Community Safety and Correctional Services. The OCCO investigates about 15,000 
deaths annually including approximately 5,800 cases requiring autopsies. In Ontario, 
approximately 250 pediatric deaths are investigated by coroners yearly23. 
 
The main objective of any death investigation system is to ensure that every death under 
its mandate is investigated and explained. Recommendations on preventing deaths in 
certain circumstances may be made. Five questions must be answered during a coroner’s 
investigation (the five “W”s): who was the deceased; when did he/she die; where did the 
death occur; what was the cause of death, and what were the means or manner of death 
(natural, accident, suicide, homicide, undetermined)24. 
 
Death investigation in cases of pediatric fatalities follows general investigative 
guidelines, but in contrast to adult deaths can be more challenging because of their 
potential complexity. Coordination among many participants (coroner, pathologist, 
police, toxicologist, Children’s Aid Society workers, pediatricians, radiologist etc.) is 
essential. In the majority of the cases, the cause and manner of death are not apparent on 
initial presentation. In a significant proportion of the cases, the cause and manner of death 
remain unknown even following a comprehensive death scene investigation and a 
complete autopsy. 
 
The coroner plays the central role in a pediatric death investigation and has a statutory 
responsibility for the overall investigation23.  He/she examines the body at the death 
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scene, communicates with the family, police, Children’s Aid Society and others, obtains 
and reviews the medical records of the deceased child and maternal records when 
applicable25.  The Investigative Questionnaire for Sudden and Unexpected Deaths of 
Infants is completed by the coroner. It includes detailed information such as: the 
circumstances of death, the child’s sleep environment, his/her past or recent health and 
development patterns, and findings observed during the external examination of the body 
at the scene. The coroner issues a warrant to the pathologist to conduct a postmortem 
examination. The coroner and police are the major sources of information for the 
pathologist who conducts the postmortem examination25. Based on the results of 
postmortem examination in conjunction with ancillary tests and the police investigation, 
the coroner completes the Coroner’s Investigation Statement and Medical Certificate of 
Death. 
Within the OFPS Service, pediatric autopsies are done by Category A and C pathologists.  
The category A pathologists have additional training and/or certification in forensic 
pathology and can perform medicolegal autopsies on all pediatric cases including 
criminally suspicious deaths and homicides. The category C pathologists do autopsies on 
non-suspicious pediatric deaths. 
An autopsy serves to determine the cause and mechanism of death (the latter refers to a 
physiological derangement that results in death) and to assist the coroner in certifying the 
manner of death. The OFPS has guidelines for a standardized approach to infant 
autopsies26. These cases require an extensive history about the child’s birth and 
development, as well as, the medical history of the child and his/her family. This allows 
the pathologist to tailor the autopsy to address specific questions raised by the history. 
The external examination, in addition to routine observations includes measurements, 
allowing evaluation of the child’s physical development. In the course of this evaluation, 
the pathologist commonly records various body measurements [body weight, length 
(crown-heel, crown-rump), circumferences of the head, chest and abdomen, and foot 
length]27. These are compared to the normal reference values to establish if the infant 
meets normal growth parameters. Many of the reference sources that are used for 
comparison are based on autopsied rather than living populations. The comparison helps 
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to identify infants who are failing to thrive or whose parameters are above the normal 
ranges.  Failure to thrive could be from poor feeding, a variety of diseases (such as 
chronic medical conditions, infections, malignancies), or physical neglect28. Above 
normal observations could be related to unhealthy nutrition, underlying metabolic 
syndromes or other diseases. A skeletal radiological survey can detect not only recent and 
old fractures but also bony abnormalities due to nutritional deficiencies. 
Recording various organ weights in the course of the internal examination guides the 
pathologist in differentiating healthy organs from those diseased26. Major organs and 
tissues are sampled for microscopy to diagnose specific pathological abnormalities. 
Additional ancillary tests that are frequently conducted in infant autopsies include: 
toxicological, biochemical (vitreous humour sampling) and microbiological analyses, 
metabolic screening, cytogenetic studies, and any other tests deemed necessary26. All 
findings are reviewed by the pathologist to reach a conclusion about a cause and 
mechanism of death. 
Police play a significant role in the pediatric death investigation. They are among the first 
responders to the scene. Police have primary role in the documentation and preservation 
of the death scene and question the family, caregivers and other witnesses to help 
reconstruct the events leading to a death. A police identification officer commonly 
attends the scene and autopsy to further document findings by photography and to collect 
evidence if necessary25.  
Cause of death is defined as “all those diseases, morbid conditions or injuries which 
either resulted in or contributed to death and the circumstances of the accident or violence 
which produced any such injuries”29. The pathologist will identify immediate and 
antecedent causes of death, as well, as other significant conditions contributing to the 
death. To correlate this with previously discussed Ontario classification of infant deaths 
(see Section 1.3 SIDS Terminology above), the first category cases have a definitive 
cause of death which directly impacts the manner of death (natural, accident or 
homicide).  In “true” SIDS cases (category 2), the manner of death is natural. In cases in 
categories 3 and 4, the cause of death and therefore manner remain undetermined. By 
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definition, the manner of death is undetermined “when the information pointing to one 
manner of death is no more compelling than one or more other competing manners of 
death when all available information is considered”30. 
To ensure the high quality of pediatric death investigation in Ontario, selected pediatric 
deaths are reviewed by specialized committees at the OCCO.  The multidisciplinary 
Death Under Five Committee reviews the deaths of children under5 years of age 
investigated by coroners in Ontario31. The committee consists of coroners, police, 
forensic pathologists, crown attorneys, child maltreatment and welfare experts, Health 
Canada product safety specialists, and Coroner’s Office support staff32. The committee 
reviews individual case findings and assesses the quality and comprehensiveness of the 
investigation and postmortem examination.  The committee identifies recurrent or 
emerging issues which will guide in creating interventions to decrease pediatric mortality. 
1.6 Infant and Neonatal Development  
1.6.1 Physical Development of a Young Child 
Fetal development is a gradual process with major structures formed during the second 
half of the pregnancy. There is a steady increase in fetal weight with 85% of the birth 
weight gained during the final half of gestation20. The most critical structural change is 
the maturation of the lungs from the canalicular to saccular and further alveolar stage, 
and development of surfactant. This transformation occurs between the 24th to 35th weeks 
of gestation, making the fetus viable. Although viable, the newborn is immature at this 
stage. Prematurity describes neonates born prior to 37 weeks of gestational age, and 
could be divided into the following subgroups: extremely preterm (less than 28 weeks), 
very preterm (28 to 32 weeks) and late preterm (32 to 37 weeks)33.  Term birth occurs 
between 37 to 41 weeks gestational age and is further subdivided into early term (37-38 
weeks), full term (39-40 weeks), and late term (41 weeks)34. Post-term births occur at 42 
weeks and greater35.  The perinatal period is defined as the days or weeks surrounding the 
child’s birth36. Depending on definition, it commences at 20-28 completed weeks of 
gestation and ends 1-4 weeks after the birth. An infant is any live birth up to 1 year of 
life. 
 9 
 
The average newborn weighs from 2500 to 4900 grams at term13. Newborns weighing 
below this range are considered small for gestation age (SGA) and newborns heavier than 
4900 grams – large for gestational age (LGA)13. Newborns that are SGA are at increased 
risk of perinatal asphyxia, respiratory distress and sepsis during the neonatal period (birth 
to 28 days of life)8. LGA neonates show increased incidence of birth defects and 
respiratory distress13.  
Body growth follows specific growth trends, such as rapid growth separated by periods of 
steady or slow growth37. Weight, for instance, drops immediately after birth (5% drop in 
birth weight in formula-fed and 10% in breastfed infants). This drop could be explained 
by the slow production of maternal milk and low enteral intake38. The lost weight is 
regained within the next 10-14 days. The infant weight increases by 900 grams a month 
for the next 3 months, doubling the birth weight by 5 months. After this time, there is a 
further increase by 450 grams per month, tripling the birth weight by the end of the first 
year of life39.   
Length tends to be between 48 and 53 cm at term and increases by approximately 2.5 cm 
per month for the first 6 months of infancy. By the first year of life, the infant’s length 
increases by 25 cm20,37.  
An increased or decreased rate of growth can indicate improper nutrition, chronic illness, 
hormonal imbalances or other underlying pathological conditions, including congenital 
syndromes or chromosomal abnormalities commonly seen in neonatal period and 
infancy. 
Monitoring young child growth and development is an essential component of primary 
health care for children and adolescents. Recommended growth monitoring includes 
obtaining serial measurements of weight and height/length of all children and head 
circumference, in addition, for infants and toddlers. These parameters are further 
interpreted relative to the reference growth charts to confirm the healthy growth and 
development or to identify a potential health or nutritional problem requiring early 
intervention. 
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Routine infant well-being checkups are recommended at 1 to 2 weeks following birth, 
and 1, 2, 4, 6, 9 and 12 months. Measurements are recorded at these serial checkups and 
during acute illness visits if routine well-child visits have been missed40. 
Canada promotes consistent practices by health care providers using current practice 
guidelines in monitoring child’s growth to ensure the health of Canadian children41. 
These guidelines were developed through the collaboration of major Canadian agencies 
including Dietitians of Canada, The Canadian Paediatric Society, The College of Family 
Physicians of Canada and Community Health Nurses of Canada41. These guidelines 
recommend evaluation of the growth of all term infants (breastfed or not) and 
preschoolers, preterm infants (once discharged from neonatal intensive care units) and 
children with special care needs using growth charts from the WHO Child Growth 
Standards (birth to 5 years of life)41,42. These charts are considered to be international 
growth standards since they reflect growth patterns of well-fed healthy preschool children 
from diverse ethnic backgrounds. These guidelines were proposed to replace previously 
used American growth charts from the Centers for Disease Control and Prevention 
(CDC)42. WHO growth charts are based on a child’s gender and age. The age is adjusted 
for prematurity if required42.  The measurements show growth trends and can be used to 
assess nutritional status and identify developmental delays including failure to thrive13,40. 
Overall children grow rapidly from birth to 1-2 years of age. Physical growth of a child 
refers to an increase not only in body size (length/height and weight) but also in the size 
of various organs10,27,43. Previous studies have shown that the heart doubles in overall size 
and weight during the first year of life20. Lung growth occurs rapidly in the first few 
months of life doubling in volume in the first 3 to 4 months and quadrupling by the 12th 
month or life44. The right lung is typically heavier than the left one. As well, the studies 
showed that the lung growth in infancy is very reactive to even minor changes in the 
general condition of the child and can lag in infants with poor nutritional status44. The 
brain is relatively large in an embryo and fetus, and its weight accounts for approximately 
14% of the total body mass at birth. During infancy and childhood, the brain becomes 
proportionately smaller relative to the total body mass accounting for 2% of body weight 
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in adulthood45. The thymus is relatively large at birth compared to the body weight and 
further increases in size with advancing age but involutes in early adulthood46.  
Infants proceed through certain developmental stages acquiring more advanced 
physical and motor skills. A child’s development follows a recognized, expected 
pattern, termed developmental milestones. By the end of the 3 rd - 4th month of life, 
infants usually are able to roll from front to back, control their head and neck 
movements when sitting, and push with their legs when their feet are in contact with a 
firm surface47. This developmental stage corresponds to the greatest incidence of SIDS 
cases, which peaks between 1st-2nd and 4th months of age48. By 6 months of age, infants 
typically are able to roll from back to stomach. This coincides with the steady decline 
of SIDS cases after the age of 6 months48. 
Overall, growth and development follows consistent, predictable patterns and 
sequences: from simple to complex (simple head movements to finger control) and 
cephalocaudally (from head to foot, e.g. from head movement to standing and 
walking)49. Proximal to distal development, defined as “inside out growth”, starts 
around 5 months when an infant can first move the torso (center of the body) and roll 
over before able to control the movements of the extremities, such as walking or 
grabbing49. The rate of development can normally vary between individuals50. 
1.6.2 Factors Affecting Child’s Development 
There are multiple causes that could cause deviations in a child’s growth and 
development. They can be divided into genetic, environmental, biological, and nutritional 
factors. These in turn could be divided into modifiable (e.g. child’s nutrition) and non-
modifiable (e.g. genetic predisposition). 
1.6.2.1 Genetic Factors  
Genetic influences, such as gender, inherited body size and ethnicity, can predispose an 
individual to be affected by adverse environmental factors. 
Fifty one percent of Ontario and Canadian births are males3. In 2012, 53% infant deaths 
were males1. Males have a 1.42-fold increased incidence of sudden infant death 
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compared to females. Some studies attribute this to more immature sleep-wake patterns 
in males who have a delay in rapid eye movement sleep development51, 52. In addition, 
males have higher incidence of birth defects and are more vulnerable to reproductive 
incidents53. Other studies found an association between the higher incidence of SIDS in 
males and a dominant X linked allele54,55. 
Height is a polygenetic inherited trait with environmental influences56. Over the last 
century, body height has been increasing, with children today taller than their parents56,57. 
The increase is attributed to advances in nutrition and treatment of various diseases, and 
improvement of detrimental socioeconomic factors58.  Height can also vary significantly 
based on inherited characteristics. If parents are smaller or larger than normal percentiles, 
the children tend to follow similar growth trends. This may initially present as a 
pathological outlier but can be explained by a thorough family history59,60.   
Ethnicity can affect the child’s stature. It has been shown that Japanese, Indian and 
Filipino children are smaller in comparison to children from the United States and 
Europe61. 
Genetic and inborn metabolic disorders can affect the growth rate of a child. For instance, 
Down Syndrome is associated with low birth weight and delayed growth62. 
1.6.2.2 Environmental Factors  
Environmental factors include: intrauterine exposures and maternal health factors, 
socioeconomic status, cultural and psychosocial influences, and environmental conditions 
(e.g. cold or hot climate, high altitude).  
Multiple studies have shown that maternal factors such as genetics (as discussed in the 
preceding section), weight, health and nutrition, all influence birth weight and could 
impair intrauterine growth13. Maternal smoking has been shown to have adverse effects 
on fetal growth, with 1.75 times increased risk of fetal demise13. Maternal substance 
abuse (alcohol or other drugs) during pregnancy is a well-documented factor causing 
dose-related growth retardation63. Growth retardation has also been linked to maternal 
hypertension, and maternal congenital heart and respiratory diseases62,64. Infants of these 
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mothers were reported to be very small for gestational age with relatively high brain 
weight, and low weights of liver, lungs and thymus. In contrast, infants born to diabetic 
mothers were large for gestational age showing characteristic patterns of increased body 
measurements and enlarged internal organs with disproportionately large liver, heart and 
adrenal glands and often a disproportionately smaller brain62,65. Other maternal factors 
influencing fetal growth include young or advanced maternal age, short intervals between 
recurrent pregnancies, multiple births, non-infectious and infectious diseases66,67. Specific 
pathogens (e.g. Trichomonas vaginalis, Bacteroides and Ureaplasma), have been shown 
to be associated with premature rupture of membranes and/or preterm labor68.  
The socioeconomic status of a family can affect birth weight and a child’s growth and 
development. Some studies have shown a higher frequency of low-birth weight infants in 
the lower socioeconomic groups69–71.  Socioeconomic factors have been attributed to 
increased infant mortality due to increased risk of poor nutrition, infections and multiple 
comorbidities72. Overcrowding, poor housing quality, single parenting, and inadequate 
prenatal care have been associated with an increased risk of sudden infant death73–76. 
Some cultural practices, such as overwrapping (swaddling), bed sharing and putting a 
child in a prone position, have been shown to increase the risk of sudden infant death77–80. 
These practices can be difficult to modify as they impact cultural identity. 
Environmental conditions such as temperatures in excess of 290C have been shown to 
increase risk of sudden infant death by 2.78 times81. Lower temperatures have also been 
shown to increase the risk of sudden infant death82. Altitude has been shown to associate 
with increased risk of sudden infant death and incidence of lower birth weight83–85. 
Psychosocial risk factors, such as stress and social environment, have been linked to 
adverse infant health. For instance, studies have shown that immigration can increase risk 
of prenatal stress and of preterm births86–89. 
1.6.2.3 Biological Factors  
Biological influences, such as birth weight, gestational age at birth, infections and 
medications, can impact child’s growth and development.  
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Birth weight is one of the most reliable indicators of an infant’s health because it has 
strong  implications for health and mortality throughout childhood and adulthood90–92. 
Prematurity has a direct impact on birth weight with future health implications93.   
Acute diseases, such as gastroenteritis, can lead to dehydration and significant weight 
loss94. Chronic disease, such as diabetes mellitus, has been associated with both an 
increase and decrease in child’s weight depending on how well metabolic control is 
maintained95. Lung infections or chronic lung disease can decrease lung capacity and 
slow overall growth96. In addition, medications can have an effect on child’s 
development, for instance, chronic steroid use by an infant has been associated with 
weight gain97.  
1.6.2.4 Nutritional Factors  
An inadequate maternal diet can lead to intrauterine growth retardation and congenital 
malformations (e.g. spina bifida)28,98. Decrease in maternal milk production is associated 
with decreased growth rate, vitamin and iron deficiency, and cognitive impairment in 
breastfed infants99. Inadequate nutrition can take on many forms, such as poor caloric 
intact, inadequate caloric absorption, excessive caloric expenditure, or forms of 
neglect100. All of these can lead to a failure to thrive. Overfeeding, as well, can lead to 
negative lifelong habits of overeating, obesity, and chronic disease91. Childhood obesity 
is linked to poorer health outcomes101. 
1.6.2.5 Prematurity and its Effects on a Child’s Growth  
Premature neonates have a 120 times higher risk of death in the first 28 days of life and 
significantly increased risk of short and long-term morbidities as a result of structural and 
functional immaturity of various organs and systems102.  
Among complications related to prematurity during the first year of life are failure to 
thrive, respiratory distress syndrome, infections, developmental delay, encephalopathies, 
prolonged hospital stay, and increased mortality, including sudden death66,103,104. The 
long term effects of prematurity include: increased rate of childhood infections and 
readmissions to hospital, asthma, learning disabilities and possible mental health 
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issues104–106. In addition, prematurity has been associated with a higher risk of diseases in 
adulthood including hypertension, diabetes and coronary artery disease, each of which 
has been linked epidemiologically to a low birth weight90,91,107. 
The patterns of illnesses in preterm children are dependent on degree of prematurity i.e. 
specific gestational age at birth13. Growth and developmental expectations of a preterm 
child are based on corrected age rather than chronological age as for a term child108. It is 
generally recommended to adjust the age of premature infants for growth measurements 
and developmental assessments until 2 years of age108. Adjusted age is calculated by 
determining how many weeks premature the birth was and subtracting the number of 
premature weeks from the chronological age of the child in weeks109. 
1.7 Current References on Autopsied Infant Growth 
Standards  
A pathologist doing a pediatric autopsy will commonly assess a child's developmental 
stage by measuring various body parameters and organs and comparing these data to 
standardized parameters using existing charts published in the literature; however, these 
references have limitations. Some criticisms of the existing reference sources for body 
measurements and organ weights of infants and neonates include the lack of the normal 
percentiles, outdated nature of the information, data limited to specific ethnic 
populations, and difficulties in understanding the data10–13. 
Although, many reference sources exist, both Canadian and international, on body and 
organ measurements for various groups (fetuses, stillbirths, neonates and infants), there 
are no updated or Ontario population specific data for children under 1 year of  
age12,43,110–117. In addition, the reference data frequently do not account for the effect of 
the cause of death in control groups and are lacking any interrelationships between body 
and organ measurements115,118. As well, the reference data range significantly between 
various sources which can lead to interobserver discrepancies depending on the 
comparison resource used113. 
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1.8 Thesis Objectives and Rational 
The first objective of this study is to assess the relative strengths and weaknesses of the 
currently available autopsy references on infant and neonate body and organ 
measurements and to develop criteria for the development of a new reference resource. 
To achieve this goal, a survey of Ontario pathologists doing coroners’ pediatric autopsies 
and a review of the existing literature was conducted. 
 
The second objective is based on the results of the above survey and literature review to 
create Ontario population-specific organ and body measurement mean charts for infants 
and neonates and growth graphs for each age category. 
 
The third objective of this study is to determine if groups, based on the cause of death, 
are different in their body and organ measurements. 
 
The hypothesis is that the differences in the body measurements and organ weights of 
Ontario neonates and infants will be statistically significant depending on the cause of 
death according to age and gender. 
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Chapter 2  
2 Survey and Review of Reference Resources Used by 
Ontario Pathologists 
2.1 Methodology  
A list of pathologists who do pediatric coroners' autopsies was requested from the Office 
of the Chief Coroner for Ontario, a branch of the Ministry of Community Safety and 
Correctional Services (MCSCS). The listing comprised category A and C pathologists 
from the Ontario Forensic Pathology Service (OFPS). The former category includes 
pathologists who do any type of coroner’s autopsy including pediatric and criminally 
suspicious cases/homicides. Category C pathologists do pediatric autopsies which are 
non-criminally suspicious. The contact information for 30 pathologists working in the 
Ontario provincial and regional forensic pathology units and in teaching and community 
hospitals was provided. Hard copy packages were sent to the pathologists. Each package 
consisted of an introductory letter stating the goals of the research, the survey (Appendix 
A), and a return envelope. In addition, an electronic package including the introductory 
letter and survey was constructed using online electronic survey software 
(SurveyMonkey). The hard copies and electronic packages were distributed to all 30 
pathologists by mail and via an email link. For those who did not respond, a second 
electronic package was emailed 3 months after the initial submission. 
The survey asked the following 6 questions:  
1. Do you or your pathologists perform coroners’ neonatal (birth to 1 month) or infant (1 
month to 1 year) autopsies?  
2a. Have you referenced any of the following sources for organ or body 
measurements?10–13,43,109,119 
2b. Please provide details (authors, journal, year, volume, page numbers or textbook) for 
any additional sources.  
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3. Which of the above sources do you reference most often and why? 
4. Are there any limitations of these sources in your opinion?  
5. What information would be most helpful for your practice in an Ontario-based study? 
6. Would you be interested in receiving a copy of the finished study? If yes, please, 
provide a delivery preference.  
All reference sources, whether provided initially to the surveyed pathologists or added by 
them, were further assessed based on the following criteria: sample size, statistically 
significant values, age span of the sampled data, gender differentiation, living vs. 
autopsied population, and originality (i.e. original data vs. review of pre-existing data). 
The above criteria were assessed as present or absent. In addition, the year of each 
publication and origin of the source (the country where the data were collected) were 
documented. 
2.2 Results  
Fourteen of 30 Ontario pathologists who do coroners’ pediatric autopsies responded to 
the survey (Appendix A).  
The responses to question 2a, the utilization frequency by pathologists of the 7 initially 
cited references in the survey, showed that 2 pathologists referenced Stowens; 6 
referenced Stocker and Dehner. and Coppoletta and Wolbach.; 7 referenced Kayser; 8 
referenced Schulz et al.; 10 referenced Wigglesworth; and 12 referenced the Centers for 
Disease Control and Prevention interactive database (CDC)10–13,43,109,119. In addition to 
the 7 references provided, the pathologists identified 13 additional sources in response to 
question 2b18,110–117,120–123. 
The replies to question 3 are shown in Figure 2-1. The references most often used were 
"Weights of Organs of Fetuses and Infants” by D. M. Schulz, D. A. Giordano and D. H. 
Schulz (8 pathologists), CDC (6 pathologists), the “Textbook of Fetal and Perinatal 
Pathology” by J. S. Wigglesworth (5 responders), and “Height and Weight in Human 
Beings: An Autopsy Report” by K. Kayser (5 responders)10,12,13,109.  
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Figure 2-1. Most Frequently Referenced Sources 
 
Results of survey - question 3 “Which of the above sources do you reference most?” Schulz  et al (8) and 
the CDC (6) were the most commonly used by the responding pathologists.  
 
The advantages of sources stated in response to question 3 were: age ranges provided; 
references readily available and widely used; references most scientific and accurate; 
standard deviations given; and data combined from multiple sources. 
The stated limitations of these publications as noted in survey question 4 were: outdated 
nature of a database; wide and limited age intervals; data not unique to SIDS/SUDS 
(Sudden Infant Death Syndrome/Sudden Unexplained Death Syndrome) populations; 
small sample size; absence of ethnic background information; single reference values (no 
ranges); standard deviations not given; and difficulty of comparison between various 
sources. 
The pathologists identified 10 features for an ideal reference resource. These features, 
identified by the responders in survey question 5, included: an up-to-date database with a 
large sample size; a dataset relevant to the Ontario population; defined 
controls/standards; provision of standard deviations, confidence intervals and p-values; 
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gender distinctions; data pertinent to SIDS/SUDS populations; updated 
demographic/ethnic breakdowns; and an electronically accessible database. 
2.3 Discussion 
2.3.1 Review of Sources Cited by the Ontario Pathologists 
The 20 publications span a period from 1933 to 2010. The oldest reference was by 
Coppoletta and Wolbach and the most recent was from the CDC43,109. Half were 
published before 2000. Figure 2-2 illustrates that from 1900 to 2015, only 40% of the 
references have data collected after 2000, and no sources had data collected beyond 2003. 
Table 2-1 shows the assessments of all references based on certain criteria. The reference 
sources included 11 journal articles, 7 textbooks, a website, and a Master of Science 
thesis10–13,18,43,109–117,119–123. Twelve sources (60%) differentiated genders, 13 (65%) listed 
actual sample sizes, 18 (90%) provided standard deviations, 11 (55%) used ranges for 
means, and 7 (35%) included data on statistical significance (e.g. p-values). Seventy 
percent had 5 or more charts or tables. Of the 20 sources, 11 (55%) were based on 
original data10,12,43,110,112–114,116,117,120,123. 
Most of the sources, 18 (90%), were based on autopsy observations with 10 of them 
(56%) based on original data. Of the 10, only 7 included data on children from birth to 
12 months of age. Two of these referenced only cardiac data, and one referenced only 
recumbent body length110,114,120. This left only 4 original reference sources for organ and 
body measurements for infants and neonates (birth to 12 months)10,12,43,113. From these, 
only 2 provided gender distinction and standard deviations or confidence intervals10,12.
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Figure 2-2. Timeline of References 
Sources most commonly used by the responding pathologists, depicted by year(s) of data collection, aligned by the oldest initial collection date to the newest. 
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Table 2-1. Sources Assessed by Proposed Criteria 
The assessment of the reference sources according to the criteria proposed by the survey respondents. 
 
 
SOURCES 
 
YEAR 
 
LOCATION* 
 
SAMPLE 
SIZE† 
AUTOPSIED 
SAMPLE‡ 
STANDARD 
DEVIATION§ 
ORIGINAL 
DATA** 
GENDER 
DISTINCTION†† 
 
SOURCE AGE RANGES‡‡ 
Archie 2006 Multiple 
 
YES YES NO NO 12 - 45 weeks gestation 
CDC 2009 Multiple 8440 NO YES NO YES birth - 19 years 
Coppoletta 1933 United States 155 YES NO YES NO birth - 12 years 
Finkbeiner  2009 Multiple 
 
YES YES NO YES 16 weeks gestation - 86 years 
Fracasso 2009 Germany 388 YES YES NO YES 1 - 12 months 
Gilbert-Barness 2005 Multiple 
 
YES YES NO YES 24 weeks gestation - 18 years 
Oyer  2004 USA 776 YES YES YES NO 15 - 42 weeks gestation 
Hansen. 2003 United States 597 YES YES YES NO 12 - 26 weeks gestation 
Kayser 1987 Germany 47,523 YES YES YES YES birth - 99 years 
Keeling 2001 Multiple 
 
YES YES NO NO 12 - 43 weeks gestation 
Kramer  2001 Canada 676,605 YES YES YES YES 22 - 43 weeks gestation 
Roche  1989 United States 504 NO YES YES YES 1 - 12 months 
Scholz. 1988 United States 200 YES YES YES YES birth - 19 years 
Schulz. 1962 United States 1339 YES YES YES YES 5 months gestation - 12 months 
Schulz (Heart) 1962 United States 1847 YES YES YES YES 5 months gestation - 12 months 
Stocker 1940 Multiple 
 
YES YES NO YES 46 days post ovulation - 19 years 
Stowens 1959 United States 
 
YES NO NO NO second lunar month - 5 years 
Thompson 2004 United States 453 YES YES YES NO birth - 12 months 
Victor 1999 Canada 2026 YES YES YES YES 18 - 43 weeks gestation 
Wigglesworth 1991 United States 
 
YES YES NO NO 12 - 42 weeks gestation 
* The country where the data were collected 
† Blank fields depict sources where sample size was not provided and/or a compilation of data sources with different sample sizes were used  
‡ YES = data collected from autopsied subjects; NO = data collected from living subjects 
§ YES = standard deviations were provided; NO = standard deviations were not provided 
** YES = authors analyzed original data; NO = authors reviewed data from other sources 
†† YES = male and female data were segregated; NO = male and female data were pooled  
‡‡ The age span of the sampled data as defined by the source
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Growth can be defined as an increase in size over time and, therefore, serial measurements are 
required for documentation116. This is not applicable to autopsy populations since only single 
observations are available. The definition of normality also poses interpretative challenges since 
it varies from author to author111. Establishing a normal group when faced with variations caused 
by pathophysiological processes can be difficult112. In the present study, a common theme in the 
20 cited references was a deficiency in the definition of standard or normal groups. Prior 
publications identified the inadequacy of the currently available norms10,43,110. Various authors 
have pointed to the lack of statistical information, such as sample size, standard deviations and 
standard errors in various sources10,110,112. Many of the reference sources were lacking a 
description of exclusion criteria and well-defined control groups120. The lack of descriptive 
information on exclusion criteria can lead to bias111. 
Schulz et al. found the lack of standardization by gender to be common in infant but not in adult 
studies10. Significant differences in norms related to gender were found by some researchers10,122 
and disproven by others, which led to a pooling of pediatric data43,112,113,115. Schulz et al. noted 
that the male brains at 8 months were significantly heavier than female ones10. 
The effect of prematurity on organ and body measurements was proposed as a significant 
factor43,113,115. Fracasso et al. found in their study that heart weights were slightly heavier during 
the first 3 months, becoming slightly lighter from 6th to 10th months when compared to similar 
studies115. The authors explained these findings by the inclusion of prematurely born neonates 
and infants in the database, which accounted for the smaller values.  
Some studies investigated whether organ weights were different between SIDS and non-SIDS 
groups113,115. No significant differences in organ weights between SIDS and control groups have 
been identified. Body measurements and organ weights can be affected by maternal and 
environmental (e.g. smoking) effects on development in utero113,115. The systemic effects of 
disease and pathophysiological processes (e.g. congestion and edema) on organ weights has been 
noted12,115.  The validity of excluding single organs affected by disease when assessing other 
organ weights was previously raised115. 
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The present review of the reference sources revealed that organ weights tended to be greater in 
more recent publications. Lack of complete data did not allow us to verify these observations 
statistically. This trend can be demonstrated when comparing both Schulz’s et al. data collected 
in 1962 to Coppoletta and Wolbach's data collected during the period of 1914-192910,43,110. The 
databases in Schulz et al. show an overall increase in organ weights with a 20% increase in heart 
size. Thompson and Cohle, based on their data collected during 1986-2000, reported a 6-100% 
increase in various organ weights when compared to one of the aforementioned studies by 
Schulz et al10,113.  These differences could be attributed to poorer nutrition and less perinatal care 
in the past. Thompson and Cohle recommended that new body measurement and organ weight 
standards needed to be developed using more current data113. Fracasso et al. also opined that the 
earlier published data were not applicable to the modern populations115. Although there is no 
completely satisfactory reference when assessing pediatric growth parameters, utilization of any 
reference is still a better practice than using none111,116. 
In summary, this part of the study identified and reviewed 20 various types of references for 
body measurements and organ weights used by Ontario pathologists in the course of their 
postmortem examinations on infants and neonates. The strengths and weaknesses of the currently 
available sources were evaluated. Based on the limitations of the current references and criteria 
suggested for improvements, the present review served as a guide to create a new autopsy-based 
body measurement and organ weight database for pediatric deaths under 1 year of age. This new 
reference source used more recent data from the Office of the Chief Coroner for Ontario and 
involved a larger sample size allowing for statistical relevance. The database aimed to be gender 
specific and to provide data for specific age intervals. 
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Chapter 3  
3 Research Design for Growth Charts  
Data were collected, analyzed and tested to determine if significant relationships were present 
between the cause of death, age and gender groups. Based on the collected data reference tables 
were created on body measurements and organ weights, with and without gender distinction.  
3.1 Ethics Approval  
This research was approved by the Research Ethics Board for Health Sciences Research 
Involving Human Subjects (Western University) (Appendix B) and the Lawson Health 
Research Institute (Appendix C). 
3.2 Data Collection 
Cases were collected from a database of infant and neonatal deaths that were investigated by 
Ontario coroners from 2000 to 2010. Only cases where complete postmortem examinations 
were performed were included in the sample population.  
The data were collected and processed according to the research agreement with the Office of 
the Chief Coroner for Ontario. A data collection sheet (Appendix D) was created and 
completed for each reviewed case. The information was collected from the coroner’s 
investigation statements and reports on postmortem examination commonly including a number 
of ancillary reports (neuropathological consultation report, toxicology, microbiology, 
biochemistry, cytogenetic studies etc.). The information was then transferred into an Excel 
document where blank fields indicated absent data. 
Collected data were arranged by the age at the time of death, cause and manner of death. For 
the purposes of confidentiality, identifying information (including date of birth, date of death 
and coroner’s or autopsy case number) were removed and a random number was assigned to 
each case. 
Cause of death and manner of death for each case were reviewed by re-evaluating specific case 
information, major findings on gross and microscopic examination, and results of ancillary 
studies. SIDS cases before 2005, i.e. the year SUDI was defined, were re-classified into the 
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appropriate category upon review of these cases. Based on this review, cases were subdivided 
into 3 major groups: SIDS, SUDS and non-SIDS/non-SUDS. SIDS deaths had no anatomical or 
toxicological cause of death identified in the course of a thorough postmortem examination 
complemented by ancillary studies, and there were no findings identified to suggest that unsafe 
sleeping might be a contributing to death factor.  SUDS group included cases where cause of 
death remained unascertained yet unsafe sleeping environment was a potential contributory 
factor. The remaining cases were included in the third group (non-SIDS/non-SUDS group). 
This group was further subdivided into several subgroups based on the underlying pathology: 
congenital abnormalities, metabolic disorders, natural diseases, systemic infections/sepsis, birth 
asphyxia, accidental deaths, suspicious deaths, and homicides. Accidental deaths incorporated 
various types of asphyxia including entrapment within a crib, obvious overlaying, hanging, 
drowning, choking, and fire deaths. The third group (non-SIDS/non-SUDS cases) were further 
reviewed to select data for a control group. The Control group consisted of pathologically 
uninvolved organs. Cases were reviewed by me and a staff forensic pathologist. Generally, the 
Control group was selected from categories 1 and 4 cases according to standardized sudden 
infant death reporting in Ontario (please see Section 1.3) 
The following criteria were used for selecting cases for the Control group.  The entire case was 
excluded, if the child was diagnosed with a pathological condition that usually had systemic 
effects. The following conditions excluded a case from the study: multiple congenital 
abnormalities, status after prolonged resuscitation at hospital, systemic infections/sepsis, 
significant decomposition, generalized body edema, and failure to thrive. In addition, upon the 
thorough review of the remaining cases, single or multiple organs that showed significant 
pathological abnormalities (grossly or microscopically) were removed from the Control group 
data (e.g. lungs in cases diagnosed with pneumonia, brain in cases with hypoxic-ischemic 
encephalopathy). In cases of traumatic death (whether homicidal or accidental) injured organs 
were excluded (e.g. brain in craniocerebral trauma, lungs in drowning). Majority of suspicious 
deaths included in the Control group were cases of head trauma where non-accidental injury 
was among differential diagnoses and brain was excluded. Cases were excluded from the study 
when the measurements indicated immaturity based on the stated chronological age, but the 
gestational age was not provided so term gestation could not be verified. Measurements with 
obvious typographic errors were removed. 
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Corrected or adjusted age was calculated for premature infants provided the gestational age at 
birth was available. Corrected age was calculated based on the following formula: 
Corrected age = actual age in weeks – weeks premature. 
The infant and neonatal data were further organized by the age groups and growth parameters, 
such as specific organ weights [heart, lungs (right, left and combined for lungs and the rest of 
paired organs), kidneys, liver, spleen, pancreas, adrenals, thymus, thyroid, uterus, prostate, 
testes, and brain], heart measurements (valve circumferences and thickness of each ventricle), 
and body measurements (body weight, crown-heel length, crown-rump length, head 
circumference, chest circumference, abdominal circumference, and foot length). The means, 
standard deviations and sample sizes for each of the above variables were recorded in order to 
create reference tables. 
3.3 Statistical Analysis 
All data were distributed into age categories divided into 2-week intervals for the 1st month 
followed by 4-week intervals from the 4th to 44th week, with the last group including cases from 
45th to 52nd weeks of age. 
All analyses were performed using the R statistical software (version 3.2.2). The significance 
level (p-value) was chosen as 0.05 for all the statistical tests in this report. If a p-value obtained 
from a test statistics was smaller than 0.05, then the corresponding factor had a significant 
effect on a studied mean value. Linear regression with a backward variable selection method 
was used to select the factors important in testing the effect of gender, age and cause of death 
on various measurements. The Akaike Information Criterion (AIC) method was used for 
variable selection. If the AIC value of modelling an organ weight was lower when a tested 
factor was removed, then that factor was regarded as important to the organ. In contrast, if the 
AIC value of modeling an organ weight was not lower when a factor was excluded, then that 
factor was insignificant and could be removed. The backward selection process was performed 
using AIC in a Stepwise Algorithm (stepAIC, MASS package). For stepwise backwards 
selection, the factor with the highest p-value was eliminated in a stepwise process until AIC 
was minimized. 
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Unpaired t-test was performed between Females/Males, Control/SIDS, Control/SUDS, and 
SIDS/SUDS groups using 0.05 as the significance level of calculated probability for each 
measurement in the given age group. If an observation contained missing values, it was not 
included in the analysis. When two sample t-test (unpaired t-test) was used, the assumption was 
made that the two populations were normally distributed. The test for normality (normal 
distribution of the population) was satisfied. There was no minimal sample size for the t-test to 
be valid. The tests of gender specific organs were analyzed relative to the age group and cause 
of death only (uterus, prostate, testes). The effects of all 3 factors (age, gender and cause of 
death) on the following 16 variables were tested for the following weights: heart, lungs (right, 
left, combined), kidneys (right, left, combined), liver, spleen, pancreas, adrenals (right, left, 
combined), brain, whole body weight, and thymus. For a given age group and organ weights, 
the unpaired t-test to compare the mean weights of males and females was done. If the number 
of observations (n) for males or females was less than 2 (equal to 0 or 1), then the observations 
were not included in the analysis.  
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Chapter 4  
4 Results 
4.1 Descriptive Statistics 
Overall, 1856 infant and neonatal deaths were investigated by Ontario coroners during the 
period from 2000 to 2010. Of these, complete information was available for 1225 cases.  In the 
remaining 631 cases, either there was no postmortem examination performed, a postmortem 
report was not available, gender no specified, or exact age in weeks or gender could not be 
calculated (e.g. no date of birth provided). 
Age inclusion was based on the corrected rather than actual, chronological age; therefore, all 
preterm pediatric deaths where the corrected age was negative (i.e. child who was born prior or 
at 36 weeks and 6 days gestational age and did not survive long enough to reach term) were 
excluded (146 cases). The remaining 1079 cases met the inclusion criteria (age and complete 
data). Upon further reviewing of the “non-SIDS/non-SUDS” group, an additional 179 cases of 
systemic pathological conditions were excluded, leaving 900 cases to create the present 
database. 
The study population distribution by age (from 0 to 52 weeks) is shown in Figure 4-1. Among 
all the cases investigated by Ontario coroners, male deaths were predominant (56.3% males vs. 
41.3% females, 2.4% case with gender unknown). A slightly higher male predominance was 
observed in the selected 900 cases (59.2 % males and 40.8% females). 
Case distribution between the cause of death groups is shown in Figure 4-2. Nearly half of the 
cases (48%) were in the Control group. The SIDS and SUDS groups were respectively 13.6% 
and 38.4%. Male predominance was slightly more prominent in the SIDS and SUDS groups in 
comparison to the Control group and was the highest in the SIDS deaths (Table 4-1).  
Distribution of the SIDS, SUDS and control cases by age and gender is demonstrated in 
Figures 4-3 and Figure 4-4. 
The distribution of body measurements and organ weights is shown in Tables 4-2 to 4-10. 
Growth curves for individual organ weight and body measurement means could be found in 
Appendix E (Figures E-1 to E-3). 
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4.2 Inferential Statistics 
The results of a backward selection process using AIC (Akaike Information Criterion) in a 
stepwise algorithm are shown in Table 4-11 and Table 4-12.  
All tested factors (age, gender and cause of death) were important for the following weights: 
brain, combined lungs, right and left lungs, liver, spleen, combined adrenals, right and left 
adrenals, combined kidneys, the right and left kidney and thymus. The age and gender but not 
the cause of death were significant for the body weight and weights of pancreas and heart.  
The gender was significant for some organs (heart, kidneys, brain, spleen and body weight) 
across several age groups, with other organ weights (lungs, liver, pancreas, adrenal glands) 
being less gender dependent. The effects of gender for each organ in different age groups are 
shown in Table 4-13 (p-values in Appendix F, Table F-1). 
All organ weights selected by AIC were further assessed for significant differences between the 
age, gender and cause of death groups using a three way pairwise t-test (between Control and 
SIDS, Control and SUDS, SIDS and SUDS groups), as shown in Tables 4-14 to 4-20 (p-values 
in Appendix F, Table F-2 to Table F-8). Statistically significant differences between various 
groups at specific age intervals are shown in Figures 4-5 to 4-24.   
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Figure 4-1. Distribution of the Study Population by Age Groups 
 
The distribution of the cases based on age. The highest incidence was during the neonatal 
period (within the first 28 days after birth) with most of the deaths reported within the first  
2 weeks of life. The frequency decreased in older children.  
 
 
 
Figure 4-2. Distribution of Cases between the Cause of Death Groups 
 
The distribution of selected cases between the cause of death groups. Nearly half of the cases 
(48%, n=432) were in the Control group, followed closely by SUDS deaths (38.4%, n=346), 
and the lowest frequency being SIDS deaths (13.6%, n=122). 
 
 
 
 
Table 4-1. Gender Distribution in the Cause of Death Groups 
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The distribution of male and female deaths in SIDS, SUDS and Control groups. SIDS deaths 
showed the highest male predominance.  There was a higher male frequency in the SUDS group 
in comparison with the controls. A chi-square test of goodness of fit (p=0.0720) with Yate`s 
correction for continuity (p=0.0923) showed no significant differences between the groups. The 
sample is roughly evenly distributed by percentages among the groups.  
 
CAUSE OF DEATH MALES FEMALES TOTAL 
SIDS 
82 
67.2% 
40 
32.8% 
122 
100% 
SUDS 
209 
60.4% 
137 
39.6% 
346 
100% 
Control 
242 
56.1% 
190 
43.9% 
432 
100% 
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Figure 4-3. Distribution of Male Deaths by Age in Each Cause of Death Group  
 
The figure shows a large variation in the sample size between the cause of death groups for the 
first 24 weeks. The sample sizes were more constant for the remainder of the 1st year. There 
was an increase in frequency of SIDS and SUDS deaths between the 1st and 6th month. 
 
 
 
 
Figure 4-4. Distribution of Female Deaths by Age in Each Cause of Death Group 
 
The figure shows the tendencies similar to the above described for the male deaths.
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Table 4-2. Male Body Measurements 
Table shows the mean, standard deviation and sample size for each organ by age in weeks. Body weight is provided in grams; the 
remainder of the measurements in centimeters. 
Age (Weeks) 
 
Body Weight Crown-Heel Crown-Rump Head Cir. Abdomen Cir. Chest Cir. Foot Length 
0-2 Mean 3591.97 51.37 36.39 34.98 31.99 32.89 7.75 
 
SD 657.75 3.21 2.50 1.94 3.11 3.02 0.64 
 
n 131 134 71 106 105 107 80 
3-4 Mean 4045.28 53.91 38.36 36.26 33.64 34.60 7.98 
 
SD 675.72 3.11 2.07 1.93 4.61 3.31 0.56 
 
n 28 31 18 29 29 29 21 
5-8 Mean 4685.39 56.47 40.30 38.01 36.11 36.51 8.42 
 
SD 686.91 3.11 2.09 1.82 2.96 2.32 0.69 
 
n 81 80 44 70 65 67 44 
9-12 Mean 5472.20 59.06 41.47 39.67 38.97 38.41 8.55 
 
SD 778.84 2.91 2.99 1.35 2.64 2.31 0.55 
 
n 66 68 40 60 54 56 33 
13-16 Mean 6329.17 61.34 43.70 40.98 40.60 40.51 8.99 
 
SD 1007.05 3.64 2.48 1.28 3.78 2.35 0.55 
 
n 48 48 28 44 40 43 25 
17-20 Mean 7003.19 64.19 45.37 42.65 40.91 41.81 9.31 
 
SD 1019.52 4.00 2.69 2.91 3.21 2.79 0.66 
 
n 47 46 30 44 38 39 29 
21-24 Mean 7230.42 65.31 45.25 42.48 43.38 42.47 9.53 
 
SD 940.94 3.15 2.96 1.88 3.38 2.18 0.67 
 
n 26 27 12 18 17 18 14 
25-28 Mean 7772.17 66.64 45.92 43.19 41.79 42.33 9.44 
 
SD 1384.25 2.10 2.27 1.40 3.25 2.17 0.55 
 
n 29 29 17 26 25 26 21 
29-32 Mean 8331.23 69.65 48.28 44.42 42.92 42.96 9.73 
 
SD 1152.27 2.84 1.72 1.99 3.65 2.10 0.63 
 
n 13 13 9 12 12 12 10 
33-36 Mean 9006.67 71.33 50.00 45.00 43.40 44.30 10.43 
 
SD 1165.21 5.09 4.24 1.00 1.34 1.25 0.81 
 
n 6 6 2 5 5 5 4 
37-40 Mean 8315.00 70.47 47.80 44.81 41.13 43.26 10.10 
 
SD 983.87 3.34 3.22 2.26 4.07 2.21 0.56 
 
n 11 11 7 10 10 10 6 
41-44 Mean 8461.43 71.00 47.67 45.75 42.67 44.08 10.17 
 
SD 623.60 3.55 2.89 2.75 3.52 2.29 1.31 
 
n 7 8 3 6 6 6 4 
45-52 Mean 9635.38 75.56 49.44 46.91 45.12 46.22 11.02 
 
SD 1402.55 2.41 1.72 1.42 3.88 3.20 0.47 
 
n 13 17 8 16 16 16 13 
Cir. (circumference) 
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Table 4-3. Male Organ Weights 
Table shows the mean, standard deviation and sample size for each organ by age in weeks. All measurements are in grams. 
Age (Weeks) 
 
Heart R. Lung L. Lung R. Kidney L. Kidney Liver Spleen Pancreas Adrenals Thymus Brain 
0-2 Mean 22.74 39.33 32.02 15.68 16.43 146.51 12.21 4.94 7.31 11.98 415.43 
 
SD 4.58 8.87 8.51 4.31 4.26 38.65 4.84 1.80 3.81 5.40 58.99 
 
n 98 48 49 122 121 126 136 99 109 120 60 
3-4 Mean 25.86 52.06 47.47 18.00 18.30 167.99 15.52 6.08 5.37 21.45 503.47 
 
SD 6.14 11.98 11.72 6.05 4.71 44.00 6.94 2.16 1.74 10.26 60.55 
 
n 25 21 21 27 27 28 30 26 26 26 20 
5-8 Mean 28.92 60.93 50.86 19.64 20.42 192.76 16.69 7.71 4.69 27.02 556.62 
 
SD 4.60 11.88 10.46 3.54 4.36 39.35 6.45 6.94 1.67 11.10 61.33 
 
n 64 62 62 74 73 76 79 60 61 62 60 
9-12 Mean 32.58 67.63 59.57 21.97 22.27 210.87 21.95 7.85 4.42 29.41 623.21 
 
SD 4.89 12.57 11.95 4.84 4.61 35.87 7.10 2.34 1.70 9.09 62.19 
 
n 62 47 47 63 63 63 66 53 56 59 54 
13-16 Mean 34.07 75.16 62.32 23.45 24.21 247.20 23.25 10.30 4.72 39.73 699.15 
 
SD 5.28 12.66 9.67 4.97 4.85 43.29 6.82 3.97 2.00 13.99 80.01 
 
n 43 39 39 43 43 45 45 39 37 44 42 
17-20 Mean 35.70 77.46 63.40 23.99 25.26 260.76 23.95 10.18 4.34 35.77 737.28 
 
SD 5.07 15.10 13.96 4.84 5.25 48.53 6.16 3.44 1.48 12.94 154.22 
 
n 41 34 34 45 44 46 42 32 41 39 34 
21-24 Mean 37.59 77.74 62.65 25.10 27.31 275.24 25.93 12.08 4.54 38.69 787.34 
 
SD 4.51 18.71 11.73 4.62 5.08 49.70 8.08 3.22 1.07 15.13 103.21 
 
n 22 20 20 24 25 24 25 19 20 24 21 
25-28 Mean 40.08 83.44 70.45 26.62 27.09 289.90 29.64 13.56 4.87 30.60 817.93 
 
SD 5.79 17.05 15.29 5.38 5.42 41.27 10.33 5.89 1.57 13.89 75.27 
 
n 27 18 17 28 28 28 26 23 25 26 22 
29-32 Mean 43.29 93.66 79.52 27.89 29.43 324.43 24.71 13.23 4.58 36.63 873.61 
 
SD 5.34 20.08 13.74 6.75 6.77 29.14 10.11 2.13 1.44 18.66 62.50 
 
n 8 5 5 12 12 11 10 11 12 11 8 
33-36 Mean 46.14 92.17 75.42 30.10 30.12 326.36 32.67 14.78 4.20 39.28 994.46 
 
SD 3.82 18.54 13.61 4.55 3.72 25.87 12.33 4.17 1.00 12.03 59.86 
 
n 5 4 4 5 5 5 6 6 6 5 5 
37-40 Mean 40.66 75.43 65.86 25.13 26.54 326.10 27.80 14.38 3.51 29.43 978.51 
 
SD 5.89 22.73 16.79 4.27 5.73 27.99 8.50 2.73 1.00 10.49 78.49 
 
n 11 9 9 9 9 11 11 10 10 12 9 
41-44 Mean 47.48 73.6 60.03 27.50 26.40 312.10 31.05 19.66 4.30 24.60 982.50 
 
SD 7.34 13.10 18.14 3.11 2.10 46.87 11.08 4.35 1.02 17.26 179.42 
 
n 4 3 3 5 5 6 6 5 4 5 4 
45-52 Mean 48.9 86.22 65.47 28.60 30.54 360.83 39.30 20.74 4.56 29.58 1058.27 
 
SD 5.75 33.41 17.60 5.55 5.73 69.91 16.51 4.97 1.75 11.67 70.41 
 
n 15 4 4 18 18 17 18 13 15 15 13 
R. (right), L. (left) 
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Table 4-4. Male Heart Measurements 
Table shows the mean, standard deviation and sample size for cardiac structures by age in weeks. Heart weight in grams, cardiac valve 
circumferences in centimeters, ventricular wall thickness in millimeters. 
Age (Weeks) 
 
Heart Weight LV RV TV PV MV AV 
0-2 Mean 22.74 5.39 3.21 39.30 23.65 33.96 21.11 
 
SD 4.58 1.14 0.83 4.85 3.30 4.21 2.50 
 
n 98 76 76 81 82 80 81 
3-4 Mean 25.86 6.14 2.86 40.43 24.24 34.00 22.24 
 
SD 6.14 1.39 1.37 4.15 3.66 5.02 3.27 
 
n 25 21 21 21 21 21 21 
5-8 Mean 28.92 6.67 2.51 44.6 26.57 37.73 24.24 
 
SD 4.60 1.30 0.76 5.12 3.27 4.25 2.88 
 
n 64 45 45 50 47 49 50 
9-12 Mean 32.58 6.72 2.13 47.02 28.71 38.45 26.25 
 
SD 4.89 0.98 0.62 5.24 4.08 4.14 3.12 
 
n 62 51 51 51 48 49 51 
13-16 Mean 34.07 7.23 2.12 49.87 30.44 41.00 27.50 
 
SD 5.28 1.01 0.54 4.18 3.57 4.47 4.52 
 
n 43 33 34 35 34 34 34 
17-20 Mean 35.70 6.82 2.20 50.62 29.64 41.04 26.81 
 
SD 5.07 1.22 0.44 5.34 3.73 3.91 3.35 
 
n 41 28 28 26 25 26 26 
21-24 Mean 37.59 7.20 2.33 52.31 31.25 43.56 29.13 
 
SD 4.51 1.37 0.62 5.53 4.36 4.10 3.36 
 
n 22 15 15 16 16 16 15 
25-28 Mean 40.08 7.32 2.37 53.59 32.26 43.00 30.17 
 
SD 5.79 1.04 0.68 4.66 2.97 5.09 4.43 
 
n 27 22 23 22 23 23 23 
29-32 Mean 43.29 6.83 2.22 58.00 37.29 46.57 31.00 
 
SD 5.34 1.22 0.44 5.13 3.30 2.82 3.87 
 
n 8 9 9 7 7 7 7 
33-36 Mean 46.14 7.80 2.10 55.00 35.40 47.80 31.20 
 
SD 3.82 1.79 0.55 4.90 2.30 3.03 1.30 
 
n 5 5 5 5 5 5 5 
37-40 Mean 40.66 7.33 1.83 55.10 34.70 44.30 30.90 
 
SD 5.89 1.32 0.35 4.56 5.19 4.76 3.96 
 
n 11 9 9 10 10 10 10 
41-44 Mean 47.48 8.25 2.75 58.00 38.00 51.50 34.50 
 
SD 7.34 1.26 1.50 6.78 4.24 5.07 4.20 
 
n 4 4 4 4 4 4 4 
45-52 Mean 48.90 8.00 2.54 59.46 36.31 48.62 31.77 
 
SD 5.75 0.82 0.52 3.20 4.21 2.75 2.17 
 
n 15 13 13 13 13 13 13 
LV (left ventricle), RV (right ventricle), TV (tricuspid valve), PV (pulmonary valve), MV (mitral valve), AV (aortic valve) 
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Table 4-5. Female Body Measurements 
Table shows the mean, standard deviation and sample size for each organ by age in weeks. Body weight is provided in grams; the 
remainder of the measurements in centimeters. 
Age (Weeks)   Body Weight Crown-Heel Crown-Rump Head Cir. Abdomen Cir. Chest Cir. Foot Length 
0-2 Mean 3496.25 51.13 35.76 34.31 31.77 32.89 7.73 
 
SD 681.26 2.62 2.27 1.84 3.27 2.66 0.56 
  n 118 119 69 97 93 95 70 
3-4 Mean 3905.71 52.73 36.67 35.35 33.24 33.24 7.58 
 
SD 595.45 2.98 2.38 2.08 4.53 2.94 0.53 
  n 31 34 20 28 28 28 21 
5-8 Mean 4525.15 55.83 39.29 37.14 36.01 36.36 8.20 
 
SD 654.67 3.29 2.02 1.71 2.37 2.26 0.73 
  n 42 43 27 36 32 34 26 
9-12 Mean 4987.36 57.65 40.04 38.49 37.39 37.58 8.22 
 
SD 720.19 3.24 2.31 1.54 3.74 2.68 0.54 
  n 42 44 25 35 36 36 23 
13-16 Mean 5777.63 60.84 42.38 39.91 39.13 39.15 8.83 
 
SD 984.79 2.85 4.38 1.45 3.47 2.51 0.56 
  n 27 29 17 23 21 22 15 
17-20 Mean 6357.17 63.72 44.47 40.79 39.33 39.77 9.08 
 
SD 721.52 3.55 2.78 1.86 3.05 1.94 0.56 
  n 23 25 16 24 23 23 16 
21-24 Mean 6381.47 65.00 45.58 41.27 39.14 40.14 9.30 
 
SD 1086.61 3.43 3.80 2.17 2.44 2.54 0.52 
  n 15 15 6 11 11 11 8 
25-28 Mean 7131.11 65.05 44.50 41.94 38.69 40.31 9.33 
 
SD 1088.40 3.72 1.94 1.01 2.07 1.60 0.61 
  n 9 10 7 9 8 8 6 
29-32 Mean 8086.73 68.50 48.33 44.00 44.25 43.75 9.66 
 
SD 813.82 2.52 4.37 1.33 4.02 1.57 0.86 
  n 11 11 6 10 10 10 8 
33-36 Mean 8339.00 70.88 50.00 47.00 49.25 44.00 9.35 
 
SD 988.54 4.37 0 1.73 1.77 4.36 0.21 
  n 2 4 2 3 2 3 2 
37-40 Mean 7962.50 69.60 47.33 45.62 40.33 40.83 10.45 
 
SD 938.45 3.51 4.73 1.11 1.53 1.61 0.53 
  n 4 5 3 4 3 3 4 
41-44 Mean 9023.33 71.67 46.92 43.94 42.92 44.00 10.75 
 
SD 898.73 4.12 2.13 1.72 2.65 2.63 0.35 
  n 6 9 6 7 6 7 2 
45-52 Mean 8810.71 73.72 48.11 45.20 43.75 44.30 10.54 
 
SD 1003.64 1.74 3.32 2.15 3.78 2.21 1.14 
  n 14 12 9 10 10 10 7 
Cir. (circumference) 
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Table 4-6. Female Organ Weights 
Table shows the mean, standard deviation and sample size for each organ by age in weeks. All measurements are in grams. 
Age (Weeks)   Heart  R. Lung L. Lung R. Kidney L. Kidney Liver Spleen Pancreas Adrenals Thymus Brain 
0-2 Mean 21.29 35.95 30.58 14.49 14.92 154.85 10.88 4.65 7.55 10.76 397.53 
 
SD 4.80 10.17 8.71 3.69 3.70 41.18 4.23 1.93 3.63 5.23 51.11 
  n 86 47 47 104 101 113 118 89 96 103 53 
3-4 Mean 22.37 45.81 40.65 16.39 17.17 151.91 13.00 5.90 4.29 20.43 460.23 
 
SD 3.77 12.78 9.65 3.73 3.95 23.20 3.85 1.94 1.32 6.62 57.41 
  n 25 21 21 28 28 29 33 25 27 26 28 
5-8 Mean 27.43 58.54 51.08 17.97 18.37 191.32 16.01 6.12 4.31 23.37 525.04 
 
SD 4.80 13.50 12.65 3.86 3.67 32.73 5.92 2.54 2.18 8.46 61.64 
  n 33 33 33 40 40 42 42 30 33 38 33 
9-12 Mean 28.79 62.17 52.59 18.74 19.02 197.20 16.91 7.18 3.74 27.13 589.03 
 
SD 4.48 11.06 11.36 3.54 3.77 32.86 6.15 2.77 1.39 8.76 54.39 
  n 41 36 36 37 37 40 43 33 33 36 40 
13-16 Mean 31.88 66.85 58.45 20.23 21.39 221.24 19.69 8.98 4.11 32.00 666.35 
 
SD 8.44 11.76 11.38 4.33 5.38 43.81 7.57 2.29 1.22 11.00 70.40 
  n 24 20 20 27 27 25 26 20 24 26 24 
17-20 Mean 32.32 71.85 62.63 22.36 23.43 228.67 21.37 10.38 3.99 32.16 692.35 
 
SD 4.38 8.29 10.93 5.28 5.74 45.27 6.14 3.81 1.49 11.04 56.75 
  n 21 14 13 20 20 25 25 20 20 17 15 
21-24 Mean 33.51 70.81 63.30 22.38 22.95 255.48 22.23 9.53 3.36 27.84 824.89 
 
SD 3.83 10.04 10.62 3.98 4.99 38.01 5.86 2.76 1.35 12.29 61.48 
  n 11 9 9 14 14 14 12 11 11 14 9 
25-28 Mean 34.59 80.83 67.53 20.37 20.61 262.49 21.02 11.00 3.64 29.39 784.99 
 
SD 4.67 8.51 7.83 5.88 4.85 26.53 5.79 2.70 0.99 8.19 90.94 
  n 8 6 6 7 7 9 9 8 5 7 7 
29-32 Mean 40.93 83.22 65.76 26.42 29.60 314.39 26.32 14.67 3.44 35.36 899.70 
 
SD 8.21 21.66 20.28 6.41 7.54 51.40 6.91 3.81 1.32 12.55 45.73 
  n 9 5 5 10 10 10 10 9 6 10 7 
33-36 Mean 38.67 56.00 47.00 23.00 26.00 256.85 31.53 14.90 4.83 40.40 - 
 
SD 8.33 - - - - 46.88 13.51 7.21 1.61 - - 
  n 3 1 1 1 1 2 3 2 3 1 - 
37-40 Mean 45.20 100.00 68.50 26.86 28.78 320.05 29.70 15.40 4.90 25.24 893.40 
 
SD 2.31 0 0.71 2.57 2.84 35.44 10.96 5.05 0.81 7.30 118.22 
  n 3 2 2 5 5 4 5 3 4 5 5 
41-44 Mean 46.94 80.80 77.37 27.69 29.68 341.60 30.70 11.53 3.36 28.76 960.13 
 
SD 6.97 18.11 20.2 7.12 5.78 87.66 11.86 4.77 1.01 4.27 93.90 
  n 7 3 3 9 9 8 8 6 7 5 7 
45-52 Mean 43.00 88.21 72.13 29.62 29.56 348.82 34.62 15.16 4.77 33.39 964.66 
 
SD 4.38 18.91 16.14 6.22 5.30 51.59 8.01 3.96 3.13 9.80 78.88 
  n 11 9 9 12 12 12 12 9 11 10 10 
R. (right), L. (left) 
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Table 4-7. Female Heart Measurements 
Table shows the mean, standard deviation and sample size for cardiac structures by age in weeks. Heart weight in grams, cardiac valve 
circumferences in centimeters, ventricular wall thickness in millimeters.  
Age (Weeks)   Heart Weight LV RV TV PV MV AV 
0-2 Mean 21.29 5.06 2.97 38.68 23.36 32.76 20.47 
 
SD 4.80 1.02 0.93 4.61 3.20 4.69 2.66 
  n 86 69 69 69 70 70 70 
3-4 Mean 22.37 5.81 2.67 38.54 23.58 31.67 21.33 
 
SD 3.77 1.54 0.66 3.58 3.88 4.52 2.96 
  n 25 21 21 24 24 24 24 
5-8 Mean 27.43 6.21 2.47 43.86 25.93 35.83 23.48 
 
SD 4.80 1.07 0.84 4.62 3.73 3.78 2.97 
  n 33 28 29 29 29 29 29 
9-12 Mean 28.79 6.62 2.27 45.97 28.12 37.47 25.06 
 
SD 4.48 1.14 0.79 3.89 3.67 5.03 3.48 
  n 41 33 32 32 32 32 32 
13-16 Mean 31.88 7.10 2.14 48.40 29.65 39.11 26.35 
 
SD 8.44 1.55 0.57 5.55 3.67 4.45 2.46 
  n 24 21 21 20 20 19 20 
17-20 Mean 32.32 6.41 1.94 49.82 28.47 39.82 26.12 
 
SD 4.38 1.37 0.56 3.49 3.52 3.15 3.20 
  n 21 17 17 17 17 17 17 
21-24 Mean 33.51 7.22 2.19 52.80 31.20 42.30 28.40 
 
SD 3.83 0.83 0.53 4.39 2.78 1.95 3.50 
  n 11 9 8 10 10 10 10 
25-28 Mean 34.59 6.33 2.00 52.00 30.67 40.5 26.67 
 
SD 4.67 0.82 0 3.41 5.43 2.95 5.61 
  n 8 6 6 6 6 6 6 
29-32 Mean 40.93 7.50 2.44 53.50 32.62 45.00 29.62 
 
SD 8.21 1.60 0.62 5.37 3.16 3.02 2.56 
  n 9 8 8 8 8 8 8 
33-36 Mean 38.67 9.00 2.00 53.00 30.50 45.50 27.50 
 
SD 8.33 1.41 1.41 9.90 4.95 6.36 3.54 
  n 3 2 2 2 2 2 2 
37-40 Mean 45.20 7.50 4.00 55.00 38.00 43.5 32.50 
 
SD 2.31 0.71 1.41 0 4.24 2.12 3.54 
  n 3 2 2 2 2 2 2 
41-44 Mean 46.94 7.60 2.40 50.67 32.80 45.00 31.00 
 
SD 6.97 0.89 0.55 10.58 3.83 3.61 2.37 
  n 7 5 5 6 5 5 6 
45-52 Mean 43.00 7.22 1.94 53.89 33.00 45.00 31.00 
 
SD 4.38 1.56 0.53 6.03 4.69 3.32 5.05 
  n 11 9 9 9 9 9 9 
LV (left ventricle), RV (right ventricle), TV (tricuspid valve), PV (pulmonary valve), MV (mitral valve), AV (aortic valve) 
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Table 4-8. Body Measurements for Both Genders 
Table shows the mean, standard deviation and sample size for each organ by age in weeks. Body weight is provided in grams; the 
remainder of the measurements in centimeters. 
Age (Weeks)   Body Weight Crown-Heel Crown-Rump Head Cir. Abdomen Cir. Chest Cir. Foot Length 
0-2 Mean 3543.73 51.25 36.06 34.65 31.91 32.90 7.74 
 
SD 671.61 2.96 2.42 1.92 3.19 2.85 0.60 
  n 251 255 142 205 199 203 151 
3-4 Mean 3971.95 53.29 37.47 35.81 33.45 33.93 7.78 
 
SD 633.16 3.08 2.37 2.03 4.53 3.18 0.58 
  n 59 65 38 57 57 57 42 
5-8 Mean 4628.30 56.23 39.89 37.73 36.05 36.44 8.34 
 
SD 679.49 3.16 2.11 1.82 2.79 2.30 0.70 
  n 125 125 73 108 99 103 71 
9-12 Mean 5294.32 58.54 40.97 39.27 38.34 38.11 8.42 
 
SD 793.88 3.11 2.82 1.56 3.20 2.47 0.56 
  n 109 113 66 96 90 93 56 
13-16 Mean 6121.57 61.15 43.18 40.61 40.10 40.05 8.93 
 
SD 1023.74 3.33 3.31 1.42 3.72 2.47 0.55 
  n 76 78 46 67 61 65 40 
17-20 Mean 6775.56 63.97 44.99 41.97 40.27 41.02 9.22 
 
SD 977.50 3.83 2.73 2.72 3.21 2.68 0.62 
  n 71 72 47 69 62 63 46 
21-24 Mean 6919.83 65.20 45.36 42.02 41.71 41.58 9.45 
 
SD 1066.77 3.22 3.15 2.04 3.67 2.55 0.62 
  n 41 42 18 29 28 29 22 
25-28 Mean 7553.57 66.10 45.39 42.79 40.83 41.71 9.41 
 
SD 1334.95 2.67 2.26 1.45 3.33 2.25 0.55 
  n 40 41 26 37 35 36 28 
29-32 Mean 8219.17 69.12 48.30 44.23 43.52 43.32 9.70 
 
SD 998.09 2.70 2.91 1.70 3.79 1.88 0.72 
  n 24 24 15 22 22 22 18 
33-36 Mean 8735.33 71.05 49.80 45.56 44.44 43.94 10.07 
 
SD 1073.51 4.34 2.17 1.59 3.42 2.47 0.84 
  n 9 11 5 9 8 9 6 
37-40 Mean 8144.69 70.19 47.74 44.91 40.95 42.51 10.19 
 
SD 968.99 3.19 3.29 1.99 3.60 2.31 0.54 
  n 16 17 11 15 13 14 11 
41-44 Mean 8697.86 71.44 47.45 44.72 42.58 43.89 10.37 
 
SD 758.92 3.67 2.30 2.27 2.95 2.35 0.98 
  n 14 18 10 14 13 14 7 
45-52 Mean 9207.78 74.80 48.74 46.25 44.60 45.48 10.86 
 
SD 1260.11 2.32 2.70 1.89 3.83 2.97 0.78 
  n 27 29 17 26 26 26 20 
Cir. (circumference)  
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Table 4-9. Organ Weights for Both Genders 
Table shows the mean, standard deviation and sample size for each organ by age in weeks. All measurements are in grams. 
Age (Weeks)   Heart  R. Lung L. Lung R. Kidney L. Kidney Liver Spleen Pancreas Adrenals Thymus Brain 
0-2 Mean 22.03 37.66 31.31 15.16 15.76 150.06 11.56 4.80 7.43 11.37 407.04 
 
SD 4.73 9.64 8.59 4.08 4.08 40.37 4.61 1.86 3.71 5.34 55.91 
  n 185 95 96 227 223 240 256 189 206 225 113 
3-4 Mean 24.11 48.94 44.06 17.18 17.73 159.81 14.20 5.99 4.82 20.94 478.24 
 
SD 5.34 12.63 11.15 5.03 4.33 35.61 5.64 2.04 1.62 8.56 61.96 
  n 50 42 42 55 55 57 63 51 53 52 48 
5-8 Mean 28.40 60.19 50.81 18.97 19.66 192.20 16.52 7.18 4.53 25.77 545.92 
 
SD 4.66 12.39 11.15 3.75 4.20 36.78 6.22 5.82 1.85 10.32 63.00 
  n 99 97 97 116 115 120 123 92 96 101 95 
9-12 Mean 31.14 65.26 56.54 20.83 21.14 205.85 19.96 8.34 4.17 28.65 610.82 
 
SD 5.09 12.17 12.13 4.67 4.61 35.16 7.12 7.45 1.61 9.01 64.29 
  n 104 83 83 101 101 104 110 87 89 96 95 
13-16 Mean 33.34 72.35 61.01 22.21 23.09 238.11 22.08 9.85 4.48 36.13 686.68 
 
SD 6.58 12.89 10.35 4.92 5.18 44.64 7.29 3.53 1.73 13.38 77.28 
  n 68 59 59 71 71 71 72 59 62 72 67 
17-20 Mean 34.49 75.80 63.19 23.42 24.65 249.38 22.87 10.17 4.22 34.47 721.49 
 
SD 5.06 13.49 12.94 4.99 5.40 49.20 6.26 3.57 1.47 12.39 132.57 
  n 63 49 48 66 65 72 68 53 62 57 50 
21-24 Mean 36.23 75.59 62.85 24.10 25.74 267.96 24.73 11.15 4.12 34.69 798.61 
 
SD 4.66 16.64 11.21 4.54 5.41 46.22 7.56 3.26 1.29 14.95 93.25 
  n 33 29 29 38 39 38 37 30 31 38 30 
25-28 Mean 38.33 80.86 68.13 24.82 25.19 280.79 26.93 12.70 4.58 29.88 806.54 
 
SD 6.19 16.17 14.33 6.25 6.27 40.18 10.03 5.23 1.57 12.56 79.80 
  n 37 26 25 37 37 39 37 33 32 35 30 
29-32 Mean 42.04 88.44 72.64 27.22 29.50 319.65 25.52 13.88 4.20 36.02 885.79 
 
SD 6.90 20.45 17.87 6.48 6.96 40.49 8.47 3.01 1.47 15.66 55.05 
  n 17 10 10 22 22 21 20 20 18 21 15 
33-36 Mean 43.82 84.94 69.74 28.36 29.37 299.04 31.03 14.14 4.41 41.33 994.46 
 
SD 6.31 22.79 17.33 4.79 3.41 46.13 11.88 4.62 1.17 11.0 59.86 
  n 9 5 5 7 7 8 10 9 9 7 5 
37-40 Mean 41.92 77.24 64.14 26.50 28.05 324.49 28.39 14.50 3.91 28.91 948.11 
 
SD 5.50 23.46 16.25 4.63 5.46 28.92 9.00 3.07 1.12 9.83 99.41 
  n 15 12 12 15 15 15 16 14 14 18 14 
41-44 Mean 46.81 78.79 68.09 27.95 29.11 333.07 31.43 15.19 3.66 26.20 969.12 
 
SD 6.52 14.04 17.98 5.78 5.32 71.37 10.92 5.80 1.03 11.55 117.10 
  n 12 7 7 15 15 15 15 12 12 11 12 
45-52 Mean 46.40 87.60 70.08 29.42 30.47 359.16 37.84 18.74 4.70 31.14 1017.57 
 
SD 5.92 22.77 16.16 6.11 5.68 63.79 13.72 5.34 2.34 10.69 86.61 
  n 26 13 13 31 31 30 31 23 27 26 23 
R. (right), L. (left) 
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Table 4-10. Heart Measurements for Both Genders 
Table shows the mean, standard deviation and sample size for cardiac structures by age in weeks. Heart weight in grams, cardiac valve 
circumferences in centimeters, ventricular wall thickness in millimeters. 
Age (Weeks) 
 
Heart Weight LV RV TV PV MV AV 
0-2 Mean 22.03 5.23 3.10 39.01 23.52 33.40 20.81 
 
SD 4.73 1.10 0.88 4.74 3.25 4.47 2.59 
 
n 185 145 145 150 152 150 151 
3-4 Mean 24.11 5.98 2.76 39.42 23.89 32.76 21.76 
 
SD 5.34 1.46 1.07 3.93 3.75 4.85 3.11 
 
n 50 42 42 45 45 45 45 
5-8 Mean 28.40 6.52 2.48 44.30 26.40 36.94 23.99 
 
SD 4.66 1.22 0.78 4.88 3.43 4.18 2.88 
 
n 99 75 76 81 78 80 81 
9-12 Mean 31.14 6.68 2.19 46.65 28.49 38.15 25.80 
 
SD 5.09 1.03 0.69 4.75 3.89 4.54 3.27 
 
n 104 85 84 84 81 82 84 
13-16 Mean 33.34 7.19 2.12 49.44 30.24 40.44 27.16 
 
SD 6.58 1.23 0.54 4.74 3.62 4.56 3.92 
 
n 68 55 56 56 55 54 55 
17-20 Mean 34.49 6.65 2.12 50.39 29.30 40.55 26.61 
 
SD 5.06 1.27 0.51 4.65 3.71 3.60 3.27 
 
n 63 46 46 44 43 44 44 
21-24 Mean 36.23 7.21 2.28 52.50 31.23 43.08 28.84 
 
SD 4.66 1.18 0.58 5.04 3.77 3.44 3.36 
 
n 33 24 23 26 26 26 25 
25-28 Mean 38.33 7.00 2.27 52.83 31.71 42.35 29.16 
 
SD 6.19 1.11 0.60 4.57 3.56 4.66 4.78 
 
n 37 30 31 30 31 31 31 
29-32 Mean 42.04 7.15 2.32 55.60 34.80 45.73 30.27 
 
SD 6.90 1.41 0.53 5.58 3.93 2.94 3.20 
 
n 17 17 17 15 15 15 15 
33-36 Mean 43.82 8.12 2.19 54.12 34.00 46.88 30.12 
 
SD 6.31 1.55 0.75 5.41 3.38 3.56 2.36 
 
n 9 8 8 8 8 8 8 
37-40 Mean 41.92 7.50 2.21 54.69 35.00 43.85 30.77 
 
SD 5.50 1.24 0.99 4.19 4.90 4.34 3.90 
 
n 15 12 12 13 13 13 13 
41-44 Mean 46.81 7.90 2.50 54.18 35.60 48.30 32.73 
 
SD 6.52 0.99 0.97 9.29 4.65 5.14 3.50 
 
n 12 10 10 11 10 10 11 
45-52 Mean 46.40 7.68 2.30 57.18 34.95 47.14 31.45 
 
SD 5.92 1.21 0.59 5.25 4.61 3.44 3.54 
 
N 26 22 22 22 22 22 22 
LV (left ventricle), RV (right ventricle), TV (tricuspid valve), PV (pulmonary valve), MV (mitral valve), AV (aortic valve) 
43 
 
 
Table 4-11. Akaike Information Criterion (AIC) Backward Selection 
 
AIC model selection based on information theory. The lower the AIC value the stronger 
the model.  (E=exponential power, positive or negative). 
 
  Age Gender Cause of Death 
Heart 1.60E-153 1.05E-10 4.62E-01 
Lungs 4.19E-94 3.85E-04 9.91E-08 
R. Lung 3.50E-88 2.07E-04 2.82E-07 
L. Lung 8.73E-81 9.74E-03 1.49E-07 
Kidneys 1.20E-105 1.86E-09 3.08E-02 
R. Kidney 6.92E-98 3.24E-08 2.61E-02 
L. Kidney 1.39E-102 7.36E-09 1.23E-01 
Liver 5.21E-89 7.02E-04 1.80E-02 
Spleen 6.28E-114 6.66E-07 8.97E-03 
Pancreas 4.43E-89 7.02E-04 3.46E-01 
Adrenals 2.50E-37 9.12E-02 5.03E-08 
R. Adrenal 1.42E-32 1.82E-01 1.19E-07 
L. Adrenal 7.59E-36 6.76E-02 7.74E-07 
Brain 5.75E-224 2.83E-06 1.32E-03 
Body 3.34E-288 7.61E-08 4.08E-01 
Thymus 3.071E-102 9.535E-05 6.953E-14 
 
Table 4-12.  P-values for Akaike Information Criterion 
 
AIC value for each individual variable based on asymptotic theory (large sample theory). 
“0” p-values represent values less than 0.000.  
 
 Age Gender Cause of Death 
Heart 0 0 0.46 
Lungs 0 0 0 
R. Lung 0 0 0 
L. Lung 0 0.01 0 
Kidneys 0 0 0.03 
R. Kidney 0 0 0.03 
L. Kidney 0 0 0.12 
Liver 0 0.01 0.02 
Spleen 0 0 0.01 
Pancreas 0 0 0.35 
Adrenals 0 0.09 0 
R. Adrenal 0 0.18 0 
L. Adrenal 0 0.07 0 
Brain 0 0 0 
Body 0 0 0.41 
Thymus 0 0 0 
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Table 4-13. Effect of Gender on Individual Organ and Body Weight for Different Age Groups 
 
The table shows how gender affects the weights of various organs and whole body weight. Significant relationships between the 
gender and specific organ or body weight are labelled as “1” (p<0.05). For all variables, “1” represents male organ heavier than female 
except the adrenals at age of 37-40 weeks. Instances with no statistical relationship are labelled as “0” (see Appendix F for p-values).  
Age in weeks Heart Lungs R.Lung L.Lung Kidneys R.Kidney L.Kidney Liver Spleen Pancreas Adre R.Adre L.Adre Brain Body 
0-2 1 0 0 0 1 1 1 0 1 0 0 0 0 0 0 
3-4 1 0 0 1 0 0 0 0 0 0 1 1 1 1 0 
5-8 0 0 0 0 1 1 1 0 0 0 0 0 0 1 0 
9-12 1 1 1 1 1 1 1 0 1 0 0 0 1 1 1 
13-16 0 1 1 0 1 1 1 1 1 0 0 0 0 0 1 
17-20 1 0 0 0 0 0 0 1 0 0 0 0 0 0 1 
21-24 1 0 0 0 1 0 1 0 0 1 1 1 0 0 1 
25-28 1 0 0 0 1 1 1 0 1 0 0 0 0 0 0 
29-32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
33-36 0 - - - - - - 1 0 0 0 0 0 - 0 
37-40 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 
41-44 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
45-52 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 
  
R. (right), L. (left), Adre. (adrenal)
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Table 4-14. Combined Lung Weight Correlated to Cause of Death 
 
The table shows statistically significant differences in combined lung weights depending 
on the cause of death, across different age groups, for each gender separately and 
combined. Significant relationship between the groups are labeled as “1” (p<0.05). 
Instances with no statistical relationship are labeled as “0” (p-values are provided in 
Appendix F). 
 
 
MALES 
 
Control-SIDS Control-SUDS SIDS-SUDS 
 
 FEMALES Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 1 0 
 
 
0-2 0 1 0 
3-4 1 1 0 
 
 
3-4 0 1 0 
5-8 0 0 0 
 
 
5-8 0 0 0 
9-12 0 0 0 
 
 
9-12 1 1 0 
13-16 0 0 0 
 
 
13-16 0 0 0 
17-20 0 0 0 
 
 
17-20 0 0 0 
21-24 1 1 0 
 
 
21-24 0 0 0 
25-28 0 0 0 
 
 
25-28 1 1 1 
29-32 0 0 0 
 
 
29-32 - - 0 
33-36 0 0 0 
 
 
33-36 - - - 
37-40 0 0 0 
 
 
37-40 - - - 
41-44 - 0 - 
 
 
41-44 0 - - 
45-52 0 0 0 
 
 
45-52 0 0 0 
 
 
 
COMBINED GENDERS Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 1 0 
3-4 1 1 0 
5-8 0 1 0 
9-12 0 0 0 
13-16 0 0 0 
17-20 0 0 0 
21-24 0 0 0 
25-28 0 0 0 
29-32 0 0 0 
33-36 0 0 0 
37-40 0 0 0 
41-44 0 0 0 
45-52 0 0 0 
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Table 4-15. Combined Kidney Weight Correlated to Cause of Death 
 
The table shows statistically significant differences in combined kidney weights 
depending on the cause of death, across different age groups, for each gender separately 
and combined. Significant relationship between the groups are labeled as “1” (p<0.05). 
Instances with no statistical relationship are labeled as “0” (p-values are provided in 
Appendix F). 
  
MALES Control-SIDS Control-SUDS SIDS-SUDS  
 
FEMALES Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 0 0 
 
 
0-2 0 0 0 
3-4 0 0 0 
 
 
3-4 0 1 0 
5-8 0 0 0 
 
 
5-8 0 0 0 
9-12 0 0 0 
 
 
9-12 0 0 1 
13-16 0 0 1 
 
 
13-16 0 0 0 
17-20 0 0 0 
 
 
17-20 0 0 0 
21-24 0 0 0 
 
 
21-24 0 0 0 
25-28 0 0 0 
 
 
25-28 0 0 0 
29-32 0 0 0 
 
 
29-32 0 0 0 
33-36 0 0 0  
 
33-36 - - - 
37-40 0 0 0 
 
 
37-40 0 0 0 
41-44 - - -  
 
41-44 0 - - 
45-52 0 0 0 
 
 
45-52 0 0 0 
 
 
 
COMBINED GENDERS Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 0 0 
3-4 0 0 0 
5-8 0 0 0 
9-12 0 0 0 
13-16 0 0 1 
17-20 0 0 0 
21-24 0 0 0 
25-28 0 0 0 
29-32 0 0 0 
33-36 0 0 0 
37-40 0 0 0 
41-44 0 - - 
45-52 0 0 0 
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Table 4-16. Liver Weight Correlated to Cause of Death 
 
The table shows statistically significant differences in liver weights depending on the 
cause of death, across different age groups, for each gender separately and combined. 
Significant relationship between the groups are labeled as “1” (p<0.05). Instances with no 
statistical relationship are labeled as “0” (p-values are provided in Appendix F). 
 
MALES Control-SIDS Control-SUDS SIDS-SUDS   FEMALES Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 0 0 
  
0-2 1 0 0 
3-4 0 0 0 
  
3-4 0 1 0 
5-8 0 0 0 
  
5-8 0 0 0 
9-12 0 0 0 
  
9-12 0 0 0 
13-16 0 0 0 
  
13-16 0 0 0 
17-20 1 0 0 
  
17-20 0 0 0 
21-24 0 0 0 
  
21-24 0 0 0 
25-28 0 0 0 
  
25-28 0 0 0 
29-32 0 0 0 
  
29-32 0 0 0 
33-36 0 1 0   33-36 - - - 
37-40 0 0 0 
  
37-40 0 0 0 
41-44 - 1 -   41-44 0 - - 
45-52 0 0 0 
  
45-52 0 0 0 
 
 
 
BOTH GENDERS Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 0 0 
3-4 0 1 0 
5-8 0 0 0 
9-12 0 0 0 
13-16 0 0 0 
17-20 1 0 0 
21-24 0 0 0 
25-28 0 0 0 
29-32 0 0 0 
33-36 0 0 0 
37-40 1 0 0 
41-44 0 0 0 
45-52 0 0 0 
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Table 4-17. Brain Weight Correlated to Cause of Death 
 
The table shows statistically significant differences in brain weights depending on the 
cause of death, across different age groups, for each gender separately and combined. 
Significant relationship between the groups are labeled as “1” (p<0.05). Instances with no 
statistical relationship are labeled as “0” (p-values are provided in Appendix F). 
 
MALES Control-SIDS Control-SUDS SIDS-SUDS   FEMALES Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 0 0 
  
0-2 0 1 0 
3-4 0 0 0 
  
3-4 0 0 0 
5-8 0 0 0 
  
5-8 0 0 0 
9-12 0 0 0 
  
9-12 1 1 0 
13-16 0 0 0 
  
13-16 0 0 0 
17-20 0 0 0 
  
17-20 0 0 0 
21-24 0 0 0 
  
21-24 0 0 0 
25-28 0 0 0 
  
25-28 0 0 0 
29-32 - 0 - 
  
29-32 - - 0 
33-36 0 0 0   33-36 - - - 
37-40 0 0 0 
  
37-40 0 0 0 
41-44 - 0 -   41-44 0 - - 
45-52 0 0 0 
  
45-52 0 0 0 
 
 
 
COMBINED GENDERS Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 1 1 
3-4 0 0 0 
5-8 0 0 0 
9-12 0 0 0 
13-16 0 1 0 
17-20 0 0 0 
21-24 0 0 0 
25-28 0 0 0 
29-32 0 0 0 
33-36 0 0 0 
37-40 0 0 0 
41-44 0 0 0 
45-52 0 0 0 
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Table 4-18. Spleen Weight Correlated to Cause of Death 
 
The table shows statistically significant differences in spleen weights depending on the 
cause of death, across different age groups, for each gender separately and combined. 
Significant relationship between the groups are labeled as “1” (p<0.05). Instances with no 
statistical relationship are labeled as “0” (p-values are provided in Appendix F). 
 
MALES Control-SIDS Control-SUDS SIDS-SUDS 
 
 FEMALES Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 0 0 
 
 
0-2 0 0 0 
3-4 0 0 0 
 
 
3-4 0 0 0 
5-8 0 0 1 
 
 
5-8 0 0 0 
9-12 0 0 0 
 
 
9-12 0 0 0 
13-16 1 0 0 
 
 
13-16 0 0 0 
17-20 0 0 0 
 
 
17-20 0 0 0 
21-24 0 0 0 
 
 
21-24 0 0 0 
25-28 0 0 0 
 
 
25-28 0 0 0 
29-32 0 0 0 
 
 
29-32 0 0 0 
33-36 0 0 0 
 
 
33-36 - - - 
37-40 - - 0 
 
 
37-40 0 0 0 
41-44 - 0 - 
 
 
41-44 0 - - 
45-52 0 0 0 
 
 
45-52 0 0 0 
 
 
 
COMBINED GENDERS Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 0 0 
3-4 0 0 0 
5-8 0 1 1 
9-12 0 0 0 
13-16 0 0 0 
17-20 0 0 0 
21-24 0 0 0 
25-28 0 0 0 
29-32 0 0 0 
33-36 0 0 0 
37-40 0 0 0 
41-44 0 0 0 
45-52 0 0 0 
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Table 4-19. Combined Adrenal Weight Correlated to Cause of Death 
 
The table shows statistically significant differences in combined adrenals weights 
depending on the cause of death, across different age groups, for each gender separately 
and combined. Significant relationship between the groups are labeled as “1” (p<0.05). 
Instances with no statistical relationship are labeled as “0” (p-values are provided in 
Appendix F). 
 
MALES Control-SIDS Control-SUDS SIDS-SUDS  
 
FEMALES Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 1 0 
 
 
0-2 1 1 0 
3-4 0 0 0 
 
 
3-4 0 0 0 
5-8 0 0 0 
 
 
5-8 0 0 0 
9-12 0 0 0 
 
 
9-12 0 1 1 
13-16 0 0 1 
 
 
13-16 0 1 1 
17-20 0 0 0 
 
 
17-20 0 1 0 
21-24 0 0 0 
 
 
21-24 0 0 0 
25-28 0 0 0 
 
 
25-28 0 0 0 
29-32 0 0 0 
 
 
29-32 0 0 0 
33-36 0 0 0  
 
33-36 - - - 
37-40 0 0 0  
 
37-40 0 - - 
41-44 - 0 -  
 
41-44 0 - - 
45-52 0 1 1 
 
 
45-52 0 0 0 
 
 
BOTH GENDERS Control-SIDS Control-SUDS SIDS-SUDS 
0-2 1 1 0 
3-4 0 0 0 
5-8 0 0 0 
9-12 0 1 1 
13-16 1 0 1 
17-20 0 0 0 
21-24 0 0 0 
25-28 0 0 0 
29-32 0 0 0 
33-36 0 0 0 
37-40 0 1 0 
41-44 0 0 0 
45-52 0 0 0 
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Table 4-20. Thymus Weight Correlated to Cause of Death 
The table shows statistically significant differences in thymus weights depending on the 
cause of death, across different age groups, for each gender separately and combined. 
Significant relationship between the groups are labeled as “1” (p<0.05). Instances with no 
statistical relationship are labeled as “0” (p-values are provided in Appendix F). 
 
 
 
MALES 
 
Control-SIDS Control-SUDS SIDS-SUDS 
 
 FEMALES Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 1 1 
 
 
0-2 0 1 0 
3-4 1 1 0 
 
 
3-4 0 0 0 
5-8 0 1 0 
 
 
5-8 0 1 0 
9-12 0 0 0 
 
 
9-12 0 0 0 
13-16 0 0 0 
 
 
13-16 0 0 0 
17-20 0 1 0 
 
 
17-20 0 0 0 
21-24 1 1 0 
 
 
21-24 0 0 0 
25-28 0 0 0 
 
 
25-28 0 0 0 
29-32 0 0 0 
 
 
29-32 0 0 0 
33-36 0 0 0 
 
 
33-36 - - - 
37-40 0 0 0 
 
 
37-40 0 0 0 
41-44 - 0 - 
 
 
41-44 0 - - 
45-52 0 0 0 
 
 
45-52 0 0 0 
 
 
 
COMBINED GENDERS Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0 1 0 
3-4 1 1 0 
5-8 1 1 0 
9-12 0 0 0 
13-16 0 0 0 
17-20 0 1 0 
21-24 1 1 1 
25-28 0 0 0 
29-32 0 0 0 
33-36 0 0 0 
37-40 0 0 0 
41-44 0 1 0 
45-52 0 0 0 
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Figure 4-5. Difference in Combined Male Lung Weights between the Cause of Death 
Groups 
 
The figure shows significant differences in the means of combined male lung weights at 
specific age intervals between the cause of death groups: 
(a). Control (n=24) and SUDS (n=22) at 0-2 weeks; (p=0.0196); 
(b). Control (n=3) and SUDS (n=14) at 3-4 weeks; (p=0.0004);  
(c). Control (n=3) and SIDS (n=5) at 3-4 weeks; (p=0.005); 
(d). Control (n=5) and SIDS (n=5) at 21-24 weeks; (p=0.0298);  
(e). Control (n=5) and SUDS (n=11) at 21-24 weeks; (p=0.0189). 
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Figure 4-6. Difference in Combined Female Lung Weights between the Cause of Death Groups 
The figure shows significant differences in the means of combined female lung weights at specific age 
intervals between the cause of death groups: 
(a). Control (n=31) and SUDS (n=18) at 0-2 weeks; (p=0.0018); 
(b). Control (n=8) and SUDS (n=12) at 3-4 weeks; (p=0.0129);  
(c). Control (n=5) and SUDS (n=25) at 9-12 weeks; (p=0.00135); 
(d). Control (n=5) and SIDS (n=6) at 9-12 weeks; (p=0.0045);  
(e). Control (n=2) and SIDS (n=1) at 25-28 weeks; (p=0.040); 
(f). Control (n=2) and SUDS (n=3) at 25-28 weeks; (p=0.0113);  
(g). SIDS (n=1) and SUDS (=3) at 25-28 weeks; (p=0.0255).  
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Figure 4-7. Difference in Combined Lung Weights between the Cause of Death 
Groups (Genders Combined) 
 
The figure shows significant differences in the means of combined lung weights at 
specific age intervals between the cause of death groups (for both genders combined): 
(a). Control (n=55) and SUDS (n=40) at 0-2 weeks; (p=0.0001); 
(b). Control (n=11) and SIDS (n=7) at 3-4 weeks; (p=0.0029); 
(c). Control (n=11) and SUDS (n=26) at 3-4 weeks; (p=0.0000); 
(d). Control (n=20) and SUDS (n=66) at 5-8 weeks; (p=0.0396). 
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Figure 4-8. Difference in Combined Kidney Weights between the Cause of Death 
Groups (Males) 
 
The figure shows significant differences in the means of combined kidney weights 
between the cause of death groups (for males): 
SIDS (n=11) and SUDS (n=25) at 13-16 weeks; (p=0.0284). 
 
 
 
 
 
Figure 4-9. Difference in Combined Kidney Weights between the Cause of Death 
Groups (Females) 
 
The figure shows significant differences in the means of combined kidney weights at 
specific age intervals between the cause of death groups (for females): 
(a). Control (n=14) and SUDS (n=11) at 3-4 weeks; (p=0.0026); 
(b). SIDS (n=6) and SUDS (n=26) at 9-12 weeks; (p=0.0026). 
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Figure 4-10. Difference in Combined Kidney Weights between the Cause of Death 
Groups (Genders Combined) 
 
The figure shows significant differences in the means of combined kidney weights 
between the cause of death groups (for both genders combined): 
SIDS (n=14) and SUDS (n=40) at 13-16 weeks; (p=0.0382).   
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Figure 4-11. Difference in Male Liver Weights between the Cause of Death Groups 
 
The figure shows significant differences in the means of liver weights at specific age 
intervals between the cause of death groups (for males): 
(a). Control (n=11) and SIDS (n=10) at 17-20 weeks; (p=0.0168); 
(b). Control (n=3) and SUDS (n=5) at 33-36 weeks; (p=0.0460); 
(c). Control (n=5) and SUDS (n=1) at 41-44 weeks; (p=0.0385). 
 
 
 
 
Figure 4-12. Difference in Female Liver Weights between the Cause of Death Groups 
 
The figure shows significant differences in the means of liver weights at specific age 
intervals between the cause of death groups (for females): 
(a). Control (n=80) and SIDS (n=6) at 0-2 weeks of age; (p=0.02170; 
(b). Control (n=16) and SUDS (n=11) at 3-4 weeks of age; (p=0.0301). 
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Figure 4-13. Difference in Liver Weights between the Cause of Death Groups 
(Genders Combined) 
 
The figure shows significant differences in the means of liver weights at specific age 
intervals between the cause of death groups (for both genders combined): 
(a). Control (n=26) and SUDS (n=24) at 3-4 weeks; (p=0.0386); 
(b). Control (n=22) and SIDS (n=13) at17-20 weeks; (p=0.0376); 
(c). Control (n=3) and SIDS (n=6) at 37-40 weeks; (p=0.0294). 
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Figure 4-14. Difference in Female Brain Weights between the Cause of Death 
Groups 
 
The figure shows significant differences in the means of brain weights at specific age 
intervals between the cause of death groups (for females): 
(a). Control (n=24) and SUDS (n=23) at 0-2 weeks; (p=0.0051); 
(b). Control (n=6) and SIDS (n=7) at 9-12 weeks; (p=0.0021); 
(c). Control (n=6) and SUDS (n=27) at 9-12 weeks; (p=0.0056). 
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Figure 4-15. Difference in Brain Weights between the Cause of Death Groups 
(Genders Combined) 
 
The figure shows significant differences in the means of brain weights at specific age 
intervals between the cause of death groups (for both genders combined): 
(a). Control (n=53) and SUDS (n=48) at 0-2weeks; (p=0.0014); 
(b). SIDS (n=12) and SUDS (n=48) at 0-2 weeks; (p=0.0400); 
(c). Control (n=14) and SUDS (n=39) at 13-16 weeks; (p=0.0410). 
  
61 
 
 
 
 
Figure 4-16. Difference in Male Spleen Weights between the Cause of Death Groups 
 
The figure shows significant differences in the means of spleen weights at specific age 
intervals between the cause of death groups (for males): 
(a). SIDS (n=9) and SUDS (n=43) at 5-8 weeks; (p=0.0243); 
(b). Control (n=9) and SIDS (n=11) at 13-16 weeks; (p=0.0169). 
 
 
 
Figure 4-17 Difference in Spleen Weights between the Cause of Death Groups 
(Genders Combined) 
 
The figure shows significant differences in the means of spleen weights at specific age 
intervals between the cause of death groups (both genders combined): 
(a). Control (n=39) and SUDS (n=69) at 5-8 weeks; (p=0.0249); 
(b). SIDS (n=13) and SUDS (n=69) at 5-8 weeks; (p=0.0097). 
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Figure 4-18. Difference in Male Combined Adrenal Weights between the Cause of 
Death Groups 
 
The figure shows significant differences in the means of combined adrenal weights at 
specific age intervals between the cause of death groups (for males): 
(a). Control (n=80) and SUDS (n=23) at 0-2 weeks; (p=0.0001); 
(b). SIDS (n=8) and SUDS (n=23) at 13-16 weeks; (p=0.0468); 
(c). Control (n=12) and SUDS (n=1) at 45-52 weeks; (p=0.0460); 
(d). SIDS (n=2) and SUDS (n=1) at 45-52 weeks; (p=0.0265). 
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Figure 4-19. Difference in Female Combined Adrenal Weights between the Cause of 
Death Groups 
 
The figure shows significant differences in the means of combined adrenal weights at 
specific age intervals between the cause of death groups (for females): 
(a). Control (n=68) and SIDS (n=5) at 0-2 weeks; (p=0.0247); 
(b). Control (n=68) and SUDS (n=23) at 0-2 weeks; (p=0.0005); 
(c). Control (n=8) and SUDS (n=20) at 9-12 weeks; (p=0.0024); 
(d). SIDS (n=5) and SUDS (n=20) at 9-12 weeks; (p=0.0257); 
(e). Control (n=7) and SUDS (n=15) at 13-16 weeks; (p=0.0483); 
(f). SIDS (n=2) and SUDS (n=15) at 13-16 weeks; (p=0.0206); 
(g). Control (n=10) and SUDS (n=8) at 17-20 weeks; (p=0.0210). 
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Figure 4-20. Difference in Combined Adrenal Weights between the Cause of Death 
Groups (Genders Combined) 
 
The figure shows significant differences in the means of combined adrenal weights at 
specific age intervals between the cause of death groups (for both genders combined): 
(a). Control (n=148) and SUDS (n=46) at 0-2 weeks; (p=0.00000); 
(b). Control (n=148) and SIDS (n=11) at 0-2 weeks; (p=0.0259); 
(c). SIDS (n=15) and SUDS (n=50) at 9-12 weeks; (p=0.0376); 
(d). Control (n=24) and SUDS (n=50) at 9-12 weeks; (p=0.0130); 
(e). Control (n=13) and SIDS (n=10) at 13-16 weeks; (p=0.0221); 
(f). SIDS (n=10) and SUDS (n=38) at 13-16 weeks; (p=0.0024); 
(g). Control (n=4) and SUDS (n=4) at 37-40 weeks; (p=0.0453). 
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Figure 4-21. Differences in Male Thymus Weights between the Causes of Death Groups 
The figure shows significant differences in the means of thymus weights at specific age 
intervals between the cause of death groups (for males): 
(a). Control (n=88) and SUDS (n=25) at 0-2 weeks; (p=0.0000); 
(b). SIDS (n=7) and SUDS (n=25) at 0-2 weeks; (p=0.0348); 
(c). Control (n=9) and SIDS (n=4) at 3-4 weeks; (p=0.0432); 
(d). Control (n=9) and SUDS (n=13) at 3-4 weeks; (p=0.0093); 
(e). Control (n=15) and SIDS (n=25) at 5-8 weeks; (p=0.0019); 
(f). Control (n=7) and SUDS (n=11) at 17-20 weeks; (p=0.00463); 
(g). Control (n=7) and SIDS (n=6) at 21-24 weeks; (p=0.0026); 
(h). Control (n=7) and SUDS (n=5) at 21-24 weeks; (p=0.0178). 
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Figure 4-22. Differences in Female Thymus Weights between the Causes of Death Groups 
The figure shows significant differences in the means of thymus weights at specific age 
intervals between the cause of death groups (for females): 
(a). Control (n=72) and SUDS (n=25) at 0-2 weeks; (p=0.0001); 
(b). Control (n=9) and SUDS (n=25) at 5-8 weeks; (p=0.0138). 
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Figure 4-23. Differences in Thymus Weights between Cause of the Death Groups 
(Genders Combined, SUDS-Controls) 
The figure shows significant differences in the means of thymus weights at specific age 
intervals between the SUDS and Control groups (for both genders combined): 
(a). Control (n=160) and SUDS (n=25) at 0-2 weeks; (p=0.00000); 
(b). Control (n=19) and SUDS (n=13) at 3-4 weeks; (p=0.0067); 
(c). Control (n=24) and SUDS (n=38) at 5-8 weeks; (p=0.0001); 
(d). Control (n=11) and SUDS (n=21) at 17-20 weeks; (p=0.0318); 
(e). Control (n=15) and SUDS (n=16) at 21-24 weeks; (p=0.0060); 
(f). Control (n=7) and SUDS (n=1) at 41-44 weeks; (p=0.0327); 
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Figure 4-24. Differences in Thymus Weights between Cause of the Death Groups 
(Genders Combined, SIDS-Controls and SIDS-SUDS) 
The figure shows significant differences in the means of thymus weights at specific age 
intervals between the cause of death groups (for both genders combined): 
(a). Control (n=19) and SIDS (n=7) at 3-4 weeks; (p=0.0145); 
(b). Control (n=24) and SIDS (n=13) at 5-8 weeks; (p=0.0339); 
(c). Control (n=15) and SIDS (n=7) at 21-24 weeks; (p=0.0001); 
(d). SIDS (n=7) and SUDS (n=16) at 21-24 weeks; (p=0.0398). 
69 
 
 
Chapter 5  
5 Discussion 
5.1 Review of Reference Resources Used by Ontario 
Pathologists 
The objectives of the initial phase of the study were to assess the relative strengths and 
weaknesses of the currently available references for infant and neonate body and organ 
measurements used by pathologists in Ontario and to establish criteria for the development of 
a new reference resource. To achieve this goal, a survey of Ontario pathologists, who do 
coroners' pediatric autopsies, was conducted.  Fourteen responders used 20 publications as 
references for body and organ measurements. Of all the cited sources, only 2 had all the 
features regarded by the pathologists as ideal for a reference source; however, both of these 
sources were based on older data10,12. These “ideal” features included: accessibility to the 
source; larger sample size; defined control population; statistical analyses, and gender 
distinctions. The results of this part of the study were used to guide the development of a new 
reference, based on data from the Office of the Chief Coroner for Ontario, to enhance 
measurement standards for pediatric autopsy practice. 
5.2 Body and Organ Measurement Charts 
The next objective of this study was to create Ontario population-specific organ and body 
measurement mean charts for infants and neonates and growth graphs for each gender.  As a 
child grows, hyperplasia (increase in number of cells) accounts for the increase of organ and 
overall body size45,124. In the present study, most organ weights and body measurements 
gradually increased with age consistent with normal development of a child (Appendix E, 
Figures E-1 and E-2)37.  Relative to the infants aged 33-36 weeks, males and females showed 
decreases for most body measurements and body weights at 37-40 weeks; at this age range, 
male infants also had relatively smaller organs by weight  (Tables 4.2, 4.4, 4.5, Figures 5-4 
to 5-7, E-1 and E-2). These trends could be attributed to smaller sample sizes or other 
confounding factors, such as cessation of breast feeding. 
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Most paired organs tend to show a symmetric increase with age indicating a normal growth 
pattern45, which was seen in most organs in this study.  The adrenal glands were an exception 
(Figures 5-2 and 5-3). Combined adrenal weight in males and females demonstrated initial 
decline during the first 12 weeks of life and later stabilized around 4-6 grams (Tables 4-3 and 
4-6). In Schulz’s et al study, combined adrenal weight was fairly constant during the first year 
of life, ranging about 4.5 to 6.0 grams10. The initial decline in adrenal weight, found in the 
present study, can be related to the rapid regression of the fetal cortex at birth. The fetal 
cortex makes up to 80% of newborn adrenal gland and disappears almost completely by the 
age of 1st year125.  The adrenal weight is more likely to be a subject of interobserver 
variability as it can be affected by the dissection techniques used by individual pathologists 
and their assistants. The inclusion of an excess periadrenal adipose tissue results in a greater 
recorded weight of an adrenal gland. Some factors that affect adrenal weight (e.g. cortical 
lipid depletion due to fetal stress in maternal chorioamnionitis126) cannot be assessed 
retrospectively, such as in the present study. 
The thymus was the other organ that did not demonstrate steady growth instead showing a 
relatively erratic growth pattern (Figures 5-2 and 5-3). In the present study, the thymic 
weight increased from approximately 10 grams at birth to 30 grams by the end of the 1st year 
(Tables 4-3 and 4-6). Similar growth patterns were observed for both genders. The thymic 
growth pattern was contrary to other studies that reported a gradual increase in weight 
reaching its near-maximum of 30 grams by 2 years of age46,127. In the present study, the 
thymus weight was found to be greater than that reported by Schulz et al, for both genders10. 
Overall, there are very limited reference sources on thymic weight. A number of factors are 
recognized that influence its size, for many of which it is difficult to account in retrospective 
studies. For instance, some studies showed a strong correlation between breast feeding and 
thymic weight128,129. In the exclusively formula-fed infants the thymus was less than half the 
size of the thymus in the breastfed infants, irrespective of body weight, length, gender or 
previous/current illness128–131. Acute thymic involution is a common response to stress from a 
prenatal (e.g. maternal chorioamnionitis) or postnatal event (e.g. infection or malnutrition in a 
child)45. The heavier weights observed for the thymus in the present study could be that there 
was less involution due to physical stressors (e.g. disease, malnutrition) in a more modern 
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population132. Considering that in the cases studied, the gland was normal based on the 
microscopic examination provided, the finding could also be attributed to accelerated thymic 
growth or selection bias (including cases with true thymic hyperplasia)133. 
 
The size disparity between male and female organ and body measurements has been reported 
in some studies10,27,122. A number of studies showed no significant differences in norms related 
to gender 43,112,113,115. The present study showed some of male organs statistically larger than 
those of females across some age groups (Table 4-13), especially heart and kidneys. The 
female adrenal glands, at age of 37-40 weeks, were larger than male counterparts; however, 
the female sample size for this age group was small (n=4) comparing to that of males (n=10), 
likely increasing the mean range. 
The data on body weights and length when compared to previously published showed overall 
similar growth trends. The body weight doubled by 5 months of age and tripled by the end of 
the 1st year of life, as expected37,39. Comparison of the study population weights to a normal 
living population (WHO and CDC data) showed more similarity to CDC growth charts109,134 
(Figures 5-4 and 5-5). For some age groups (over 20 weeks of age) the weights were lower 
than both WHO and CDC data which could be attributed to the smaller sample sizes for these 
older age groups. Both, this study and the CDC body weights were slightly lower when 
compared to the WHO standards. This is not surprising considering that the WHO standard 
source is a concept of what the norm should be in a healthy full-term infant with optimum 
nutrition and favorable socioeconomic conditions135,136. The WHO standards, as well, are 
based on a more diverse comparison population since the data from multiple countries are 
included42,134. 
The population body lengths in the present study showed an expected increase by about  
25 cm during the 1st year of life (from the birth length of approximately 50 cm) and were 
comparable to other published data37(Figures 5-6 and 5-7). In the present study, there was a 
similar tendency in head circumference growth with an exception of a “spike” in 33-36-week-
old females likely related to a small size of this age group (n=3) (Figures 5-8 and 5-9). 
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The specific organ weights of the studied population were similar to Fracasso, Vennemann et 
al, and the non-SIDS Thompson and Cohle data113,115(Figure 5-1). The organ weights were 
consistently heavier than those reported by Coppoletta and Wolbach with an exception of 
combined kidney weights43(Figure 5-1). The organ weights were slightly higher than those 
published by Schulz et al, and Kayser10,12(Figures 5-2 and 5-3). One more recent study had 
reported a 6% to 100% increase in individual organ weights in comparison to the Schulz et al 
1962 data and attributed it to growing public awareness of healthy lifestyle, improved pre- 
and postnatal care, and improved medical investigations and nutrition10,113.  
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Figure 5-1. Present Data Compared to Previously Published (Combined Genders) 
 
The specific organ weights of the studied population were similar to Fracasso et al. and non-
SIDS Thompson and Cohle data.  The weights were consistently heavier than those reported 
by Coppoletta and Wolbach with an exception of combined kidney weights. All weights in 
grams.  
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Figure 5-2. Present Study Data Compared to Previously Published Literature  
(Male Deaths) 
 
The male organ weight means for adrenals and thymus differ from the previously published 
Schulz’s et al. data. The present means for combined lung weights are larger than Kayser’s 
data. The present data closely follows the curves for the remaining organs. All weights in 
grams. 
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Figure 5-3. Present Data Compared to Previously Published (Female Deaths) 
 
The female thymus and combined lung mean weights in this study were much higher than 
those published by Schulz et al. and Kayser while those for kidneys and adrenals were smaller. 
The other mean organ weights were slightly higher than those published by Schulz et al. and 
Kayser. All weights in grams. 
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Figure 5-4. Male Body Weight Compared to the CDC and WHO Standards  
 
Comparison of the study population male body weights to a normal living population  
(WHO and CDC data) shows more similarity to CDC growth charts.  For some age groups 
over 20 weeks the weights are lower than both CDC and WHO standards.  Both, this study 
and CDC body weights are slightly lower than WHO standards. 
 
 
Figure 5-5. Female Body Weight Compared to the CDC and WHO Standards 
 
Comparison of the study population female body weights to a normal living population  
(WHO and CDC) shows similar tendency as in the studied male population (see Figure 5-4).  
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Figure 5-6. Crown-Heel Length Compared to the CDC Data (Male Deaths) 
 
Comparison of the study population male crown-heel length to a normal living population 
(CDC) shows similar growth tendencies. 
 
 
 
Figure 5-7. Crown-Heel Length Compared to the CDC Data (Female Deaths) 
 
Comparison of the study population female crown-heel length to a normal living population 
(CDC) shows similar growth tendencies.     
30
35
40
45
50
55
60
65
70
75
80
M
EA
N
AGE IN WEEKS
Crown-Heel Length
Present Data
CDC Data
30
35
40
45
50
55
60
65
70
75
80
M
EA
N
AGE IN WEEKS
Crown-Heel Length
Present Data
CDC Data
78 
 
 
 
 
Figure 5-8. Head Circumference Compared to the CDC Data (Male Deaths) 
 
Comparison of the study population head circumference to a normal living population (CDC) 
shows similar growth tendencies in males. 
 
 
Figure 5-9. Head Circumference Compared to the CDC Data (Female Deaths) 
 
Comparison of the female head circumference to a normal living population (CDC) shows 
similar growth tendencies with an exception of a “spike” at 33-36 weeks.  
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Figure 5-10. SIDS Data Compared to Previously Published Thompson and Cohle’s Data 
(Combined Genders) 
 
The individual organ weights in the SIDS group were similar to the data on SIDS deaths in 
the Thompson and Cohle’s study. All weights in grams.   
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5.3 Body and Organ Measurements Correlated to Cause of 
Death 
The final objective of this study was to determine if groups, based on the cause of death 
(SIDS, SUDS and Control groups), were different in their body and organ measurements, 
when accounted for age and gender. 
Sudden Infant Death Syndrome is generally a diagnosis of exclusion when any anatomical, 
toxicological, metabolic etc. causes of death have been ruled out in the course of thorough 
multidisciplinary investigations. The incidence of reported SIDS varies considerably partly 
due to the variable use of terminology and death certification in different death investigation 
systems. Statistics Canada reported SIDS in 2.8% of all infant deaths in 2012134. According to 
2014 CDC data, SIDS was the cause of 7% of infant deaths in the United States137,138. Ontario 
had recently adopted a more strict definition of SIDS excluding any case which had an unsafe 
sleeping environment and a background of adverse socioeconomic factors. As a result of the 
strict application of the definition of SIDS, of the 70 cases reviewed by the Ontario Death 
Under Five Committee in 2013, no SIDS cases were identified22. In nearly half (51%) of the 
cases reviewed by the committee, death occurred in the presence of sleep associated 
circumstances, and in less than 3% social risk factors were present (without sleep-associated 
circumstances). 
For the purpose of this study, the cases in the database were classified as SIDS when the 
sleeping environment appeared safe and SUDS when any adverse sleep circumstances (e.g. 
unsafe sleeping surface, bed sharing with an adult) were identified.  Of the 900 cases 
assessed, approximately 14% were classified as SIDS and 38% as SUDS. The SIDS 
frequency is higher than the Canadian SIDS data since it relates to a selected autopsied 
population only rather than infant mortality overall. The SIDS data is certainly higher than the 
more recent Ontario data, reflecting both the decrease in SIDS incidence and more strict 
definitions/guidelines in Ontario pediatric death investigations. 
Strict categorization of infant deaths allows the development of strategies for further research 
and pediatric death prevention. Although the etiology of SIDS has yet to be identified, 
multiple theories have been put forth as possible mechanisms in SIDS deaths, including but 
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not limited to: apnea, overheating, inflammatory mechanisms, immunizations, long Q-T 
syndrome and other arrhythmias, seizure disorders, and complications of prematurity48,83,139–
146. According to some studies, various metabolic abnormalities have been detected in 10% of 
SIDS deaths147. Some studies emphasized a potential role of respiratory viruses in SIDS and 
reported their presence in 20-45% of sudden infant deaths148–151. 
Common autopsy findings in SIDS deaths include petechial hemorrhages (e.g. pleural and 
thymic), pulmonary congestion and edema, effusions in various body cavities, fatty changes 
in the liver, positive respiratory samples for viruses or bacteria (without microscopic findings 
of significant infection)152–158. 
The subject of organ weights and body measurements in SIDS cases has been discussed in 
several previous studies, and the data are rather controversial. Some studies found no 
difference in the body measurements/organ weights between the SIDS and normal 
populations27,113,115,159. Other studies reported significant differences in various parameters 
possibly indicating a disturbance of normal growth patterns of vital organs in SIDS cases160–163. 
One study reported SIDS body weights being lower than in normal infants160. Another study 
has identified a poor postnatal weight gain to be independently associated with an increased 
risk of SIDS164. The crown-rump length and head circumference were shown not to be 
associated with an increased risk of SIDS163,165. 
Some studies found the brain, lungs, liver and thymus to be significantly heavier in SIDS 
deaths compared to the normal population160,162,166. Another study identified a pattern of 
abnormal relative size of the brain, heart, liver, and kidneys167. The increase in the weights of 
these organs relative to the total body weight among SIDS victims was approximately 3 times 
the increase among controls in the first year of life167. In contrast, the adrenal glands in SIDS 
infants have been shown to be smaller than normal160,168. Other studies showed no significant 
weight differences between SIDS and control infants for kidneys or pancreas27,169. 
Overall, a large number of statistically significant relationships were identified in the present 
study based on the cause of death, age and gender. However, number of cases in each age 
group had dropped significantly after 6 months of age. As a result, inferences cannot be made 
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from most of the relationships in the older age groups (after 25-28 weeks) due to small 
sample sizes. The decline in the incidence of infant deaths after 6 months reflects the natural 
history of SIDS with the highest incidence of death between the 1st and 6th of an infant’s 
life170. SUDS incidence had decreased after 6 months, as well, due to increased physical 
mobility of an infant who around that age usually is able to roll, sit on his/her own, and 
control the upper body and arms47. This increased mobility lessened the risks of an unsafe 
sleeping environment. 
The organ weights in the SIDS group in the present study were similar to the data on SIDS 
deaths in Thompson and Cohle’s study (Figure 5-10)113. 
In the present study, there was no difference between the groups in relation to the body 
weight, heart and pancreas weights (Tables 4-11 and 4-12). A study by Siebert and Hass 
based on 500 autopsies, reported SIDS mean body weights generally below the 50 th percentile 
when compared to living infants160. The heart weights in this study showed a marginally 
significant increase above published norms. 
From birth to the 12th week of life, the combined lung weight means were greater in SUDS 
than in SIDS group with the latter showing greater means than the Control group 
(SUDS>SIDS>Control) (Appendix G, Table G-1). An exception was the combined female 
lung weight in 9-12 weeks age group (SIDS>SUDS>Control). From the 12th to 24th week, the 
female lungs showed similar tendencies being heavier in SUDS than in SIDS group, while the 
male lungs were heavier in SIDS group in comparison to SUDS group.  The tendencies were 
proven statistically significant for both genders separately and combined for the age from 
birth to 4 weeks, females in 9-12 weeks group and males in 21-24 weeks group (Table 4-14, 
Figures 4-5 to 4-7). Heavier lung weight in the SUDS group is most likely related to the 
effects of unsafe sleeping environment171. Although exact cause and manner of death in this 
group are undetermined, asphyxia is considered as potential mechanism of death since unsafe 
sleep factors (e.g. bed sharing, cluttered crib) might interfere with an infant’s breathing and/or 
cause entrapment, overlaying, or suffocation. Pulmonary congestion and edema are very 
common findings in asphyxial deaths171,172. 
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SIDS lungs were heavier than controls for all age groups and both genders, except in females 
in 13-16 and 21-24 weeks age groups; however, each of these groups had small sample size 
(Appendix G, Table G-1). These observations were statistically significant for 3-4-week-old 
males and both genders combined, 9-12-week-old females and 21-24-week-old males (Table 
4-14, Figure 4-5 to 4-7). Although exact mechanisms of SIDS deaths are uncertain, some 
studies reported pulmonary congestion and edema and minor microscopic inflammatory 
infiltrates in the lungs of SIDS victims160,173. 
One study reported SIDS kidneys to be smaller than controls and hypothesized that delayed 
kidney growth may be an indicator of increased risk of SIDS in infants under 1 year174. Another 
study has found reduced glomerular numbers in SIDS subjects with both normal and low birth 
weights175. In the present study, there was no significant difference between SIDS and control 
kidney weights for all age groups and both genders (separately and combined) (Table 4-15, 
Figures 4-8 to 4-10). SUDS kidneys were significantly lighter than SIDS for females at 9-12 
weeks and for males and genders combined at 13-16 weeks. The SUDS kidneys were 
significantly lighter than controls in females at 3-4 weeks. One study reported that low birth 
weight was associated not only with small kidneys at birth and decreased nephron numbers 
but with impaired kidney growth in early childhood. The study suggested that intrauterine 
growth had a regulatory influence on nephron formation and renal function in humans 
reaching beyond the neonatal period176. Some studies reported decreased kidney weight in 
cases of prenatal hypoxia177,178. 
There was no difference between SIDS and SUDS liver weights for all age groups and both 
genders (Table 4-16). Although the mean liver weights were higher in SIDS and SUDS 
groups when compared to the controls for most age groups below 25 weeks (for each gender 
separately and combined) (Appendix G, Table G-3). The difference was significant for: 
SUDS vs. Control for females and genders combined at 3-4 weeks and SIDS vs. Control for 
males and genders combined for 17-20 weeks (Figures 4-11 to 4-13). Common causes of 
hepatomegaly in children under 1 year of age who die include hepatic congestion and fatty 
changes. Both are nonspecific findings and have been reported in autopsies of SIDS and 
SUDS infants160. Increased liver weight in SIDS deaths could be, as well, due to undiagnosed 
fatty acid oxidation or other metabolic disorders179,180. Postmortem diagnosis of fatty acid 
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oxidation might be difficult. True prevalence of these cases among SIDS is unknown. Female 
SIDS livers in this study were significantly smaller than controls during the first 2 weeks of 
life (Figure 4-12), a finding of uncertain significance. 
Male brains showed no weight difference between the age groups and cause of death groups. 
SUDS brains were significantly heavier than controls in females younger than 2 weeks and 
for combined genders in this age group (Table 4-17, Figures 4-14 and 4-15). In 9-12 weeks 
age group, both SIDS and SUDS female brains were significantly heavier than controls 
(Figure 4-14). Heavier brains in infants who died in unsafe sleeping environment could be 
related to hypoxic-ischemic effects of asphyxia on the brain leading to cerebral 
edema172,181,182. The role of brain weight in etiology of SIDS is controversial. One study 
showed a trend towards higher brain-body weight ratios in SIDS infants, which, however, 
failed to reach significance165. In another study, brain weights in SIDS cases were 
significantly greater than published norms160. 
SIDS spleens showed a tendency of being smaller than controls at 0-8 weeks and larger than 
controls at 9-28 weeks for males, females and combined genders (except 13-20-week-old 
females who showed smaller than controls spleens) (Appendix G, Table G-5). Only for the 
13-16 weeks age male group SIDS>Control relationship was proven to be significant (Table 
4-18, Figure 4-16). SUDS spleens showed a tendency of being larger than controls in males 
and genders combined at 0-16 and 21-24 weeks and smaller than controls at 17-20 weeks 
(Appendix G, Table G-5). The SUDS>Control and SUDS>SIDS relationships were proven 
to be significant for 5-8 weeks for combined gender group (Figure 4-17). SUDS spleens 
tended to be larger than controls in 0-2- and 5-12-week-old females and smaller than controls 
in 3-4-week and 13-24-week-old females (Appendix G, Table G-5). None of female 
relationships reached the established significance level. 
Splenomegaly (increased spleen size/weight) can be attributed to undiagnosed infections, 
increased blood flow (hyperemia), reduced venous flow (congestion) or coexistent liver 
disease. In some animal models, excessive polycythemic response to hypoxic exposure was 
linked to profound splenic erythropoiesis183,184. Hypoxic mechanisms arising from an unsafe 
sleep environment in SUDS could be responsible for splenic enlargement. In addition, around 
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5-8 weeks of life, an infant receives his/her first immunization (including Diphtheria, Tetanus, 
Pertussis, Polio, Haemophilus Influenzae type B, Pneumococcal Conjugate 13, and Rotavirus 
vaccines)185. The spleen at this age shows an increase in size/weight due to an immune 
reaction to the above vaccines186. This could explain larger spleens after 9 weeks of age in the 
present study. 
Overall, the mean values for combined adrenal glands in SUDS cases were smaller than 
controls for all age groups (below 25 weeks) when genders were combined and for most of 
the age groups for males and females (Appendix G, Table G-6). This relationship was 
significant (p<0.05) for combined genders at 0-2 and 9-12 weeks age groups, for 0-2 week-
old males and females and for 9-20-week-old females (Figures 4-18 to 4-20). 
 At 13-16 weeks, the mean values for combined adrenal glands in SIDS group were greater 
than controls, for either gender (Appendix G, Table G-6). The tendency was significant 
when the genders were combined (Table 4-19, Figure 4-20). In 0-2-weeks age group, SIDS 
deaths showed smaller adrenals than in controls (relationship was significant for females and 
genders combined). Although in the remaining age groups, the SIDS means for the adrenals 
showed a tendency of being smaller than the controls, these differences did not reach the pre-
established significance level. 
The authors in one study found a uniform decrease in adrenal weights, but their calculated 
slopes of linear regressions were low, hampering statistical analysis160. Another study of 146 
SIDS cases found a normal maturation of the adrenal glands in SIDS cases187. Although some 
morphological alterations were noted (e.g. a focal lipid depletion in the zona fasciculata, 
hyperemia, siderosis, and calcifications), they were similar to the control cases, and none of 
them explained the sudden death of the infants in this series. 
Small (hypoplastic) adrenal glands are seen in cases of congenital adrenal hypoplasia. This 
condition can cause acute adrenal insufficiency resulting in a sudden death. Frequently, no 
specific pathological changes are found at autopsy, and diagnosis is confirmed with genetic 
testing188–190. This condition typically presents in infancy and more commonly affects males 
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since one variant is X-linked191,192. Some of the lower adrenal weights in the present SIDS 
cases could represent undiagnosed cases of congenital adrenal hypoplasia.  
A subset of SIDS adrenals is this study (age group 13-16 weeks) was heavier than controls. 
Some of larger adrenal glands could represent cases of undiagnosed congenital adrenal 
hyperplasia (CAH). The latter is reported as cause of unexplained infant death resembling 
SIDS. CAH can present with adrenal crisis characterized by cardiovascular collapse typically 
in the first month of life or more rarely in mid infancy168. Cases of CAH can be identified by 
metabolic screening. While the classical salt-wasting form is easier to diagnose in females (by 
characteristic ambiguous genitalia), male infants have normal appearing external genitalia at 
birth and are more likely to be undiagnosed. Chronic stress is another condition which was 
shown to induce adrenal hyperplasia and hypertrophy in specific-zone distribution leading to 
increased adrenal weight132. 
Adrenal glands in SUDS group were smaller than SIDS adrenals in 9-12 and 13-16-weeks age 
groups for genders combined (Figure 4-20).  It coincides with a peak in SUDS deaths 
(Figures 4-3 and 4-4). The possible explanation is that the children in an unsafe sleep 
environment might be predisposed to sudden death because their smaller adrenals have 
impaired reserves to respond to stress. 
Overall, the mean values for thymus in both SIDS and SUDS groups were greater than 
controls for all age groups (below 25 weeks) for either gender and genders combined [with an 
exception of 13-16-week-old female SIDS cases: their thymuses were smaller than controls 
but sample size for this group was small (n=3)]. (Appendix G, Table G-7). SUDS>Control 
relationship was significant (p<0.05) for combined genders and males at 0-8 and 17-24 weeks 
age groups, for 0-2- and 5-8-week-old females (Table 4-20 and Figures 4-21 to 4-24). 
SIDS>Controls relationship was proven significant for combined genders at age of 3-8 and 
21-24 weeks and 3-4- and 21-24-week-old males. For 0-2 week-old males, SUDS thymuses 
were significantly heavier than SIDS (Figure 4-21). 
Some studies reported thymic weight in SIDS cases to be greater than in controls115,160,166. 
Another study found no difference between SIDS and control thymuses113. The older concept 
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of status tymico-lymphaticus (pathological enlargement of thymus in SIDS cases) is long 
abandoned. One study suggested that thymic size in SIDS infants who were usually 
previously healthy was more representative of the living infant population than weights in 
infants dying of other causes who may have been exposed to various thymolytic factors11. It is 
possible that the control thymuses in this study were smaller for the same reasons. 
 
5.4 Limitations 
The retrospective nature of this study meant that the standardized case data pertaining to 
detailed information about the circumstances of a child’s demise, and the associated social 
and maternal history were sometimes lacking. This deficiency could potentially lead to an 
underestimation of the role of adverse sleeping environments and socioeconomic factors in 
the deaths of the infants studied. 
In addition, a lack of uniform autopsy dissection techniques and measuring equipment used at 
different sites in Ontario could inadvertently result in an interobserver variability in recording 
various measurements. Measurements with fairly standard measuring techniques and not 
requiring dissections (e.g. body length and various body circumferences), showed less 
interobserver variability and smaller standard deviations. Lack of documentation of specific 
measurements reduced sample sizes for some organs and affected statistical analyses. For 
example, pancreatic weights were documented in 672 cases, thyroid weights in 163 cases and 
body lengths in 890 of 900 cases. The variability of histological sampling of organs and 
diagnostic interpretation meant that disease and/or pathophysiological processes affecting 
organ weights could not always be assessed. 
The third major limitation of this study was the sample size, especially evident in the older 
age groups. Further assessment with a larger sample size particularly in the 6-month to 1-year 
age groups would provide a better understanding of the overall trends. 
Although, an attempt was made to create a reliable control group limiting it to the cases or 
individual organs uninvolved by any pathological process, such standardization is suboptimal 
in the context of a retrospective study. A prospective study with standardized autopsy 
88 
 
 
techniques and documentation would assure a more strict selection process. Moreover, the 
simple elimination of the affected/deceased organ from the database was previously criticized 
as artificial since it did not take into account the systemic implications of the illness115. In this 
study, an attempt was made to carefully evaluate individual organs and to exclude all organs 
apparently affected by pathological processes, whether related or unrelated to the cause of 
death. A control group based on healthy infants who died rapidly as a result of accidents or 
homicides with no resuscitation might be a better alternative in standardizing organ weights, 
but the prevalence of these manners of death in the first year of life is very low. 
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Chapter 6  
6 Conclusions 
Although Canada has significantly reduced infant mortality over the last few decades, the rate 
continues to be relatively high considering the country’s level of socioeconomic development. 
Sudden death in infants is a major mortality category in children younger than 1 year. Ontario 
recently adopted a more strict defintion of SIDS, which excludes unsafe sleep environoments 
and adverse socioeconomic factors. If these factors are evident during a death investigation, 
then the case can be classified as SUDS. This new infant death categorization assists in the 
standardization of classifying the cause and manner of death as well as death prevention. In 
the present study, over one third of the deaths were SUDS and about 14% were SIDS. 
The first objective of the present study was to assess the currently available autopsy 
references on infant and neonate body and organ measurements. A survey of Ontario 
pathologists and literature review revealed that many of the currently used reference resources 
were outdated, contained small sample sizes, had limited age intervals, and lacked statistical 
information.  Many reference sources were lacking well-defined control groups and 
descriptions of exclusion criteria. 
The second objective of this study was to create Ontario population-specific organ and body 
measurement mean charts for infants and neonates as well as growth graphs for each age 
category.  Based on the review of the strengths and weaknesses of the currently available 
reference sources, a new reference resource for the body and organ measurements of neonates 
and infants has been developed. This resource is based on an Ontario population database 
derived from the Office of the Chief Coroner. The database consists of a larger sample size 
with defined control groups, provision of standard deviations, p-values, and gender 
distinctions. 
When compared to previously published literature, data in the present study showed similar 
growth trends, although organ weights tended to be heavier than in the older series. In 
contrast, adrenal glands diminished in size in the first 3 months of life, and thymus weight, 
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although increasing, was more erratic in its growth. The body weight and length data had 
more similarities to the CDC than the WHO growth standards.  
The third objective of the study was to determine if there were any differences in the body 
and organ measurements based on the cause of death. Overall, a number of statistically 
significant relationships were identified based on the cause of death, age, and gender. The 
size disparity between male and female organs was most significant for the heart and kidneys 
across most of the age groups. The tendencies in growth patterns between SIDS, SUDS, and 
Control groups demonstrated somewhat complex patterns across various age groups and 
between the genders. There was no difference between the cause of death groups in relation to 
the weight of the body, heart or pancreas. The lungs, brain, liver, spleen and thymus tended to 
be heavier in SIDS and SUDS cases compared to the Control group, while adrenal glands and 
kidneys had a tendency of being smaller.  
 
Heavier lung weights in SUDS cases were likely related to the effects of unsafe sleeping 
environments where asphyxia with resultant pulmonary edema was among the potential 
mechanisms of death. Heavier lung weights in SIDS cases could be related to terminal 
pulmonary congestion and edema or undiagnosed natural disease. Cerebral edema in settings 
of an unsafe sleeping environment could explain heavier brain weights in some SUDS cases.  
Increased liver weights in SIDS and SUDS groups could be attributed to hepatic congestion, 
hypoxia- induced  fatty changes or undiagnosed fatty acid oxidation, and other metabolic 
disorders. Lower kidney weights in both SIDS and SUDS groups could be related to renal 
growth restriction in the settings of intrauterine hypoxia or effects of prematurity.  Although 
there was a tendency for SIDS and SUDS thymus weights to be heavier, this trend could be 
relative, because the thymus in the control infants could have involuted secondary to natural 
disease.   
The data revealed that SUDS cases for both genders peaked in the approximately 5-16-weeks 
age group. In the analysis of organ weights, the adrenal glands were smaller in the 9-16-
weeks age group. This suggests that a child placed in an unsafe sleeping environment may be 
less able to deal with consequent physical stress in this setting. Also of interest  was that 
children aged 5-8 weeks had relatively enlarged spleens in the SUDS group. Hypoxic 
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mechanisms arising from usafe sleeping conditions could be responsible for splenic 
enlargement. 
This study further emphasized the need for standardization of the classification as well as 
investigative and autopsy approaches to sudden infant deaths, specifically SIDS and SUDS 
cases with adverse sleep and social environments. Further standardization of pediatric autopsy 
practice will assist in the advancement of more refined research on the causes and 
mechanisms of sudden death in young children. 
92 
 
 
References 
1.  Statistics Canada, Canadian Vital Statistics B and DD. Deaths: Table 4-1 — Deaths by Age 
Group and Geography — Both Sexes.; 2012. 
2.  World Health Association. Children: reducing mortality. WHO. 
http://www.who.int/mediacentre/factsheets/fs178/en/. Published 2016. Accessed June 8, 2016. 
3.  Statistics Canada. Table 051-0013. Table - 051-0013 - Estimates of Births, by Sex, Canada, 
Provinces and Territories. CANSIM (Database).; 2015. 
4.  The Conference Board of Canada. Infant Mortality. 
http://www.conferenceboard.ca/hcp/details/health/infant-mortality-rate.aspx. Published 2016. 
Accessed June 8, 2016. 
5.  Statistics Canada. Deaths – 2009 Deaths by Age Group and Geography — Both Sexes Statistics 
Canada – Catalogue No . 84F0211X Deaths – 2009 Table 4-1 – Continued Deaths by Age 
Group and Geography — Both Sexes Statistics Canada – Catalogue No . 84F0211X.; 2012. 
6.  Government of Canada PHA of C. Safe Sleep for Your Baby brochure - Public Health Agency of 
Canada. March 2010. http://www.phac-aspc.gc.ca/hp-ps/dca-dea/stages-etapes/childhood-
enfance_0-2/sids/ssb_brochure-eng.php. Accessed January 11, 2016. 
7.  Government of Canada PHA of C. Joint Statement on Safe Sleep: Preventing Sudden Infant 
Deaths in Canada - Public Health Agency of Canada. June 2011. http://www.phac-
aspc.gc.ca/hp-ps/dca-dea/stages-etapes/childhood-enfance_0-2/sids/jsss-ecss-eng.php. 
Accessed January 11, 2016. 
8.  Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: When? Where? Why? Lancet. 
2005;365(9462):891-900. 
9.  Bryce J, Boschi-Pinto C, Shibuya K, Black R. WHO estimates of the causes of death in children. 
Lancet. 2005;365(9465):1147-1152. 
10.  Schulz DM, Giordano DA, Schulz DH. Weights of organs of fetuses and infants. Arch Pathol. 
1962;74:244-250. 
11.  Stocker J, Dehner L. Pediatric Pathology. 2nd Editio. Philadelphia: Lippincott Williams & Wilkins; 
1940. 
12.  Kayser K. Height and Weight in Human Beings: Autopsy Report. (Oldenbourg, ed.). Munich: 
Verlag für angewandte Wissenschaften; 1987. 
13.  Wigglesworth J. Textbook of Fetal and Perinatal Pathology. Boston: Blackwell Scientific 
Publication; 1991. 
14.  American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. The changing 
concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the 
sleeping environment, and new variables to consider in reducing risk. Pediatrics. 
2005;116(5):1245-1255. 
15.  Gilbert-Barness E. Potter’s Pathology of the Fetus, Infant, and Child. Mosby Elsevier; 2007. 
16.  Loughrey CM, Preece MA, Green A. Sudden unexpected death in infancy (SUDI). J Clin Pathol. 
2005;58(1):20-21. 
17.  Côté A, Russo P, Michaud J. Sudden unexpected deaths in infancy: what are the causes? J 
Pediatr. 1999;135(4):437-443. 
18.  Gilbert-Barness E, Spicer DE, Steffensen TS. Handbook of Pediatric Autopsy Pathology. Totowa, 
NJ: Humana Press; 2005. 
19.  Willinger M, James LS, Catz C. Defining the sudden infant death syndrome (SIDS): deliberations 
93 
 
 
of an expert panel convened by the National Institute of Child Health and Human Development. 
Pediatr Pathol. 1991;11(5):677-684. 
20.  Moini J. Introduction to Pathology for the Physical Therapist Assistant. Boston: Jones & Bartlett 
Learning; 2013. 
21.  Office of the Chief Coroner. Paediatric Death Review Committee and Deaths Under Five 
Committee Annual Report 2015. 
http://www.mcscs.jus.gov.on.ca/english/Deathinvestigations/OfficeChiefCoroner/Publicationsrepo
rts/PDRC_2015.html. Published 2015. Accessed January 21, 2016. 
22.  Office of the Chief Coroner for Ontario. Paediatric Death Review Committee and Deaths Under 
Five Committee Annual Report 2013. 
http://www.mcscs.jus.gov.on.ca/sites/default/files/content/mcscs/docs/ec163306.pdf. Accessed 
June 8, 2016. 
23.  Ministry of Community Safety & Correctional Services. Death Investigation. 
http://www.mcscs.jus.gov.on.ca/english/DeathInvestigations/Ourcommitment/DI_Strat_plan_15_
20.html. Published 2016. Accessed June 8, 2016. 
24.  Ministry of Community Safety and Correctional Services. Common questions about death 
investigations. 
http://www.mcscs.jus.gov.on.ca/english/DeathInvestigations/CommonQuestionsAboutCoronersIn
vestigations/OCC_common_questions.html. Accessed January 11, 2016. 
25.  The Honourable Stephen T. Goudge. Inquiry into Pediatric Forensic Pathology in Ontario. 
Toronto; 2008. 
26.  Forensic Pathology Unit Office of the Chief Coroner. Guideline On Autopsy Practice for Sudden 
Unexpected Deaths of Infant and Children Under 5 Years. Toronto; 2014. 
27.  Pryce JW, Bamber AR, Ashworth MT, Kiho L, Malone M, Sebire NJ. Reference ranges for organ 
weights of infants at autopsy: results of (greater than) 1,000 consecutive cases from a single 
centre. BMC Clin Pathol. 2014;14(1):18. 
28.  Block RW, Krebs NF, American Academy of Pediatrics Committee on Child Abuse and Neglect, 
American Academy of Pediatrics Committee on Nutrition. Failure to thrive as a manifestation of 
child neglect. Pediatrics. 2005;116(5):1234-1237. 
http://www.ncbi.nlm.nih.gov/pubmed/16264015. Accessed June 8, 2016. 
29.  World Health Organization. International Statistical Classification of Diseases and Related Health 
Problems 10th Revision.; 2010. 
30.  Center for Disease Control and Prevention. Medical Examiners’ and Coroners' Handbook on 
Death Registration and Fetal Death Reporting.; 2003. 
31.  Ministry of Community Safety and Correctional Services. 2013 Report. 
http://www.mcscs.jus.gov.on.ca/english/DeathInvestigations/office_coroner/PublicationsandRepo
rts/PDRC/2013Report/PDRC_2013.html#25. Accessed January 12, 2016. 
32.  Ministry of Community Safety and Correctional Services. 2014 Report. 
http://www.mcscs.jus.gov.on.ca/english/DeathInvestigations/office_coroner/PublicationsandRepo
rts/PDRC/2014Report/PDRC_2014.html. Accessed January 21, 2016. 
33.  Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of 
preterm birth rates in the year 2010 with time trends since 1990 for selected countries: A 
systematic analysis and implications. Lancet. 2012;379(9832):2162-2172. 
34.  Reddy UM, Bettegowda VR, Dias T, Yamada-Kushnir T, Ko C-W, Willinger M. Term pregnancy: 
a period of heterogeneous risk for infant mortality. Obstet Gynecol. 2011;117(6):1279-1287. 
35.  The American College of Obstetricians and Gynecologists Committee on Obstetric Practice 
Society for Maternal-Fetal Medicine. AGOC Committee Opinion No 579: Definition of term 
pregnancy. Obstet Gynecol. 2013;122(5):1139-1140. 
94 
 
 
36.  Barfield WD. Standard terminology for fetal, infant, and perinatal deaths. Pediatrics. 
2011;128(1):177-181. 
37.  Burdi A, Huelke D, Snyder R, Lowrey G. Infants and children in the adult world of automobile 
safety design: pediatric and anatomical considerations for design of child restraints. J Biomech. 
1969;2(3):267-280. 
38.  Flaherman VJ, Schaefer EW, Kuzniewicz MW, Li SX, Walsh EM, Paul IM. Early weight loss 
nomograms for exclusively breastfed newborns. Pediatrics. 2015;135(1):16-23. 
39.  Krogman W. Growth of Man. Uitgeverij Dr. W. Junk; 1941. 
40.  Khadilkar V, Khadlikar A, Choudhury P, Agarwal K, Ugar D, Shah N. IAP growth monitoring 
guidelines for children from birth to 18 years. Indian Pediatr. 2007;44(3):187-197. 
41.  Dietitians of Canada, Canadian Paediatric Society, The College of Family Physcians of Canada, 
Canada CHN of. Promoting optimal monitoring of child growth in Canada: Using the new World 
Health Organization growth charts - Executive Summary. Paediatr Child Health. 2010;15(2):77-
83. 
42.  Dietitians of Canada and Canadian Paediatric Society. A Health Professional’s Guide for Using 
the WHO Growth Charts for Canada.; 2014. 
43.  Coppoletta JM, Wolbach SB. Body length and organ weights of infants and children: a study of 
the body length and normal weights of the more important vital organs of the body between birth 
and twelve years of age. Am J Pathol. 1933;9(1):55-70. 
44.  Engel S. Growth of the lung in healthy and sick infants. Arch Dis Child. 1935;17(89):41-48. 
45.  Cole TJ. Growth and organ development. Adv Exp Med Biol. 2009;639:1-13. 
http://www.ncbi.nlm.nih.gov/pubmed/19227530. Accessed May 11, 2016. 
46.  Kendall MD, Johnson HR, Singh J. The weight of the human thymus gland at necropsy. J Anat. 
1980;131(Pt 3):483-497. 
47.  Grenier D, Leduc D. Well Beings: A Guide to Health in Child Care. 3rd Editio. (Leduc D, ed.). 
Canadian Paediatric Society/Societe canadienne de pediatrie; 2015. 
48.  Leach CEA, Blair PS, Fleming PJ, et al. Epidemiology of SIDS and explained sudden infant 
deaths. Pediatrics. 1999;104(4):e43. 
49.  Nucci L. Nice Is Not Enough: Facilitating Moral Development. 1st Editio. Merrill: Prentice Hall; 
2009. 
50.  Patterson C. Child Development. Boston: McGraw-Hill Higher Education; 2008. 
51.  Mitchell E, Stewart A. Gender and the sudden infant death syndrome. Acta Paediatr. 
2008;86(8):854-856. http://doi.wiley.com/10.1111/j.1651-2227.1997.tb08611.x. Accessed June 
10, 2016. 
52.  Cornwell AC. Sex differences in the maturation of sleep/wake patterns in high risk for SIDS 
infants. Neuropediatrics. 1993;24(1):8-14. http://www.ncbi.nlm.nih.gov/pubmed/8474614. 
Accessed June 13, 2016. 
53.  Davis DL, Gottlieb MB, Stampnitzky JR. Reduced ratio of male to female births in several 
industrial countries: a sentinel health indicator? JAMA. 1998;279(13):1018-1023. 
54.  Mage DT, Donner M. The X-linkage hypotheses for SIDS and the male excess in infant mortality. 
Med Hypotheses. 2004;62(4):564-567. 
http://linkinghub.elsevier.com/retrieve/pii/S0306987704000088. Accessed June 13, 2016. 
55.  Mage DT, Donner M. A unifying theory for SIDS. Int J Pediatr. 2009;2009:1-10. 
http://www.hindawi.com/journals/ijpedi/2009/368270/. Accessed June 13, 2016. 
56.  Silventoinen K, Sammalisto S, Perola M, et al. Heritability of adult body height: a comparative 
95 
 
 
study of twin cohorts in eight countries. Twin Res. 2003;6(5):399-408. 
http://www.journals.cambridge.org/abstract_S1369052300004001. Accessed June 10, 2016. 
57.  Silventoinen K. Determinants of variation in adult body height. J Biosoc Sci. 2003;35(2):263-285. 
58.  Kuh D, Wadsworth M. Parental height: childhood environment and subsequent adult height in a 
national birth cohort. Int J Epidemiol. 1989;18(3):663-668. 
http://ije.oxfordjournals.org/cgi/doi/10.1093/ije/18.3.663. Accessed June 10, 2016. 
59.  Nwosu BU, Lee MM. Evaluation of short and tall stature in children. Am Fam Physician. 
2008;78(5):597-604. 
60.  Lee JM, Appugliese D, Coleman SM, et al. Short stature in a population-based cohort: social, 
emotional, and behavioral functioning. Pediatrics. 2009;124(3):903-910. 
http://www.ncbi.nlm.nih.gov/pubmed/19706592. Accessed June 13, 2016. 
61.  Eveleth PB. Population Differences in Growth: Environmental and Genetic Factors. In: Human 
Growth. Boston, MA: Springer US; 1979:373-394. 
62.  Cameron N, Demerath EW. Critical periods in human growth and their relationship to diseases of 
aging. Am J Phys Anthropol. 2002;Suppl 35:159-184. 
63.  Doberczak TM, Thornton JC, Bernstein J, Kandall SR. Impact of maternal drug dependency on 
birth weight and head circumference of offspring. Am J Dis Child. 1987;141(11):1163-1167. 
64.  Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in 
women with heart disease. Circulation. 2001;104(5):515-521. 
65.  Naeye RL. Infants of diabetic mothers: a quantitative, morphologic study. Pediatrics. 
1965;35:980-988. 
66.  Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. 
Lancet. 2008;371(9606):75-84. 
67.  Muglia L, Katz M. The enigma of spontaneous preterm birth. N Engl J Med. 2010;362(6):529-
535. 
68.  Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature 
rupture of membranes: A prospective study of the vaginal flora in pregnancy. Am J Obstet 
Gynecol. 1984;150(8):965-972. 
69.  Hughes D, Simpson L. The role of social change in preventing low birth weight. Future Child. 
1995;5(1):87-102. 
70.  Fedrick J, Adelstein P. Factors associated with low birth weight of infants delivered at term. Br J 
Obstet Gynaecol. 1978;85(1):1-7. 
71.  Paneth N, Wallenstein S, Kiely JL, Susser M. Social class indicators and mortality in low birth 
weight infants. Am J Epidemiol. 1982;116(2):364-375. 
72.  Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet. 
2003;361(9376):2226-2234. 
73.  Spencer N, Logan S. Sudden unexpected death in infancy and socioeconomic status: a 
systematic review. J Epidemiol Community Health. 2004;58(5):366-373. 
74.  Valdés-Dapena MA. Sudden infant death syndrome: a review of the medical literature 1974-
1979. Pediatrics. 1980;66(4):597-614. 
75.  Byard RW. Sudden Death in Infancy, Childhood, and Adolescence. 2nd Editio. Cambridge: 
Cambridge University Press; 2004. 
76.  Cage RA, Foster J. Overcrowding and infant mortality: a tale of two cities. Scott J Polit Econ. 
2002;49(2):129-149. 
77.  van Sleuwen BE, Engelberts AC, Boere-Boonekamp MM, Kuis W, Schulpen TWJ, L’Hoir MP. 
96 
 
 
Swaddling: a systematic review. Pediatrics. 2007;120(4):e1097-e1106. 
78.  Abel S, Park J, Tipene-Leach D, Finau S, Lennan M. Infant care practices in New Zealand: a 
cross-cultural qualitative study. Soc Sci Med. 2001;53(9):1135-1148. 
79.  McKenna JJ. Sudden infant death syndrome in cross-cultural perspective: is infant-parent 
cosleeping protective? Annu Rev Anthropol. 1996;25(1):201-216. 
http://www.annualreviews.org/doi/abs/10.1146/annurev.anthro.25.1.201. Accessed June 9, 2016. 
80.  Ball HL, Volpe LE. Sudden infant death syndrome (SIDS) risk reduction and infant sleep location 
– Moving the discussion forward. Soc Sci Med. 2013;79(1):84-91. 
http://linkinghub.elsevier.com/retrieve/pii/S0277953612002924. Accessed June 10, 2016. 
81.  Auger N, Fraser WD, Smargiassi A, Kosatsky T. Ambient heat and sudden infant death: a case-
crossover study spanning 30 years in Montreal, Canada. Environ Health Perspect. 
2015;123(7):712-716. 
82.  Ponsonby AL, Jones ME, Lumley J, Dwyer T, Gilbert N. Climatic temperature and variation in the 
incidence of sudden infant death syndrome between the Australian states. Med J Aust. 
1992;156(4):246-248, 251. 
83.  Katz D, Shore S, Bandle B, Niermeyer S, Bol KA, Khanna A. Sudden infant death syndrome and 
residential altitude. Pediatrics. 2015;135(6):1442-1449. 
84.  Kohlendorfer U, Kiechl S, Sperl W. Living at high altitude and risk of sudden infant death 
syndrome. Arch Dis Child. 1998;79(6):506-509. http://adc.bmj.com/cgi/doi/10.1136/adc.79.6.506. 
Accessed June 10, 2016. 
85.  Barkin RM, Hartley MR, Brooks JG. Influence of high altitude on sudden infant death syndrome. 
Pediatrics. 1981;68(6):891-892. 
86.  Dressler WW, Oths KS, Gravlee CC. Race and ethnicity in public health research: models to 
explain health disparities. Annu Rev Anthropol. 2005;34:231-252. 
87.  Kleinman J, Fingerhut L, Prager K. Differences in infant mortality by race nativity status and other 
maternal characteristics. Am J Dis Child. 1991;145(2):194-199. 
88.  Zambrana RE, Scrimshaw SC, Collins N, Dunkel-Schetter C. Prenatal health behaviors and 
psychosocial risk factors in pregnant women of Mexican origin: the role of acculturation. Am J 
Public Health. 1997;87(6):1022-1026. 
89.  Morales LS, Lara M, Kington RS, Valdez RO, Escarce JJ. Socioeconomic, cultural, and 
behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved. 
2002;13(4):477-503. 
90.  Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and 
adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996;94(12):3246-
3250. http://circ.ahajournals.org/cgi/doi/10.1161/01.CIR.94.12.3246. Accessed June 10, 2016. 
91.  Li Y, Ley SH, Tobias DK, et al. Birth weight and later life adherence to unhealthy lifestyles in 
predicting type 2 diabetes: prospective cohort study. BMJ. 2015;351(11):h3672. 
92.  Cosmi E, Fanelli T, Visentin S, et al. Consequences in infants that were intrauterine growth 
restricted. J Pregnancy. 2011:1-6. http://www.hindawi.com/journals/jp/2011/364381/. Accessed 
June 10, 2016. 
93.  Fenton TR. A new growth chart for preterm babies: Babson and Benda’s chart updated with 
recent data and a new format. BMC Pediatr. 2003;3:13. 
94.  Isolauri E, Juntunen M, Wiren S, Vuorinen P, Koivula T. Intestinal permeability changes in acute 
gastroenteritis: effects of clinical factors and nutritional management. J Pediatr Gastroenterol 
Nutr. 1989;8(4):466-473. 
95.  Daneman D, Frank M, Perlman K, Wittenberg J. The infant and toddler with diabetes: challenges 
97 
 
 
of diagnosis and management. Paediatr Child Health. 1999;4(1):57-63. 
96.  World Health Organization. Pocket Book of Hospital Care for Children: Guidelines for the 
Management of Common Childhood Illnesses. 2nd Editio. Geneva: World Health Organization; 
2013. 
97.  Razavi Z, Sanginabadi M. Linear growth arrest without weight gain due to overuse of topical 
clobetasol. Oman Med J. 2014;29(6):454-457. http://www.ncbi.nlm.nih.gov/pubmed/25584165. 
Accessed June 13, 2016. 
98.  Groenen PM, van Rooij IA, Peer PG, Ocké MC, Zielhuis GA, Steegers-Theunissen RP. Low 
maternal dietary intakes of iron, magnesium, and niacin are associated with spina bifida in the 
offspring. J Nutr. 2004;134(6):1516-1522. 
99.  Walker SP, Wachs TD, Gardner JM, et al. Child development: risk factors for adverse outcomes 
in developing countries. Lancet. 2007;369(9556):145-157. 
100.  Cole SZ, Lanham J. Failure to Thrive: An Update. Am Fam Physician. 2011;83(7):829-834. 
101.  Swallen KC, Reither EN, Haas SA, Meier AM. Overweight, obesity, and health-related quality of 
life among adolescents: the National Longitudinal Study of Adolescent Health. Pediatrics. 
2005;115(2):340-347. http://www.ncbi.nlm.nih.gov/pubmed/15687442. Accessed June 13, 2016. 
102.  Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer DM. The preterm labor syndrome. 
Ann N Y Acad Sci. 1994;734:414-429. 
103.  Volpe JJ. The encephalopathy of prematurity--brain injury and impaired brain development 
inextricably intertwined. Semin Pediatr Neurol. 2009;16(4):167-178. 
http://linkinghub.elsevier.com/retrieve/pii/S1071909109000631. Accessed June 13, 2016. 
104.  Eichenwald EC, Stark AR. Management and outcomes of very low birth weight. N Engl J Med. 
2008;358(16):1700-1711. 
105.  Vanderbilt D, Gleason MM. Mental health concerns of the premature infant through the lifespan. 
Pediatr Clin North Am. 2011;58(4):815-832. 
106.  Schlotz W, Phillips DI. Fetal origins of mental health: evidence and mechanisms. Brain Behav 
Immun. 2009;23(7):905-916. 
107.  Barker D, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in 
England and Wales. Lancet. 1986;1(8489):1077-1081. 
http://linkinghub.elsevier.com/retrieve/pii/S0140673686913401. Accessed June 10, 2016. 
108.  Center for Disease Control and Prevention. Guidelines for Growth Charts and Gestational Age 
Adjustment for Premature Infants and Children Up To The Age Of 24 Months.; 2000. 
109.  Center for Disease Control and Prevention. Growth Charts.; 2009. 
http://www.cdc.gov/growthcharts/percentile_data_files.htm. Accessed December 7, 2015. 
110.  Schulz DM, Giordano DA. Hearts of infants and children. Weights and measurements. Arch 
Pathol. 1962;74:464-471. 
111.  Archie JG, Collins JS, Lebel RR. Quantitative standards for fetal and neonatal autopsy. Am J Clin 
Pathol. 2006;126(2):256-265. 
112.  Hansen K, Sung CJ, Huang C, Pinar H, Singer DB, Oyer CE. Reference values for second 
trimester fetal and neonatal organ weights and measurements. Pediatr Dev Pathol. 
2003;6(2):160-167. 
113.  Thompson WS, Cohle SD. Fifteen-year retrospective study of infant organ weights and revision 
of standard weight tables. J Forensic Sci. 2004;49(3):575-585. 
114.  Roche AF, Guo S, Moore WM. Weight and recumbent length from 1 to 12 mo of age: reference 
data for 1-mo increments. Am J Clin Nutr. 1989;49(4):599-607. 
98 
 
 
115.  Fracasso T, Vennemann M, Pfeiffer H, Bajanowski T. Organ weights in cases of sudden infant 
death syndrome: a German study. Am J Forensic Med Pathol. 2009;30(3):231-234. 
116.  Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian 
reference for birth weight for gestational age. Pediatrics. 2001;108(2):E35. 
117.  Victor JC. Ontario Organ Growth Standards for Perinatal Autopsy [Dissertation]. London ON: 
University of Western Ontario; 1999. 
118.  Mitropoulos G, Scurry J, Cussen L. Organ weight/bodyweight ratios: growth rates of fetal organs 
in the latter half of pregnancy with a simple method for calculating mean organ weights. J 
Paediatr Child Health. 1992;28(3):236-239. 
119.  Stowens D. Pediatric Pathology. Baltimore: Williams & Wilkins; 1959. 
120.  Scholz DG, Kitzman DW, Hagen PT, Ilstrup DM, Edwards WD. Age-related changes in normal 
human hearts during the first 10 decades of life. Part I (Growth): A quantitative anatomic study of 
200 specimens from subjects from birth to 19 years old. Mayo Clin Proc. 1988;63(2):126-136. 
121.  Keeling J. Fetal and Neonatal Pathology 3rd Edition. New York: Springer; 2003. 
122.  Finkbeiner WE, Ursell PC, Davis RL. Autopsy Pathology: A Manual and Atlas. Philadelphia: 
Churchill Livingstone; 2009. 
123.  Oyer CE, Sung CJ, Friedman R, et al. Reference values for valve circumferences and ventricular 
wall thicknesses of fetal and neonatal hearts. Pediatr Dev Pathol. 2004;7(5):499-505. 
124.  Prentice A, Paul A, Prentice A, Black A, Cole T, Whitehead R. Cross-Cultural Differences in 
Lactational Performance. In: Human Lactation 2. Boston, MA: Springer US; 1986:13-44. 
125.  Folligan K, Bouvier R, Targe F, Morel Y, Trouillas J. Development of the human adrenal glands. 
Ann Endocrinol (Paris). 2005;66(4):325-332. 
126.  de Sa DJ. Adrenal changes in chorioamnionitis. Arch Dis Child. 1974;49(2):149-151. 
127.  Crelin ES. Functional Anatomy of the Newborn. New Haven and London: Yale University Press; 
1973. 
128.  Hasselbalch H, Jeppesen D, Engelmann M, Michaelsen K, Nielsen M. Decreased thymus size in 
formula-fed infants compared with breastfed infants. Acta Paediatr. 1996;85(9):1029-1032. 
http://doi.wiley.com/10.1111/j.1651-2227.1996.tb14211.x. Accessed May 11, 2016. 
129.  Hasselbalch H, Engelmann MD, Ersboll AK, Jeppesen DL, Fleischer-Michaelsen K. Breast-
feeding influences thymic size in late infancy. Eur J Pediatr. 1999;158(12):964-967. 
130.  Gui J, Mustachio LM, Su D-M, Craig RW. Thymus size and age-related thymic involution: early 
programming, sexual dimorphism, progenitors and stroma. Aging Dis. 2012;3(3):280-290. 
131.  Toti P, De Felice C, Stumpo M, et al. Acute thymic involution in fetuses and neonates with 
chorioamnionitis. Hum Pathol. 2000;31(9):1121-1128. 
http://www.humanpathol.com/article/S0046817700565976/fulltext. Accessed May 11, 2016. 
132.  Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, Herman JP. Chronic 
stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J 
Physiol Endocrinol Metab. 2006;291(5):E965-E973. 
133.  Kim H-J, Jang S-H, Park J-S, et al. A case of true thymic hyperplasia in the mediastinum with 
ectopic thymus in the neck. Korean J Pediatr. 2006;49(9):996-999. 
134.  World Health Organization. The WHO Child Growth Standards. WHO. 2006. 
http://www.who.int/childgrowth/standards/en/. Accessed June 27, 2016. 
135.  Kuczmarski R, Ogden C, Guo S, et al. 2000 CDC Growth Charts for the United States: Methods 
and Development. Vital Heal Stat 11. 2002;(246):1-190. 
http://www.cdc.gov/nchs/data/series/sr_11/sr11_246.pdf. Accessed June 23, 2016. 
99 
 
 
136.  Use and interpretation of anthropometric indicators of nutritional status. WHO Working Group. 
Bull World Health Organ. 1986;64(6):929-941. 
137.  Statistics Canada. Table 102-0562- Leading causes of death, infant, by sex, Canada, annual. 
CANSIM (database). http://www5.statcan.gc.ca/cansim/pick-choisir. Accessed June 27, 2016. 
138.  Center for Disease Control and Prevention. National Vital Statistics System-Compressed 
Mortality, 1999-2014 Request. 2014. http://wonder.cdc.gov/cmf-ICD10.html. Accessed June 27, 
2016. 
139.  Mitchell EA. What is the mechanism of SIDS? Clues from epidemiology. Dev Psychobiol. 
2009;51(2):215-222. 
140.  Rohde MC, Corydon TJ, Hansen J, et al. Heat stress and sudden infant death syndrome—stress 
gene expression after exposure to moderate heat stress. Forensic Sci Int. 2013;232(1-3):16-24. 
141.  Hoffman H, Damus K, Hillman L, Krongrad E. Risk factors for SIDS. Results of the National 
Institute of Child Health and Human Development SIDS cooperative epidemiological study. Ann 
N Y Acad Sci. 1988;533:13-30. 
142.  Grasmeyer S, Madea B. Myocardial apoptosis and SIDS. Forensic Sci Int. 2015;246:1-5. 
143.  Campuzano O, Allegue C, Sarquella-Brugada G, et al. The role of clinical, genetic and 
segregation evaluation in sudden infant death. Forensic Sci Int. 2014;242:9-15. 
144.  Berul CI, Perry JC. Contribution of long-QT syndrome genes to sudden infant death syndrome: is 
it time to consider newborn electrocardiographic screening? Circulation. 2007;115(3):294-296. 
145.  Miller ER, Moro PL, Cano M, Shimabukuro TT. Deaths following vaccination: what does the 
evidence show? Vaccine. 2015;33(29):3288-3292. 
146.  Sturner WQ. Can baby organs be donated in all forensic cases? Proposed guidelines for organ 
donation from infants under medical examiner jurisdiction. Am J Forensic Med Pathol. 
1995;16(3):215-218. 
147.  Bonham JR, Downing M. Metabolic deficiencies and SIDS. J Clin Pathol. 1992;45(11 Suppl):33-
38. 
148.  Garcia M, Beby-Defaux A, Lévêque N. Respiratory viruses as a cause of sudden death. Expert 
Rev Anti Infect Ther. 2016;14(4):359-363. 
149.  Weber MA, Hartley JC, Ashworth MT, Malone M, Sebire NJ. Virological investigations in sudden 
unexpected deaths in infancy (SUDI). Forensic Sci Med Pathol. 2010;6(4):261-267. 
150.  Desmons A, Terrade C, Boulagnon C, et al. Post-mortem diagnosis, of cytomegalovirus and 
varicella zoster virus co-infection by combined histology and tissue molecular biology, in a 
sudden unexplained infant death. J Clin Virol. 2013;58(2):486-489. 
151.  Burger MC, Dempers JJ, de Beer C, et al. Profiling the approach to the investigation of viral 
infections in cases of sudden unexpected death in infancy in the Western Cape Province, South 
Africa. Forensic Sci Int. 2014;239:27-30. 
152.  Guntheroth WG. Sudden infant death syndrome (crib death). Am Heart J. 1977;93(6):784-793. 
153.  Risse M, Weiler G. Differential diagnosis SIDS/non-SIDS on the basis of histological findings of 
petechial thymus hemorrhages. Forensic Sci Int. 1989;43(1):1-7. 
154.  Berry PJ. Pathological findings in SIDS. J Clin Pathol. 1992;45(11 Suppl):11-16. 
155.  Krous HF. The microscopic distribution of intrathoracic petechiae in sudden infant death 
syndrome. Arch Pathol Lab Med. 1984;108(1):77-79. 
156.  Rajs J, Hammarquist F. Sudden infant death in Stockholm. A forensic pathology study covering 
ten years. Acta Paediatr Scand. 1988;77(6):812-820. 
157.  Molz G, Brodzinowski A, Bär W, Vonlanthen B. Morphologic variations in 180 cases of sudden 
100 
 
 
infant death and 180 controls. Am J Forensic Med Pathol. 1992;13(3):186-190. 
158.  Helweg-Larsen K. Sudden, unexplained infant death--sudden infant death syndrome. Forensic 
pathological aspects. Ugeskr Laeger. 1992;154(49):3477-3482. 
159.  Råsten-Almqvist P, Eksborg S, Rajs J. Heart weight in infants--a comparison between sudden 
infant death syndrome and other causes of death. Acta Paediatr. 2000;89(9):1062-1067. 
160.  Siebert JR, Haas J. Organ Weights in Sudden Infant Death Syndrome. Fetal Pediatr Pathol. 
1994;14(6):973-985. 
161.  Kelmanson IA. Differences in somatic and organ growth rates in infants who died of sudden 
infant death syndrome. J Perinat Med. 1992;20(3):183-188. 
162.  Falck G, Rajs J. Brain weight and sudden infant death syndrome. J Child Neurol. 
1995;10(2):123-126. 
163.  Kadhim H, Sébire G, Khalifa M, et al. Incongruent cerebral growth in sudden infant death 
syndrome. J Child Neurol. 2005;20(3):244-246. 
164.  Blair PS, Nadin P, Cole TJ, et al. Weight gain and sudden infant death syndrome: changes in 
weight z scores may identify infants at increased risk. Arch Dis Child. 2000;82(6):462-469. 
165.  Elliott JA, Vink R, Jensen L, Byard RW. Brain weight-body weight ratio in sudden infant death 
syndrome revisited. Med Sci Law. 2012;52(4):207-209. 
166.  Goldwater PN. Sudden infant death syndrome: a critical review of approaches to research. Arch 
Dis Child. 2003;88(12):1095-1100. 
167.  Little BB, Kemp PM, Bost RO, Snell LM, Peterman MA. Abnormal allometric size of vital body 
organs among sudden infant death syndrome victims. Am J Hum Biol. 2000;12(3):382-387. 
168.  Gassner HL, Toppari J, Quinteiro González S, Miller WL. Near-miss apparent SIDS from adrenal 
crisis. J Pediatr. 2004;145(2):178-183. 
169.  Weber MA, Pryce JW, Ashworth MT, Malone M, Sebire NJ. Histological examination in sudden 
unexpected death in infancy: evidence base for histological sampling. J Clin Pathol. 
2012;65(1):58-63. 
170.  American Academy of Pediatrics. Committee on Child Abuse and Neglect. American Academy of 
Pediatrics: Distinguishing sudden infant death syndrome from child abuse fatalities. Pediatrics. 
2001;107(2):437-441. 
171.  Schnitzer PG, Covington TM, Dykstra HK. Sudden unexpected infant deaths: sleep environment 
and circumstances. Am J Public Health. 2012;102(6):1204-1212. 
172.  Randall BB, Paterson DS, Haas EA, et al. Potential asphyxia and brainstem abnormalities in 
sudden and unexpected death in infants. Pediatrics. 2013;132(6):e1616-e1625. 
173.  Krous HF. Sudden infant death syndrome: pathology and pathophysiology. Pathol Annu. 1984;19 
Pt 1:1-14. 
174.  Kelmanson IA. Evidence for retarded kidney growth in sudden infant death syndrome. Pediatr 
Nephrol. 1996;10(6):683-686. 
175.  Hinchliffe SA, Howard C V, Lynch MR, Sargent PH, Judd BA, van Velzen D. Renal 
developmental arrest in sudden infant death syndrome. Pediatr Pathol. 13(3):333-343. 
176.  Schmidt I, Chellakooty M, Boisen KA, et al. Impaired kidney growth in low-birth-weight children: 
distinct effects of maturity and weight for gestational age. Kidney Int. 2005;68(2):731-740. 
177.  Tang J, Zhu Z, Xia S, et al. Chronic hypoxia in pregnancy affected vascular tone of renal 
interlobar arteries in the offspring. Sci Rep. 2015;5:9723. 
178.  Farahani R, Kanaan A, Gavrialov O, et al. Differential effects of chronic intermittent and chronic 
constant hypoxia on postnatal growth and development. Pediatr Pulmonol. 2008;43(1):20-28. 
101 
 
 
179.  Leslie ND, Valencia CA, Strauss AW, Connor J, Zhang K. Very Long-Chain Acyl-Coenzyme A 
Dehydrogenase Deficiency. University of Washington, Seattle; 1993. 
180.  Boles RG, Buck EA, Blitzer MG, et al. Retrospective biochemical screening of fatty acid oxidation 
disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr. 
1998;132(6):924-933. 
181.  Randall BB, Wadee SA, Sens MA, et al. A practical classification schema incorporating 
consideration of possible asphyxia in cases of sudden unexpected infant death. Forensic Sci 
Med Pathol. 2009;5(4):254-260. 
182.  Task Force on Sudden Infant Death Syndrome, Moon RY. SIDS and other sleep-related infant 
deaths: expansion of recommendations for a safe infant sleeping environment. Pediatrics. 
2011;128(5):1030-1039. 
183.  Kam HY, Ou LC, Thron CD, Smith RP, Leiter JC. Role of the spleen in the exaggerated 
polycythemic response to hypoxia in chronic mountain sickness in rats. J Appl Physiol. 
1999;87(5):1901-1908. 
184.  Kubanek B, Ferrari L, Tyler WS, Howard D, Jay S, Stohlman F. Regulation of erythropoiesis. 23. 
Dissociation between stem cell and erythroid response to hypoxia. Blood. 1968;32(4):586-596. 
185.  Publicly Funded Immunization Schedule for Ontario-October 2015. 
http://www.health.gov.on.ca/en/pro/programs/immunization/docs/immunization_schedule.pdf. 
Published 2015. Accessed June 29, 2016. 
186.  Siegrist C-A. The challenges of vaccine responses in early life: selected examples. J Comp 
Pathol. 2007;137:S4-S9. 
187.  Pérez-Platz U, Saeger W, Dhom G, Bajanowski T. The pathology of the adrenal glands in 
sudden infant death syndrome (SIDS). Int J Legal Med. 1994;106(5):244-248. 
188.  Kyritsi EM, Sertedaki A, Chrousos G, Charmandari E. Familial Or Sporadic Adrenal Hypoplasia 
Syndrome. In: Endotext INC, ed. Endotext. South Dartmouth; 2000. 
189.  Loureiro M, Reis F, Robalo B, Pereira C, Sampaio L. Adrenal hypoplasia congenita: a rare cause 
of primary adrenal insufficiency and hypogonadotropic hypogonadism. Pediatr Rep. 
2015;7(3):5936. 
190.  Achermann JC, Vilain EJ. X-Linked Adrenal Hypoplasia Congenita. Seattle: GeneReviews; 2001. 
191.  Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF, Jameson JL. Adrenal hypoplasia 
congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to 
combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest. 
1996;98(4):1055-1062. 
192.  Uttley WS. Familial congenital adrenal hypoplasia. Arch Dis Child. 1968;43(232):724-730. 
 
  
102 
 
 
Appendices 
Appendix A    Autopsy Body and Organ References Survey 
 
 
  
Autopsy Body and Organ References Survey 
1)  Do you or your pathologists perform Coroners’ neonatal (Birth – 1 month) or infant (1 month -1 
year) autopsies?    Please circle the appropriate response     Yes   or    No 
 
2) Have you referenced any of the following sources for organ or body measurements? Please provide 
details (Authors, Journal, Year, Volume, Page #s or Textbook) for any additional sources. 
 
 Kayser  K. Height and weight in human beings; Autopsy report. Munich: Oldenbourg, 
1987.51 
 Schulz DM, Giordano DA, Schulz DH. Weights of Organs of Fetuses and Infants. Arch Pathol 
1962; 74:244 
 Sung CJ, Singer DB, Wingglesworth JS. Fetal growth and maturation: with standards for 
body and organ development. In: Wingglesworth JS, Singer DB, eds. Textbook of Fetal and 
Perinatal Pathology, 2nd ed. Boston. Blackwell Scientific Publications, Sung CJ, Singer DB, 
Wingglesworth JS. 1998; 8-40 
 Stocker JT, Dehner LP. Pediatric Pathology 2nd ed. Philadelphia. Lippincott Williams and 
Wilkins. 1940. 
 Coppoletta JM, Wolback SB. Body length and organ weights in infants and children: Study 
of body lengths and normal weights of more important vital organs and body between 
birth and 12 years of age. Am J Pathol 1933;9:55-70  
 Stowens  D. Pediatric Pathology. Baltimore. The Williams and Wilkins Co. 1959 
 Centers for Disease Control (CDC) 
http://www.cdc.gov/growthcharts/percentile_data_files.htm 
 Other (Please specify) ________________________________________________________ 
 __________________________________________________________________________ 
 __________________________________________________________________________ 
 __________________________________________________________________________ 
 __________________________________________________________________________ 
 
3) Which of the above sources do you reference most often and why? __________________________ 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
 
4) Are there any limitations of these sources in your opinion? 
__________________________________________________________________________________ 
__________________________________________________________________________________ 
__________________________________________________________________________________ 
__________________________________________________________________________________ 
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Appendix B  The University of Western Ontario Research Ethics Board 
for Health Sciences Research Involving Human Subjects Approval 
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Appendix C Lawson Health Research Institute Approval  
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Appendix D Data Collection Sheet 
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Appendix E Growth Curves for Individual Organs and Body Measurements  
 
 
 
Figure E-1. Growth Curves for Individual Organs 
Mean individual organ weights in grams plotted by age in weeks. Weights gradually increased with age consistent with normal 
development of a child. 
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Figure E-2. Growth Curves for Individual Organs 
Mean individual organ weights in grams plotted by age in weeks. Most weights gradually increased with age consistent with normal 
development of a child, except thymus and adrenal glands.  
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Figure E-3. Growth Curves for Individual Body Measurements 
Means of body measurements plotted by age in weeks (weight in grams, crown-heel and foot length in centimeters). The body 
measurements gradually increased with age consistent with normal development of a child. 
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Appendix F P-values  
 
Table F-1. P-values for the Effect of Gender on Individual Organ and Body Weight for Different Age Groups 
 
Of the 56 significant relationships (p<0.05), 44 were at age less than 25 weeks. 
 
 
AGE Heart Lungs R.Lung L.Lung Kidneys R.Kidney L.Kidney Liver Spleen Pancreas Adrenals R.Adrenal L.Adrenal Brain Body 
0-2 0.0376 0.0909 0.0867 0.4147 0.0103 0.0277 0.0056 0.1077 0.0214 0.2859 0.6524 0.6675 0.7325 0.0895 0.2607 
3-4 0.0191 0.2462 0.1099 0.0458 0.2614 0.2372 0.3389 0.0885 0.0764 0.7602 0.0139 0.0246 0.0168 0.0155 0.4025 
5-8 0.141 0.4942 0.3773 0.927 0.0099 0.0214 0.0133 0.8403 0.5709 0.2276 0.351 0.4274 0.3099 0.0198 0.2151 
9-12 0.0001 0.0108 0.0424 0.0086 0.0003 0.0006 0.0004 0.0544 0.0002 0.2338 0.0525 0.1551 0.0205 0.0067 0.0016 
13-16 0.195 0.0369 0.0176 0.1754 0.0118 0.0074 0.026 0.0195 0.0457 0.1778 0.1839 0.3199 0.1222 0.0996 0.0246 
17-20 0.0119 0.2657 0.1975 0.8587 0.2508 0.2267 0.2136 0.0082 0.1017 0.8415 0.3999 0.4365 0.3612 0.2809 0.0083 
21-24 0.0152 0.3291 0.308 0.8876 0.0185 0.0741 0.0138 0.2079 0.1664 0.0359 0.0124 0.019 0.088 0.3207 0.0122 
25-28 0.0196 0.9093 0.7247 0.6627 0.0016 0.0108 0.0069 0.071 0.0242 0.2489 0.106 0.2289 0.0771 0.3453 0.2127 
29-32 0.5006 0.329 0.4521 0.2446 0.8225 0.6081 0.9548 0.5837 0.682 0.2992 0.1265 0.316 0.0562 0.3794 0.5616 
33-36 0.1244 - - - - - - 0.0449 0.903 0.9773 0.4807 0.0724 0.2582 - 0.4993 
37-40 0.2256 0.3926 0.1766 0.8356 0.3869 0.4294 0.4348 0.7342 0.7096 0.6452 0.0297 0.0448 0.0515 0.1291 0.5459 
41-44 0.9074 0.4328 0.6066 0.3308 0.5683 0.9565 0.251 0.4715 0.9561 0.0169 0.1713 0.2337 0.0784 0.7881 0.2114 
45-52 0.009 0.7221 0.8919 0.517 0.9934 0.6413 0.6372 0.6176 0.3709 0.011 0.8263 0.7883 0.8911 0.0068 0.0894 
 
R. (right). L. (left),  
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Table F-2.  P-Values – Difference in Combined Lung Weights between the Cause of Death Groups 
P-values distribution for the combined lung weights between the cause of death groups for males, females and combined genders. 
Significance threshold of p <0.05. 
 
Female Control-SIDS Control-SUDS SIDS-SUDS 
 
Male Control-SIDS Control-SUDS SIDS-SUDS 
 
All Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0.16 0.0018 0.6954 
 
0-2 0.2095 0.0196 0.9621 
 
0-2 0.0502 0.0001 0.7397 
3-4 0.163 0.0129 0.892 
 
3-4 0.005 0.0004 0.4156 
 
3-4 0.0029 0.0000 0.5812 
5-8 0.7942 0.196 0.4299 
 
5-8 0.4864 0.1029 0.6026 
 
5-8 0.4991 0.0396 0.3664 
9-12 0.0135 0.0045 0.8478 
 
9-12 0.9398 0.579 0.6123 
 
9-12 0.171 0.0627 0.8209 
13-16 0.5286 0.8495 0.4114 
 
13-16 0.9979 0.2925 0.1479 
 
13-16 0.5759 0.6394 0.2091 
17-20 0.9547 0.2869 0.2419 
 
17-20 0.0817 0.1598 0.2806 
 
17-20 0.0703 0.1152 0.5073 
21-24 0.6797 0.8558 0.79 
 
21-24 0.0298 0.0189 0.8528 
 
21-24 0.1087 0.0564 0.993 
25-28 0.004 0.0113 0.0255 
 
25-28 0.2489 0.3062 0.8276 
 
25-28 0.0972 0.1582 0.6787 
29-32 0.9439 - - 
 
29-32 0.4209 0.658 0.5485 
 
29-32 0.2895 0.4869 0.4999 
33-36 - - - 
 
33-36 0.4573 0.4404 0.9652 
 
33-36 0.8406 0.8149 0.9781 
37-40 - - - 
 
37-40 0.9342 0.6857 0.6018 
 
37-40 0.5082 0.8683 0.5642 
41-44 0.4887 - - 
 
41-44 - 0.2405 - 
 
41-44 0.0902 0.186 0.8337 
45-52 0.3374 0.2422 0.7321 
 
45-52 0.9084 0.9549 0.9594 
 
45-52 0.3602 0.3285 0.891 
 
  
  
1
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Table F-3.  P-Values – Difference in Combined Kidney Weights between the Cause of Death Groups 
P-values distribution for the combined kidney weights between the cause of death groups for males, females and combined genders. 
Significance threshold of p <0.05. 
  
Female Control-SIDS Control-SUDS SIDS-SUDS 
 
Male Control-SIDS Control-SUDS SIDS-SUDS 
 
All Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0.0983 0.9802 0.1186 
 
0-2 0.8904 0.1215 0.524 
 
0-2 0.21 0.2099 0.5882 
3-4 0.316 0.0026 0.2936 
 
3-4 0.3687 0.7798 0.4665 
 
3-4 0.1936 0.0782 0.9134 
5-8 0.2095 0.1445 0.7039 
 
5-8 0.8052 0.7118 0.9778 
 
5-8 0.4146 0.3374 0.8012 
9-12 0.0638 0.5306 0.0026 
 
9-12 0.5545 0.756 0.6954 
 
9-12 0.9346 0.193 0.2086 
13-16 0.3942 0.3579 0.7746 
 
13-16 0.1453 0.808 0.0284 
 
13-16 0.1843 0.5772 0.0382 
17-20 0.1674 0.0684 0.7659 
 
17-20 0.2474 0.4581 0.548 
 
17-20 0.8014 0.5711 0.4459 
21-24 0.7107 0.5122 0.921 
 
21-24 0.5877 0.8407 0.6862 
 
21-24 0.5083 0.8657 0.5965 
25-28 0.3515 0.6072 0.5231 
 
25-28 0.2714 0.1271 0.7196 
 
25-28 0.8966 0.2829 0.4008 
29-32 0.1085 0.2077 0.5814 
 
29-32 0.9557 0.5161 0.7531 
 
29-32 0.2934 0.8496 0.3819 
33-36 - - - 
 
33-36 0.831 0.366 0.5322 
 
33-36 0.9293 0.5192 0.561 
37-40 0.5436 0.9398 0.6534 
 
37-40 0.5218 0.6937 0.1452 
 
37-40 0.8589 0.2354 0.1477 
41-44 0.551 - - 
 
41-44 - - - 
 
41-44 0.3542 - - 
45-52 0.7234 0.327 0.6084 
 
45-52 0.1086 0.9678 0.2959 
 
45-52 0.1648 0.3566 0.7976 
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Table F-4.  P-Values – Difference in Liver Weights between the Cause of Death Groups 
P-values distribution for the liver weights between the cause of death groups for males, females and combined genders. Significance 
threshold of p <0.05. 
 
Female Control-SIDS Control-SUDS SIDS-SUDS 
 
Male Control-SIDS Control-SUDS SIDS-SUDS 
 
All Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0.0217 0.4884 0.0684 
 
0-2 0.5826 0.8218 0.5325 
 
0-2 0.2268 0.5564 0.4068 
3-4 0.54 0.0301 0.5784 
 
3-4 0.207 0.3308 0.5835 
 
3-4 0.0555 0.0386 0.589 
5-8 0.1812 0.0641 0.8336 
 
5-8 0.3776 0.8191 0.4401 
 
5-8 0.1539 0.2606 0.4453 
9-12 0.249 0.6191 0.3389 
 
9-12 0.6966 0.3118 0.1679 
 
9-12 0.7615 0.3768 0.6347 
13-16 0.6748 0.3957 0.9637 
 
13-16 0.5931 0.8186 0.3593 
 
13-16 0.1258 0.464 0.2851 
17-20 0.6102 0.8876 0.676 
 
17-20 0.0168 0.1199 0.1777 
 
17-20 0.0376 0.1688 0.2625 
21-24 0.351 0.8595 0.437 
 
21-24 0.2704 0.585 0.4839 
 
21-24 0.0975 0.4495 0.2803 
25-28 0.8652 0.8215 0.9855 
 
25-28 0.904 0.6483 0.7432 
 
25-28 0.5968 0.517 0.9343 
29-32 0.3169 0.6361 0.6024 
 
29-32 0.4764 0.2367 0.987 
 
29-32 0.6013 0.7654 0.4687 
33-36 - - - 
 
33-36 0.9447 0.046 0.0689 
 
33-36 0.6022 0.6969 0.4884 
37-40 0.4648 0.9521 0.4898 
 
37-40 0.1016 0.3568 0.1696 
 
37-40 0.0294 0.455 0.0595 
41-44 0.4984 - - 
 
41-44 - 0.0385 - 
 
41-44 0.2117 0.2908 0.8056 
45-52 0.6849 0.3266 0.2792 
 
45-52 0.3693 0.991 0.5824 
 
45-52 0.2836 0.5756 0.2275 
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Table F-5.  P-Values – Difference in Brain Weights between the Cause of Death Groups 
P-values distribution for the brain weights between the cause of death groups for males, females and combined genders. Significance 
threshold of p <0.05. 
  
Female Control-SIDS Control-SUDS SIDS-SUDS 
 
Male Control-SIDS Control-SUDS SIDS-SUDS 
 
All Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0.9404 0.0051 0.0797 
 
0-2 0.9516 0.0581 0.2271 
 
0-2 0.9504 0.0014 0.04 
3-4 0.5654 0.512 0.813 
 
3-4 0.7691 0.406 0.738 
 
3-4 0.3662 0.1818 0.9318 
5-8 0.6988 0.4027 0.9281 
 
5-8 0.1834 0.085 0.8615 
 
5-8 0.1522 0.0829 0.7219 
9-12 0.0021 0.0056 0.2316 
 
9-12 0.5819 0.2996 0.1356 
 
9-12 0.3441 0.0872 0.6481 
13-16 0.4235 0.28 0.9381 
 
13-16 0.297 0.1281 0.7027 
 
13-16 0.1226 0.041 0.8829 
17-20 0.4111 0.2654 0.954 
 
17-20 0.5835 0.7943 0.6838 
 
17-20 0.949 0.8048 0.7406 
21-24 0.6032 0.1349 0.3811 
 
21-24 0.0716 0.1961 0.4604 
 
21-24 0.1747 0.6 0.3285 
25-28 0.4979 0.5178 0.2442 
 
25-28 0.2048 0.7621 0.2732 
 
25-28 0.2206 0.9016 0.1402 
29-32 - - 0.5758 
 
29-32 - 0.8765 - 
 
29-32 0.8355 0.7466 0.9533 
33-36 - - - 
 
33-36 0.8404 0.6642 0.8429 
 
33-36 0.8404 0.6642 0.8429 
37-40 0.4669 0.7548 0.4152 
 
37-40 0.3867 0.0948 0.1483 
 
37-40 0.2341 0.7588 0.1232 
41-44 0.9263 - - 
 
41-44 - 0.7009 - 
 
41-44 0.9635 0.4888 0.5038 
45-52 0.7476 0.6676 0.5192 
 
45-52 0.5652 0.2794 0.2281 
 
45-52 0.182 0.7452 0.214 
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Table F-6.  P-Values – Difference in Spleen Weights between the Cause of Death Groups 
P-values distribution for the spleen weights between the cause of death groups for males, females and combined genders. Significance 
threshold of p <0.05. 
 
Female Control-SIDS Control-SUDS SIDS-SUDS 
 
Male Control-SIDS Control-SUDS SIDS-SUDS 
 
All Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0.6849 0.1325 0.2641 
 
0-2 0.7944 0.7541 0.6893 
 
0-2 0.6432 0.2625 0.3221 
3-4 0.83 0.1885 0.5798 
 
3-4 0.8959 0.2395 0.2955 
 
3-4 0.8392 0.6293 0.5973 
5-8 0.9116 0.0864 0.214 
 
5-8 0.2491 0.1117 0.0243 
 
5-8 0.2914 0.0249 0.0097 
9-12 0.0519 0.1513 0.3045 
 
9-12 0.5783 0.3285 0.8451 
 
9-12 0.1741 0.2086 0.639 
13-16 0.5549 0.6455 0.7556 
 
13-16 0.0169 0.2109 0.0918 
 
13-16 0.0704 0.5175 0.1364 
17-20 0.4161 0.8948 0.4664 
 
17-20 0.1818 0.8952 0.0921 
 
17-20 0.2739 0.9644 0.2241 
21-24 0.3907 0.8151 0.3301 
 
21-24 0.124 0.1674 0.6969 
 
21-24 0.0625 0.194 0.4153 
25-28 0.7814 0.7418 0.6293 
 
25-28 0.9915 0.8959 0.9133 
 
25-28 0.7314 0.9581 0.7014 
29-32 0.5272 0.06 0.1701 
 
29-32 0.8653 0.5582 0.8107 
 
29-32 0.6848 0.0821 0.2868 
33-36 - - - 
 
33-36 0.9372 0.1153 0.1687 
 
33-36 0.7993 0.1074 0.154 
37-40 0.3016 0.0851 0.2748 
 
37-40 - - 0.7315 
 
37-40 0.3553 0.3175 0.8968 
41-44 0.209 - - 
 
41-44 - 0.3669 - 
 
41-44 0.1762 0.2487 0.783 
45-52 0.5407 0.5889 0.9408 
 
45-52 0.8381 0.0632 0.0888 
 
45-52 0.6318 0.1985 0.1663 
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Table F-7.  P-Values – Difference in Combined Adrenal Weights between the Cause of Death Groups 
P-values distribution for the combined adrenal weights between the cause of death groups for males, females and combined genders. 
Significance threshold of p <0.05. 
 
Female Control-SIDS Control-SUDS SIDS-SUDS 
 
Male Control-SIDS Control-SUDS SIDS-SUDS 
 
All Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0.0247 0.0005 0.7133 
 
0-2 0.3299 0.0001 0.2098 
 
0-2 0.0259 0.0000 0.4901 
3-4 0.3841 0.8578 0.3268 
 
3-4 0.4233 0.4337 0.1672 
 
3-4 0.6889 0.6926 0.4997 
5-8 0.6856 0.513 0.3579 
 
5-8 0.2128 0.1256 0.7814 
 
5-8 0.1928 0.4494 0.3877 
9-12 0.7094 0.0024 0.0257 
 
9-12 0.8751 0.3062 0.2984 
 
9-12 0.9801 0.013 0.0376 
13-16 0.2614 0.0483 0.0206 
 
13-16 0.0542 0.6192 0.0468 
 
13-16 0.0221 0.6608 0.0024 
17-20 0.0829 0.021 0.7831 
 
17-20 0.8494 0.907 0.7466 
 
17-20 0.2938 0.2625 0.8438 
21-24 0.6767 0.2853 0.5835 
 
21-24 0.5458 0.2197 0.5811 
 
21-24 0.9478 0.6027 0.7025 
25-28 0.8193 0.7315 0.6467 
 
25-28 0.4067 0.3736 0.9971 
 
25-28 0.5558 0.6614 0.8629 
29-32 0.7262 0.7634 0.9272 
 
29-32 0.6115 0.4355 0.3612 
 
29-32 0.5474 0.8841 0.5002 
33-36 - - - 
 
33-36 0.4214 0.3089 0.1876 
 
33-36 0.597 0.2769 0.2331 
37-40 0.0927 - - 
 
37-40 0.8518 0.2827 0.1487 
 
37-40 0.7853 0.0453 0.0506 
41-44 0.3277 - - 
 
41-44 - 0.609 - 
 
41-44 0.6997 0.9539 0.8415 
45-52 0.1469 0.5933 0.1785 
 
45-52 0.3267 0.046 0.0265 
 
45-52 0.2662 0.6479 0.7869 
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Table F-8.  P-Values – Difference in Thymus Weights between the Cause of Death Groups 
P-values distribution for the thymus weights between the cause of death groups for males, females and combined genders. 
Significance threshold of p <0.05. 
 
Female Control-SIDS Control-SUDS SIDS-SUDS 
 
Male Control-SIDS Control-SUDS SIDS-SUDS 
 
All Control-SIDS Control-SUDS SIDS-SUDS 
0-2 0.1029 0.0001 0.6088 
 
0-2 0.4383 0.0000 0.0348 
 
0-2 0.0967 0.0000 0.0660 
3-4 0.1655 0.3490 0.4072 
 
3-4 0.0432 0.0093 0.9237 
 
3-4 0.0145 0.0067 0.5350 
5-8 0.0582 0.0138 0.7558 
 
5-8 0.1831 0.0019 0.2561 
 
5-8 0.0339 0.0001 0.4553 
9-12 0.0544 0.3935 0.1067 
 
9-12 0.7055 0.1575 0.4452 
 
9-12 0.1641 0.1756 0.6766 
13-16 0.6072 0.5815 0.3662 
 
13-16 0.1152 0.1694 0.6363 
 
13-16 0.0715 0.0929 0.6187 
17-20 1.0000 0.4103 0.5296 
 
17-20 0.0630 0.0463 0.9425 
 
17-20 0.0630 0.0318 0.9824 
21-24 0.0643 0.4056 0.1515 
 
21-24 0.0026 0.0178 0.2083 
 
21-24 0.0001 0.0060 0.0398 
25-28 0.9646 0.9702 0.9382 
 
25-28 0.8296 0.6725 0.5173 
 
25-28 0.8191 0.6990 0.5357 
29-32 0.2506 0.3699 0.7146 
 
29-32 0.6093 0.4910 0.9251 
 
29-32 0.2673 0.2749 0.8207 
33-36 - - - 
 
33-36 0.5525 0.8671 0.7135 
 
33-36 0.4551 0.8523 0.6414 
37-40 0.6574 0.1513 0.2920 
 
37-40 0.4037 0.5119 0.7508 
 
37-40 0.1565 0.1750 0.9773 
41-44 0.7592 - - 
 
41-44 - 0.0943 - 
 
41-44 0.3849 0.0327 0.1307 
45-52 0.9177 0.8937 0.8591 
 
45-52 0.5792 0.4229 0.7327 
 
45-52 0.5720 0.7790 0.8276 
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Appendix G Raw Data 
 
The following tables demonstrate descriptive statistics (mean, standard deviations and sample 
sizes) for the individual organs that showed significant weight differences in relationship to 
cause of death, age and gender (by Backward Selection stepAIC). Means are given in grams. “-“ 
represents no data. 
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Table G-1. Lung Descriptive Statistics by Cause of Death Groups 
  
CONTROL 
 
Female Male Combined 
 
SIDS 
 
Female Male Combined 
 
SUDS 
 
Female Male Combined 
0-2 Mean 59.38 65.69 62.13 
 
0-2 Mean 71.72 76.4 74.06 
 
0-2 Mean 75.27 76.8 76.11 
0-2 SD 16.03 17.38 16.78 
 
0-2 SD 19.14 22.88 19.69 
 
0-2 SD 16.21 11.76 13.77 
0-2 n 31 24 55 
 
0-2 n 4 4 8 
 
0-2 n 18 22 40 
3-4 Mean 69.82 62.26 67.76 
 
3-4 Mean 100.1 100.58 100.44 
 
3-4 Mean 102.88 107.75 105.5 
3-4 SD 21.12 19.93 20.1 
 
3-4 SD 2.26 15.25 12.49 
 
3-4 SD 30.31 16.35 23.44 
3-4 n 8 3 11 
 
3-4 n 2 5 7 
 
3-4 n 12 14 26 
5-8 Mean 97.27 104.11 102.05 
 
5-8 Mean 101.56 110.55 107.55 
 
5-8 Mean 112.43 114.75 113.87 
5-8 SD 34.02 24.61 27.01 
 
5-8 SD 10.93 21.57 18.66 
 
5-8 SD 24.39 19.18 21.15 
5-8 n 6 14 20 
 
5-8 n 4 8 12 
 
5-8 n 25 41 66 
9-12 Mean 91.22 123.76 111.25 
 
9-12 Mean 119.85 124.61 122.83 
 
9-12 Mean 118.26 128.97 124.27 
9-12 SD 27.95 31.1 33.11 
 
9-12 SD 16.39 23.96 20.97 
 
9-12 SD 16.28 21.36 19.87 
9-12 n 5 8 13 
 
9-12 n 6 10 16 
 
9-12 n 25 32 57 
13-16 Mean 125.04 143.46 134.25 
 
13-16 Mean 113.5 143.49 139.2 
 
13-16 Mean 127.21 132.69 130.65 
13-16 SD 9.89 24.08 19.89 
 
13-16 SD 10.61 19.22 20.97 
 
13-16 SD 24.67 20.14 21.74 
13-16 n 5 5 10 
 
13-16 n 2 12 14 
 
13-16 n 13 22 35 
17-20 Mean 121.8 99.3 114.3 
 
17-20 Mean 122.73 149.89 143.62 
 
17-20 Mean 137.02 138.74 138.22 
17-20 SD 25.74 - 22.36 
 
17-20 SD 14.48 28.44 27.99 
 
17-20 SD 17.15 26.11 23.5 
17-20 n 2 1 3 
 
17-20 n 3 10 13 
 
17-20 n 10 23 33 
21-24 Mean 133.55 113.46 122.39 
 
21-24 Mean 124.95 150.84 143.44 
 
21-24 Mean 130.47 148.3 143.55 
21-24 SD 14.75 26.4 23.28 
 
21-24 SD 2.9 17.52 19.12 
 
21-24 SD 31.95 26.97 28.37 
21-24 n 4 5 9 
 
21-24 n 2 5 7 
 
21-24 n 4 11 15 
25-28 Mean 131.1 123.6 127.35 
 
25-28 Mean 171.76 155.11 156.96 
 
25-28 Mean 152.07 151.43 151.6 
25-28 SD 5.09 40.87 24.17 
 
25-28 SD - 30.64 29.19 
 
25-28 SD 3.52 34.48 28.89 
25-28 n 2 2 4 
 
25-28 n 1 8 9 
 
25-28 n 3 8 11 
29-32 Mean - 196 196 
 
29-32 Mean 147.63 145.4 147.07 
 
29-32 Mean 151 174.83 165.3 
29-32 SD - - - 
 
29-32 SD 50.93 - 41.6 
 
29-32 SD 42.43 35.62 35.42 
29-32 n - 1 1 
 
29-32 n 3 1 4 
 
29-32 n 2 3 5 
33-36 Mean 103 189.9 160.93 
 
33-36 Mean - 146.5 146.5 
 
33-36 Mean - 144.1 144.1 
33-36 SD - 30.97 54.74 
 
33-36 SD - - - 
 
33-36 SD - - - 
33-36 n 1 2 3 
 
33-36 n - 1 1 
 
33-36 n - 1 1 
37-40 Mean 168.5 132.5 156.5 
 
37-40 Mean - 136.49 136.49 
 
37-40 Mean - 151.76 151.76 
37-40 SD 0.71 
 
20.79 
 
37-40 SD - 59.83 59.83 
 
37-40 SD - 18.82 18.82 
37-40 n 2 1 3 
 
37-40 n - 4 4 
 
37-40 n - 5 5 
41-44 Mean 127 116.9 120.27 
 
41-44 Mean 173.75 - 173.75 
 
41-44 Mean - 167.1 167.1 
41-44 SD - 16.26 12.89 
 
41-44 SD 36.84 - 36.84 
 
41-44 SD - - - 
41-44 n 1 2 3 
 
41-44 n 2 - 2 
 
41-44 n - 1 1 
45-52 Mean 142.65 146 143.77 
 
45-52 Mean 170 161.3 167.82 
 
45-52 Mean 181.25 153.5 172 
45-52 SD 36.66 86.27 47.93 
 
45-52 SD 30.61 - 25.37 
 
45-52 SD 34.29 - 29.06 
45-52 n 4 2 6 
 
45-52 n 3 1 4 
 
45-52 n 2 1 3 
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Table G-2. Kidney Descriptive Statistics by Cause of Death Groups 
CONTROL 
 
Female Male Combined 
 
SIDS 
 
Female Male Combined 
 
SUDS 
 
Female Male Combined 
0-2 Mean 29.65 32.75 31.39 
 
0-2 Mean 24.5 32.27 28.38 
 
0-2 Mean 29.69 29.85 29.77 
0-2 SD 7.81 8.53 8.34 
 
0-2 SD 7.63 13 10.94 
 
0-2 SD 5.24 6.25 5.72 
0-2 n 70 89 159 
 
0-2 n 6 6 12 
 
0-2 n 25 26 51 
3-4 Mean 37.39 37.76 37.54 
 
3-4 Mean 33.23 32.02 32.54 
 
3-4 Mean 28.77 36.5 32.96 
3-4 SD 6.6 13.85 9.98 
 
3-4 SD 8.52 6.95 6.98 
 
3-4 SD 5.55 8.23 8.01 
3-4 n 14 10 24 
 
3-4 n 3 4 7 
 
3-4 n 11 13 24 
5-8 Mean 33.4 39.63 37.68 
 
5-8 Mean 38.73 40.43 39.81 
 
5-8 Mean 37.25 40.34 39.19 
5-8 SD 6.48 6.85 7.26 
 
5-8 SD 7.19 6.01 6.16 
 
5-8 SD 7.39 7.99 7.86 
5-8 n 11 24 35 
 
5-8 n 4 7 11 
 
5-8 n 25 42 67 
9-12 Mean 37.94 45.06 43.51 
 
9-12 Mean 45.17 42.96 43.74 
 
9-12 Mean 36.01 44.22 40.66 
9-12 SD 5.29 12.18 11.34 
 
9-12 SD 10.35 8.04 8.66 
 
9-12 SD 5.18 7.6 7.78 
9-12 n 5 18 23 
 
9-12 n 6 11 17 
 
9-12 n 26 34 60 
13-16 Mean 44.34 46.53 45.3 
 
13-16 Mean 38.8 53.14 50.07 
 
13-16 Mean 40.55 45.57 43.69 
13-16 SD 12.21 5.35 9.6 
 
13-16 SD 3.63 11.99 12.24 
 
13-16 SD 8.37 8.62 8.77 
13-16 n 9 7 16 
 
13-16 n 3 11 14 
 
13-16 n 15 25 40 
17-20 Mean 51.71 46.82 49.02 
 
17-20 Mean 40.25 51.7 49.94 
 
17-20 Mean 42.64 49.52 47.37 
17-20 SD 11.96 9.4 10.63 
 
17-20 SD 3.18 12.44 12.18 
 
17-20 SD 8.91 8.36 8.99 
17-20 n 9 11 20 
 
17-20 n 2 11 13 
 
17-20 n 10 22 32 
21-24 Mean 46.36 51.11 48.58 
 
21-24 Mean 43.6 54.17 51.52 
 
21-24 Mean 42.82 52.09 49.2 
21-24 SD 10.35 11.25 10.67 
 
21-24 SD 11.6 11.09 11.45 
 
21-24 SD 5.72 8.43 8.7 
21-24 n 8 7 15 
 
21-24 n 2 6 8 
 
21-24 n 5 11 16 
25-28 Mean 36.1 57.69 52.71 
 
25-28 Mean 48.99 52.44 52.05 
 
25-28 Mean 40.65 50.74 47.86 
25-28 SD 4.26 6.22 11.03 
 
25-28 SD 
 
11.76 11.06 
 
25-28 SD 13.6 11.1 12.26 
25-28 n 3 10 13 
 
25-28 n 1 8 9 
 
25-28 n 4 10 14 
29-32 Mean 66.83 55.23 58.71 
 
29-32 Mean 48.27 56.1 50.23 
 
29-32 Mean 53.73 61.27 57.5 
29-32 SD 21.43 11.77 15.03 
 
29-32 SD 4.31 - 5.26 
 
29-32 SD 6.19 18.28 13.26 
29-32 n 3 7 10 
 
29-32 n 3 1 4 
 
29-32 n 4 4 8 
33-36 Mean 49 63.03 59.52 
 
33-36 Mean - 60.6 60.6 
 
33-36 Mean 51.4 51.4 - 
33-36 SD - 8.69 9.98 
 
33-36 SD - - - 
 
33-36 SD - - - 
33-36 n 1 3 4 
 
33-36 n - 1 1 
 
33-36 n 1 1 - 
37-40 Mean 56.4 49.4 54.65 
 
37-40 Mean 53 56.06 55.55 
 
37-40 Mean 56 45.13 47.85 
37-40 SD 4.06 - 4.82 
 
37-40 SD - 10.25 9.26 
 
37-40 SD 5.43 7.01 - 
37-40 n 3 1 4 
 
37-40 n 1 5 6 
 
37-40 n 1 3 4 
41-44 Mean 55.43 53.9 54.74 
 
41-44 Mean 61.23 - 61.23 
 
41-44 Mean - - - 
41-44 SD 14.07 4.43 10.37 
 
41-44 SD 10.28 - 10.28 
 
41-44 SD - - - 
41-44 n 6 5 11 
 
41-44 n 3 - 3 
 
41-44 n 0 0 - 
45-52 Mean 61.35 60.57 60.84 
 
45-52 Mean 57.95 47.5 52.73 
 
45-52 Mean 51.7 61 54.8 
45-52 SD 13.23 10.42 11.18 
 
45-52 SD 4.31 5.8 7.34 
 
45-52 SD 1.84 5.52 - 
45-52 n 8 15 23 
 
45-52 n 2 2 4 
 
45-52 n 2 1 3 
  
1
2
0 
 
Table G- 3. Liver Descriptive Statistics by Cause of Death Groups 
CONTROL 
 
Female Male Combined 
 
SIDS 
 
Female Male Combined 
 
SUDS 
 
Female Male Combined 
0-2 Mean 158.47 146.45 152.04 
 
0-2 Mean 118.52 154.86 138.08 
 
0-2 Mean 152.19 144.53 148.36 
0-2 SD 41.83 40.63 41.51 
 
0-2 SD 29.95 47.87 43.3 
 
0-2 SD 38.23 29.23 33.93 
0-2 n 80 92 172 
 
0-2 n 6 7 13 
 
0-2 n 27 27 54 
3-4 Mean 143.73 153.87 147.63 
 
3-4 Mean 153.95 185.14 176.23 
 
3-4 Mean 163.45 172.25 168.22 
3-4 SD 24.45 51.55 36.61 
 
3-4 SD 23.97 53.09 46.97 
 
3-4 SD 17.28 33.41 27.06 
3-4 n 16 10 26 
 
3-4 n 2 5 7 
 
3-4 n 11 13 24 
5-8 Mean 174.89 189.92 185.45 
 
5-8 Mean 200.3 203.53 202.54 
 
5-8 Mean 196.68 192.2 193.98 
5-8 SD 32.97 52.97 47.95 
 
5-8 SD 39.08 47.01 43.1 
 
5-8 SD 30.63 26 27.79 
5-8 n 11 26 37 
 
5-8 n 4 9 13 
 
5-8 n 27 41 68 
9-12 Mean 188.99 205.5 200.25 
 
9-12 Mean 209.7 200.07 203.62 
 
9-12 Mean 196.05 216.71 208.05 
9-12 SD 47.51 49.85 48.61 
 
9-12 SD 36.96 29.09 31.54 
 
9-12 SD 27.4 30.52 30.79 
9-12 n 7 15 22 
 
9-12 n 7 12 19 
 
9-12 n 26 36 62 
13-16 Mean 211.54 246.53 228.11 
 
13-16 Mean 226.35 256.95 252.58 
 
13-16 Mean 227.92 242.58 237.43 
13-16 SD 43.12 44.3 46.09 
 
13-16 SD 72.62 53.11 54 
 
13-16 SD 43.28 38.5 40.27 
13-16 n 10 9 19 
 
13-16 n 2 12 14 
 
13-16 n 13 24 37 
17-20 Mean 231.83 235.32 233.58 
 
17-20 Mean 216 285.75 269.65 
 
17-20 Mean 228.97 261.96 251.88 
17-20 SD 54.94 50.57 51.56 
 
17-20 SD 13 59.74 60.34 
 
17-20 SD 42.5 38.12 41.83 
17-20 n 11 11 22 
 
17-20 n 3 10 13 
 
17-20 n 11 25 36 
21-24 Mean 249.56 261.09 255.32 
 
21-24 Mean 280.5 292.88 289.79 
 
21-24 Mean 253.76 274.62 268.1 
21-24 SD 45.8 58.22 50.68 
 
21-24 SD 57.28 25.55 31.11 
 
21-24 SD 18.72 54.71 46.78 
21-24 n 7 7 14 
 
21-24 n 2 6 8 
 
21-24 n 5 11 16 
25-28 Mean 260.09 286.22 277.51 
 
25-28 Mean 266 288.61 286.35 
 
25-28 Mean 265.33 295.28 287.79 
25-28 SD 26.63 39.56 37.03 
 
25-28 SD 25.05 24.68 - 
 
25-28 SD 36.95 57.52 53.27 
25-28 n 5 10 15 
 
25-28 n 1 9 10 
 
25-28 n 3 9 12 
29-32 Mean 294.95 335.4 319.22 
 
29-32 Mean 339.37 311.7 332.45 
 
29-32 Mean 315.33 311.15 312.94 
29-32 SD 61.36 27.87 46.08 
 
29-32 SD 55.08 47.05 - 
 
29-32 SD 38.89 31.71 31.81 
29-32 n 4 6 10 
 
29-32 n 3 1 4 
 
29-32 n 3 4 7 
33-36 Mean 256.85 337.67 305.34 
 
33-36 Mean 336.7 336.7 - 
 
33-36 Mean 282.1 282.1 - 
33-36 SD 46.88 10.69 50.66 
 
33-36 SD - - - 
 
33-36 SD - - - 
33-36 n 2 3 5 
 
33-36 n 1 1 - 
 
33-36 n 1 1 - 
37-40 Mean 307.6 290.8 302 
 
37-40 Mean 361 341.6 344.83 
 
37-40 Mean 304 317.66 315.38 
37-40 SD 39.03 29.25 - 
 
37-40 SD 27.55 25.88 - 
 
37-40 SD 22.33 20.74 - 
37-40 n 2 1 3 
 
37-40 n 1 5 6 
 
37-40 n 1 5 6 
41-44 Mean 323.68 296.12 309.9 
 
41-44 Mean 371.47 371.47 - 
 
41-44 Mean 392 392 - 
41-44 SD 107.17 28.81 75.39 
 
41-44 SD 42.26 42.26 - 
 
41-44 SD - - - 
41-44 n 5 5 10 
 
41-44 n 3 3 - 
 
41-44 n 1 1 - 
45-52 Mean 344.51 366.87 358.74 
 
45-52 Mean 327 316 321.5 
 
45-52 Mean 387.85 366 380.57 
45-52 SD 59.1 73.98 68.36 
 
45-52 SD 4.24 50.06 29.69 
 
45-52 SD 25.67 22.1 - 
45-52 n 8 14 22 
 
45-52 n 2 2 4 
 
45-52 n 2 1 3 
  
1
2
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Table G-4. Brain Descriptive Statistics by Cause of Death Groups 
CONTROL 
 
Female Male Combined 
 
SIDS 
 
Female Male Combined 
 
SUDS 
 
Female Male Combined 
0-2 Mean 379.61 402.85 392.33 
 
0-2 Mean 381.25 401.27 391.26 
 
0-2 Mean 420.48 433.43 427.23 
0-2 SD 39.34 48.87 45.9 
 
0-2 SD 36.07 74.81 56.96 
 
0-2 SD 57.34 63.42 60.3 
0-2 n 24 29 53 
 
0-2 n 6 6 12 
 
0-2 n 23 25 48 
3-4 Mean 451.22 486.58 462.39 
 
3-4 Mean 477.3 499.8 490.8 
 
3-4 Mean 466.6 513.68 488.18 
3-4 SD 53.63 83.39 64.3 
 
3-4 SD 21.64 45.11 35.86 
 
3-4 SD 65.72 52.84 63.58 
3-4 n 13 6 19 
 
3-4 n 2 3 5 
 
3-4 n 13 11 24 
5-8 Mean 505.43 529.52 521.91 
 
5-8 Mean 525.5 567.81 558.41 
 
5-8 Mean 529.71 563.46 550.48 
5-8 SD 62.44 69.46 66.57 
 
5-8 SD 27.58 56.03 52.9 
 
5-8 SD 64.06 58.38 62.37 
5-8 n 6 13 19 
 
5-8 n 2 7 9 
 
5-8 n 25 40 65 
9-12 Mean 529.92 613.69 588.55 
 
9-12 Mean 619.36 599.07 607.94 
 
9-12 Mean 594.31 634.52 615.8 
9-12 SD 62.67 62.85 72.72 
 
9-12 SD 40.39 27.32 34.04 
 
9-12 SD 47.15 67.61 61.88 
9-12 n 6 14 20 
 
9-12 n 7 9 16 
 
9-12 n 27 31 58 
13-16 Mean 639.94 657.77 648.86 
 
13-16 Mean 680.17 699.24 694.84 
 
13-16 Mean 676.6 710.7 698.46 
13-16 SD 79.28 83.98 79 
 
13-16 SD 141.94 78.72 89.86 
 
13-16 SD 47.28 78.82 70.45 
13-16 n 7 7 14 
 
13-16 n 3 10 13 
 
13-16 n 14 25 39 
17-20 Mean 666.36 760.99 717.98 
 
17-20 Mean 707.5 715.7 714.33 
 
17-20 Mean 704.81 741.37 730.12 
17-20 SD 63.94 58.24 75.98 
 
17-20 SD 45.96 271.12 245.65 
 
17-20 SD 55.48 75.92 71.25 
17-20 n 5 6 11 
 
17-20 n 2 10 12 
 
17-20 n 8 18 26 
21-24 Mean 865.13 726.13 772.47 
 
21-24 Mean 836.25 835.42 835.62 
 
21-24 Mean 789.02 796.1 793.92 
21-24 SD 49.34 132.35 128.01 
 
21-24 SD 52.68 74.06 65.68 
 
21-24 SD 64.11 87.32 78.24 
21-24 n 3 6 9 
 
21-24 n 2 6 8 
 
21-24 n 4 9 13 
25-28 Mean 764.95 840.4 821.54 
 
25-28 Mean 682 785.43 772.5 
 
25-28 Mean 820.75 828.22 825.92 
25-28 SD 148.42 97.61 105.7 
 
25-28 SD - 66.1 71.29 
 
25-28 SD 60.74 64.96 61.22 
25-28 n 2 6 8 
 
25-28 n 1 7 8 
 
25-28 n 4 9 13 
29-32 Mean - 877.48 877.48 
 
29-32 Mean 887.07 - 887.07 
 
29-32 Mean 909.17 869.75 889.46 
29-32 SD - 84.51 84.51 
 
29-32 SD 32.62 - 32.62 
 
29-32 SD 56.52 43.97 51.4 
29-32 n - 4 4 
 
29-32 n 3 - 3 
 
29-32 n 4 4 8 
33-36 Mean - 981 981 
 
33-36 Mean - 1002 1002 
 
33-36 Mean - 1027.3 1027.3 
33-36 SD - 79.54 79.54 
 
33-36 SD - - - 
 
33-36 SD - - - 
33-36 n - 3 3 
 
33-36 n - 1 1 
 
33-36 n - 1 1 
37-40 Mean 877 1075 926.5 
 
37-40 Mean 1014 1005.5 1007.2 
 
37-40 Mean 822 927.4 906.32 
37-40 SD 133.15 - 147.04 
 
37-40 SD - 69.83 60.59 
 
37-40 SD - 63.22 72.24 
37-40 n 3 1 4 
 
37-40 n 1 4 5 
 
37-40 n 1 4 5 
41-44 Mean 963.4 955.67 960.09 
 
41-44 Mean 955.77 - 955.77 
 
41-44 Mean - 1063 1063 
41-44 SD 82.48 209.68 134.44 
 
41-44 SD 127.26 - 127.26 
 
41-44 SD - - - 
41-44 n 4 3 7 
 
41-44 n 3 - 3 
 
41-44 n - 1 1 
45-52 Mean 964.52 1055.13 1026.82 
 
45-52 Mean 943.33 1011 960.25 
 
45-52 Mean 997 1140 1044.67 
45-52 SD 106.68 71.05 91 
 
45-52 SD 53.26 - 55.1 
 
45-52 SD 36.77 - 86.56 
45-52 n 5 11 16 
 
45-52 n 3 1 4 
 
45-52 n 2 1 3 
  
1
2
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Table G-5. Spleen Descriptive Statistics by Cause of Death Groups 
 
 
Control 
 
Female Male Combined 
 
SIDS 
 
Female Male Combined 
 
SUDS 
 
Female Male Combined 
0-2 Mean 10.59 12.17 11.45 
 
0-2 Mean 9.87 11.67 10.84 
 
0-2 Mean 12 12.5 12.25 
0-2 SD 4.37 5.26 4.93 
 
0-2 SD 4.88 3.62 4.17 
 
0-2 SD 3.55 3.32 3.42 
0-2 n 85 102 187 
 
0-2 n 6 7 13 
 
0-2 n 27 27 54 
3-4 Mean 13.86 14.03 13.93 
 
3-4 Mean 13.33 13.54 13.46 
 
3-4 Mean 11.96 17.4 14.68 
3-4 SD 4.36 6.44 5.19 
 
3-4 SD 4.51 3.93 3.83 
 
3-4 SD 3.06 7.97 6.54 
3-4 n 16 11 27 
 
3-4 n 3 5 8 
 
3-4 n 14 14 28 
5-8 Mean 13.85 15.66 15.1 
 
5-8 Mean 13.47 12.86 13.05 
 
5-8 Mean 17.4 18.14 17.86 
5-8 SD 6 5.58 5.69 
 
5-8 SD 0.98 5.33 4.39 
 
5-8 SD 6.03 6.83 6.51 
5-8 n 12 27 39 
 
5-8 n 4 9 13 
 
5-8 n 26 43 69 
9-12 Mean 13.97 20.61 18.32 
 
9-12 Mean 19.89 22.13 21.25 
 
9-12 Mean 17.23 22.61 20.35 
9-12 SD 5.24 6.95 7.08 
 
9-12 SD 7 10.81 9.34 
 
9-12 SD 5.98 5.84 6.43 
9-12 n 10 19 29 
 
9-12 n 7 11 18 
 
9-12 n 26 36 62 
13-16 Mean 20.89 19.69 20.29 
 
13-16 Mean 17.77 26.96 24.99 
 
13-16 Mean 19.33 22.9 21.62 
13-16 SD 8.96 4.45 6.89 
 
13-16 SD 10.04 8.57 9.35 
 
13-16 SD 6.59 6.07 6.42 
13-16 n 9 9 18 
 
13-16 n 3 11 14 
 
13-16 n 14 25 39 
17-20 Mean 21.94 23.24 22.56 
 
17-20 Mean 18.53 26.93 24.99 
 
17-20 Mean 21.58 22.93 22.48 
17-20 SD 7.83 7.16 7.36 
 
17-20 SD 3.14 5.31 6.03 
 
17-20 SD 4.94 5.88 5.54 
17-20 n 11 10 21 
 
17-20 n 3 10 13 
 
17-20 n 11 22 33 
21-24 Mean 21.8 21.99 21.91 
 
21-24 Mean 26.3 28.82 28.19 
 
21-24 Mean 20.85 27.23 25.53 
21-24 SD 7.01 6.04 6.21 
 
21-24 SD 5.8 7.86 7.09 
 
21-24 SD 4.36 9 8.4 
21-24 n 6 8 14 
 
21-24 n 2 6 8 
 
21-24 n 4 11 15 
25-28 Mean 21.49 29.4 27.14 
 
25-28 Mean 23.61 29.46 28.73 
 
25-28 Mean 19.9 30.05 26.93 
25-28 SD 7.96 11.87 11.22 
 
25-28 SD - 8.19 7.86 
 
25-28 SD 4.68 11.15 10.59 
25-28 n 4 10 14 
 
25-28 n 1 7 8 
 
25-28 n 4 9 13 
29-32 Mean 21.34 23.4 22.78 
 
29-32 Mean 24.53 25.5 24.77 
 
29-32 Mean 31.4 28.9 30.57 
29-32 SD 5.64 12.04 10.23 
 
29-32 SD 8.22 - 6.73 
 
29-32 SD 3.79 1.56 3.28 
29-32 n 3 7 10 
 
29-32 n 3 1 4 
 
29-32 n 4 2 6 
33-36 Mean 31.53 36.48 34.36 
 
33-36 Mean - 37.4 37.4 
 
33-36 Mean - 12.7 12.7 
33-36 SD 13.51 9.67 10.71 
 
33-36 SD - - - 
 
33-36 SD - - - 
33-36 n 3 4 7 
 
33-36 n - 1 1 
 
33-36 n - 1 1 
37-40 Mean 23.17 - 23.17 
 
37-40 Mean 33 28.67 29.29 
 
37-40 Mean 46 26.76 29.97 
37-40 SD 6.17 - 6.17 
 
37-40 SD - 9.93 9.22 
 
37-40 SD - 7.39 10.27 
37-40 n 3 0 3 
 
37-40 n 1 6 7 
 
37-40 n 1 5 6 
41-44 Mean 26.42 29 27.71 
 
41-44 Mean 37.83 - 37.83 
 
41-44 Mean - 41.3 41.3 
41-44 SD 10.04 11.05 10.04 
 
41-44 SD 12.98 - 12.98 
 
41-44 SD - - - 
41-44 n 5 5 10 
 
41-44 n 3 - 3 
 
41-44 n - 1 1 
45-52 Mean 35.75 37.78 37.02 
 
45-52 Mean 31.5 35.35 33.42 
 
45-52 Mean 30.7 70 50.35 
45-52 SD 7.4 15.07 12.58 
 
45-52 SD 14.85 21.14 15.08 
 
45-52 SD - - 27.79 
45-52 n 9 15 24 
 
45-52 n 2 2 4 
 
45-52 n 1 1 2 
  
1
2
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Table G-6. Adrenal Descriptive Statistics by Cause of Death Groups 
CONTROL 
 
Female Male Combined 
 
SIDS 
 
Female Male Combined 
 
SUDS 
 
Female Male Combined 
0-2 Mean 8.45 8.14 8.28 
 
0-2 Mean 4.87 6.67 5.85 
 
0-2 Mean 5.49 4.61 5.05 
0-2 SD 3.74 3.88 3.81 
 
0-2 SD 2.56 2.42 2.53 
 
0-2 SD 2.1 2.4 2.27 
0-2 n 68 80 148 
 
0-2 n 5 6 11 
 
0-2 n 23 23 46 
3-4 Mean 4.33 5.51 4.87 
 
3-4 Mean 3.57 6.35 5.16 
 
3-4 Mean 4.43 4.92 4.68 
3-4 SD 0.73 1.8 1.43 
 
3-4 SD 0.86 2.1 2.16 
 
3-4 SD 1.8 1.56 1.67 
3-4 n 12 10 22 
 
3-4 n 3 4 7 
 
3-4 n 12 12 24 
5-8 Mean 4.02 5.16 4.83 
 
5-8 Mean 3.48 4.26 3.97 
 
5-8 Mean 4.61 4.45 4.51 
5-8 SD 1.34 1.92 1.83 
 
5-8 SD 0.46 1.15 1.01 
 
5-8 SD 2.63 1.54 2.01 
5-8 n 9 22 31 
 
5-8 n 4 7 11 
 
5-8 n 20 32 52 
9-12 Mean 4.78 4.69 4.72 
 
9-12 Mean 4.52 4.8 4.71 
 
9-12 Mean 3.12 4.15 3.74 
9-12 SD 1.99 2.12 2.04 
 
9-12 SD 0.91 1.09 1.01 
 
9-12 SD 0.77 1.61 1.42 
9-12 n 8 16 24 
 
9-12 n 5 10 15 
 
9-12 n 20 30 50 
13-16 Mean 4.66 4 4.36 
 
13-16 Mean 5.65 6.06 5.98 
 
13-16 Mean 3.64 4.44 4.13 
13-16 SD 0.84 0.93 0.91 
 
13-16 SD 2.62 3.52 3.23 
 
13-16 SD 0.95 1.24 1.19 
13-16 n 7 6 13 
 
13-16 n 2 8 10 
 
13-16 n 15 23 38 
17-20 Mean 4.81 4.33 4.56 
 
17-20 Mean 2.95 4.2 3.97 
 
17-20 Mean 3.24 4.4 4.08 
17-20 SD 1.57 1.61 1.57 
 
17-20 SD 1.34 0.74 0.93 
 
17-20 SD 0.82 1.68 1.57 
17-20 n 10 11 21 
 
17-20 n 2 9 11 
 
17-20 n 8 21 29 
21-24 Mean 3.69 5.02 4.24 
 
21-24 Mean 3.2 4.6 4.2 
 
21-24 Mean 2.4 4.27 3.96 
21-24 SD 1.56 1.43 1.6 
 
21-24 SD 0.99 0.93 1.1 
 
21-24 SD 0.14 0.95 1.13 
21-24 n 7 5 12 
 
21-24 n 2 5 7 
 
21-24 n 2 10 12 
25-28 Mean 3.6 5.31 4.88 
 
25-28 Mean 3.21 4.63 4.45 
 
25-28 Mean 4.2 4.63 4.58 
25-28 SD 1.31 1.43 1.55 
 
25-28 SD - 1.29 1.29 
 
25-28 SD - 1.95 1.84 
25-28 n 3 9 12 
 
25-28 n 1 7 8 
 
25-28 n 1 9 10 
29-32 Mean 2.87 4.44 4.26 
 
29-32 Mean 3.65 3.6 3.63 
 
29-32 Mean 3.5 5.27 4.38 
29-32 SD - 1.14 1.18 
 
29-32 SD 1.91 - 1.35 
 
29-32 SD 1.51 2.37 2.02 
29-32 n 1 8 9 
 
29-32 n 2 1 3 
 
29-32 n 3 3 6 
33-36 Mean 4.83 4.25 4.5 
 
33-36 Mean - 5.2 5.2 
 
33-36 Mean - 3 3 
33-36 SD 1.61 0.91 1.17 
 
33-36 SD - - - 
 
33-36 SD - - - 
33-36 n 3 4 7 
 
33-36 n - 1 1 
 
33-36 n - 1 1 
37-40 Mean 4.53 4.1 4.42 
 
37-40 Mean 6 3.9 4.25 
 
37-40 Mean - 2.88 2.88 
37-40 SD 0.42 - 0.4 
 
37-40 SD - 1.17 1.35 
 
37-40 SD - 0.49 0.49 
37-40 n 3 1 4 
 
37-40 n 1 5 6 
 
37-40 n - 4 4 
41-44 Mean 3.1 4.5 3.62 
 
41-44 Mean 4 - 4 
 
41-44 Mean - 3.7 3.7 
41-44 SD 1.11 1.15 1.27 
 
41-44 SD 0.14 - 0.14 
 
41-44 SD - - - 
41-44 n 5 3 8 
 
41-44 n 2 - 2 
 
41-44 n - 1 1 
45-52 Mean 4.05 4.49 4.32 
 
45-52 Mean 7.3 3.3 5.7 
 
45-52 Mean 2.3 8 5.15 
45-52 SD 0.52 1.56 1.28 
 
45-52 SD 5.8 0.85 4.67 
 
45-52 SD - - 4.03 
45-52 n 7 12 19 
 
45-52 n 3 2 5 
 
45-52 n 1 1 2 
  
1
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Table G- 7. Thymus Descriptive Statistics by Cause of Death Groups 
CONTROL 
 
Female Male Combined 
 
SIDS 
 
Female Male Combined 
 
SUDS 
 
Female Male Combined 
0-2 Mean 9.45 10.65 10.11 
 
0-2 Mean 12.87 12.14 12.48 
 
0-2 Mean 14.01 16.6 15.3 
0-2 SD 4.12 4.6 4.42 
 
0-2 SD 6.62 4.69 5.42 
 
0-2 SD 6.31 5.82 6.15 
0-2 N 72 88 160 
 
0-2 n 6 7 13 
 
0-2 n 25 25 50 
3-4 Mean 18.39 14.08 16.35 
 
3-4 Mean 24.6 25.73 25.24 
 
3-4 Mean 21.04 25.22 23.13 
3-4 SD 6.3 8.18 7.38 
 
3-4 SD 6.02 9.88 7.83 
 
3-4 SD 6.88 9.38 8.34 
3-4 N 10 9 19 
 
3-4 n 3 4 7 
 
3-4 n 13 13 26 
5-8 Mean 17.16 19.85 18.84 
 
5-8 Mean 26.45 25.74 25.96 
 
5-8 Mean 25.12 30.16 28.16 
5-8 SD 8.7 9.57 9.16 
 
5-8 SD 6.02 10.46 9.06 
 
5-8 SD 7.83 10.65 9.88 
5-8 N 9 15 24 
 
5-8 n 4 9 13 
 
5-8 n 25 38 63 
9-12 Mean 23.27 27.06 26.07 
 
9-12 Mean 33.05 28.43 30.16 
 
9-12 Mean 26.62 30.96 29.1 
9-12 SD 8.25 10 9.54 
 
9-12 SD 12.66 6.22 9.05 
 
9-12 SD 7.34 9.27 8.7 
9-12 N 6 17 23 
 
9-12 n 6 10 16 
 
9-12 n 24 32 56 
13-16 Mean 30.05 32.11 30.95 
 
13-16 Mean 26.63 42.73 39.51 
 
13-16 Mean 32.4 40.41 37.54 
13-16 SD 12.71 12.73 12.33 
 
13-16 SD 6.25 14.67 14.8 
 
13-16 SD 8.12 13.77 12.55 
13-16 N 9 7 16 
 
13-16 n 3 12 15 
 
13-16 n 14 25 39 
17-20 Mean 28.5 26.44 27.19 
 
17-20 Mean 28.5 38.04 36.57 
 
17-20 Mean 34.16 37.7 36.48 
17-20 SD 16.35 11.31 12.57 
 
17-20 SD 17.68 9.86 10.95 
 
17-20 SD 8.43 13.93 12.29 
17-20 N 4 7 11 
 
17-20 n 2 11 13 
 
17-20 n 11 21 32 
21-24 Mean 24.1 25.57 24.79 
 
21-24 Mean 48.7 49.43 49.33 
 
21-24 Mean 29.66 41.17 37.57 
21-24 SD 12.13 9.06 10.46 
 
21-24 SD - 13.46 12.29 
 
21-24 SD 9.6 13.8 13.49 
21-24 N 8 7 15 
 
21-24 n 1 6 7 
 
21-24 n 5 11 16 
25-28 Mean 29.28 29.96 29.82 
 
25-28 Mean 28.7 28.4 28.43 
 
25-28 Mean 29.62 32.87 31.94 
25-28 SD 3.71 20.19 17.85 
 
25-28 SD - 10.41 9.74 
 
25-28 SD 11.38 11.13 10.86 
25-28 N 2 8 10 
 
25-28 n 1 8 9 
 
25-28 n 4 10 14 
29-32 Mean 27.7 32.18 30.69 
 
29-32 Mean 40.77 43.7 41.5 
 
29-32 Mean 37.05 41.52 39.29 
29-32 SD 16.81 21.99 19.44 
 
29-32 SD 8.08 - 6.76 
 
29-32 SD 12.2 16.31 13.55 
29-32 N 3 6 9 
 
29-32 n 3 1 4 
 
29-32 n 4 4 8 
33-36 Mean 40.4 42.43 41.92 
 
33-36 Mean - 30 30 
 
33-36 Mean - 39.1 39.1 
33-36 SD - 15.22 12.47 
 
33-36 SD - - - 
 
33-36 SD - - - 
33-36 n 1 3 4 
 
33-36 n - 1 1 
 
33-36 n - 1 1 
37-40 Mean 21.73 20.7 21.48 
 
37-40 Mean 25 31.23 30.34 
 
37-40 Mean 36 29.02 30.18 
37-40 SD 5.49 - 4.51 
 
37-40 SD - 10.32 9.71 
 
37-40 SD - 12.05 11.15 
37-40 n 3 1 4 
 
37-40 n 1 6 7 
 
37-40 n 1 5 6 
41-44 Mean 28.17 18.32 22.54 
 
41-44 Mean 29.65 - 29.65 
 
41-44 Mean 49.7 49.7 49.7 
41-44 SD 5.48 11.61 10.25 
 
41-44 SD 3.18 - 3.18 
 
41-44 SD - - - 
41-44 n 3 4 7 
 
41-44 n 2 - 2 
 
41-44 n - 1 1 
45-52 Mean 33.27 30.99 31.83 
 
45-52 Mean 32 25.7 27.8 
 
45-52 Mean 34.5 20.5 29.83 
45-52 SD 11.8 12.63 12.05 
 
45-52 SD - 3.82 4.53 
 
45-52 SD 4.95 - 8.81 
45-52 n 7 12 19 
 
45-52 n 1 2 3 
 
45-52 n 2 1 3 
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